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natural and experimental maedi-visna infection.
So. ofwords in the main text ofThesis.
The pulmonary immunopathology of maedi-visna virus (MVV) infection was
investigated, firstly performing in vivo, and in vitro studies and secondly, by reproducing the
disease experimentally.
Peripheral blood (PB) and bronchoalveolar lavage fluid (BALF) cells of naturally MVV-
infected and control sheep were phenotypically characterised by using single-colour flow
cytometry. BALF from MW-infected sheep had significandy increased percentages of
lymphocytes, neutrophils and CD8+ lymphocytes, decreased percentages of CD4+ and CD5*
lymphocytes (p< 0.05), significant (p< 0.001) inversion of the CD4+/CDS* ratio, increased MHC
Class II expression on BALF macrophages and upregulated expression of LFA-1 and LFA-3 on
BALF lymphocytes (p< 0.05). These data show the phenotypic changes in the cellular
components of BALF during the course of natural MYY infection, and suggest a state of
activation of BALF lymphocytes, and a pulmonary compartmentalisation of the cellular immune
response during the course of the disease.
The stage of activation of BALF and PB lymphocytes in MW-infected and control sheep
was investigated by using dual-colour flow cytometry and several parameters of lymphocyte
activation. Upregulation of DR and DQ MHC Class II molecules was present in BALF ofMW-
infected animals, with no changes in cell size and complexity or increased expression of IL-2R,
suggesting an impaired process of lymphocyte activation in BALF lymphocytes of these animals.
There was no evidence of lymphocyte activation in PB.
To investigate if the impaired lymphocyte activation observed during the course of the
natural disease was maintained under in vitro conditions, the response of BALF and PB
lymphocytes to in vitro activation by exogenous mitogen was studied. BALF and PB
lymphocytes from control and MW-infected animals were cultured for three days after Con A
stimulation, and EL-2R surface expression was quantified by dual-colour flow cytometry.
Cultured BALF T lymphocytes from MW-infected animals, after in vitro mitogen stimulation,
expressed lower IL-2R than those of controls. These results suggest a dysfunction on cell-
mediated immunity during maedi.
A model of experimental MW infection was developed to study progressive early
phenotypic changes in BALF T cells and to quantify TGF-p levels present in pulmonary
epithelial lining fluid (PELF). Animals were inoculated by the respiratory route. Six animals
received 107-2 TCID50 of MW EV1 strain, two sheep were challenged with heat inactivated
MVV EV1 strain and four sheep were sham-inoculated with virus-free buffer solution.
Experimental infection was followed for 16 weeks post-inoculation (PI). Dual and single colour
flow cytometry analyses and differential cell counts were performed on BALF cells. Precipitating
antibodies to MW developed in the MW-inoculated animals between 2 and 4 weeks PI.
Changes in the cellular composition of BALF were observed in all three groups of animals.
Phenotypic changes in BALF T lymphocytes from MW-inoculated animals were characterised
by significantly (p< 0.05) decreased percentages of CD4+, CD5* and y5 T lymphocytes, a
significantly (p< 0.05) increased percentage of CD8* lymphocytes and a significant (p< 0.05)
inversion of the CD4+/CD8+ ratio. Upregulated expression of MHC Class II and EL-2R
molecules was observed on BALF T lymphocytes from all three groups of animals. No
significant differences in the concentrations of plasma or PELF TGF-P were observed among the
timee groups of animals.
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ABBREVIATIONS
AGEDT Agar gel immunodiffusion test
AIDS Acquired immunodeficiency syndrome
BAL Bronchoalveolar lavage
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G-CSF Granulocyte-colony stimulating factor
GM-CSF Granulocyte macrophage-colony
stimulating factor
HIC Heat inactivated maedi-visna virus
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HIV-1 Human immunodeficiency virus type 1
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IGF Insulinlike growth factor
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LV-IFN Lentivirus-induced interferon like
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NK Natural killer cells
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NRS Normal rat serum
OLA Ovine leukocyte antigens
OPP Ovine progressive pneumonia
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PBL Peripheral blood lymphocytes
PBMC Peripheral blood mononuclear cells
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GENERAL INTRODUCTION
Different aspects of the pulmonary immunopathology of maedi-visna virus
(MVV) infection are presented by chapters. Each chapter begins with an oudine of its
aim and ends with an evaluation of the results.
Chapter 1 of this thesis is a literature review. Firstly, a review on MVV
infection is presented: its history, causative agent, pathogenesis, clinical signs, lesions,
epidemiology and control. Secondly, the pulmonary immune responses ocurring
during lentiviral infection are described using HIV as a model. A review of
bronchoalveolar lavage (BAL) and flow cytometry techniques and a characterisation
of sheep leukocyte molecules are also included in this chapter.
Chapter 2 is a description of the 'Materials and Methods' employed in the
different chapters for the present work.
Chapter 3 studies the natural disease in vivo, concentrating on the cellular
phenotypic changes that occur in bronchoalveolar lavage fluid (BALF) and peripheral
blood (PB) during the course of MVV-infection.
Chapter 4 describes in vivo studies on the natural disease, investigating the
stage of activation of BALF and PB lymphocytes in MVV-infected sheep.
Chapter 5 is an in vitro study of the response of BALF and PB lymphocytes to
exogenous mitogen activation.
Chapter 6 studies experimental MVV infection, focussing attention on early
phenotypic changes in BALF T cell subsets, and in the levels of the cytokine TGF-(3
in pulmonary epithelial lining fluid (PELF).
Finally, Chapter 7 discusses the main conclusions from the previous chapters




1.1. MAEDI-VISNA: A REVIEW
Maedi visna virus (MVV) is a member of the Retroviridae family.
Representatives of this family are likely to infect many different animal species,
causing a range of pathological processes (Varmus, 1988). All known retroviruses are
classified according to their genomic structure into three main subfamilies: (1)
Spumaviridae, which infect cats, nonhuman primates, and probably man without
causing any apparent disease; (2) Oncovirinae, animal and human tumour viruses; (3)
Lentivirinae, a group of nontransforming, cytopathic viruses that are known to be
associated with states of immunodeficiency and neurologic disorders in several animal
species.
With the discovery of a lentivirus as the causal agent of the human acquired
immune deficiency syndrome (AIDS) there has been a resurgence of interest in the
biology of these viruses and the pathogenesis of all the other animal diseases they
cause namely maedi-visna (MV) of sheep, caprine-arthritis-encephalitis (CAE)
(Crawford et al, 1980), equine infectious anaemia (EIA) (Dreguss and Lombard,
1954), feline immunodeficiency syndrome (Pedersen et al, 1987) and bovine
immunodeficiency syndrome (Van der Maaten et al, 1972; Gonda et al, 1987).
Maedi-visna virus (MVV) is considered as the prototype of the animal
lentiviruses, having recently acquired a great relevance from the comparative
biological point of view. It is significant as a model of human retroviral diseases,
sharing morphologic similarities and genome sequence homology with the
aetiological agent of AIDS, (Sonigo et al, 1985). In addition, MVV causes a
multisystemic disease of sheep which includes a diffuse interstitial pneumonia
promising, hence, to be a useful prototype for the understanding of the human
20
interstitial lung diseases as well as for the study of the interaction between lentiviruses
and their target cells, particularly macrophages.
1.1.1 APPROACH TO LENTIVIRUSES
Lentiviruses of the subfamily Lentivirinae are exogenous enveloped RNA
viruses with a 60 to 70S single-stranded RNA genome and a RNA-dependent DNA
polymerase (Haase and Varmus, 1973). With a complex biology and pathogenesis,
they are unique and insidious pathogens, causing a chronic degenerative disease with
involvement of different organ systems, variable prepatent period and clinical
presentation and unpredictable recrudescence of the acute signs (Haase, 1986a).
They are particularly resistant against the host defence mechanisms (due to
their ability to integrate their proviral DNA into host cell DNA, in particular the DNA
of cells of the monocyte/macrophage lineage) and against the humoral immune
defences (by undergoing antigenic variation). The 'Achilles heel' of these agents is
their absolute dependence on body fluids for host-to-host transmission.
Replication of these viruses deserves a special mention as they are able to
replicate even in the presence of virus specific immune responses. However, their
replication in vivo is maintained at a restricted level throughout the infection, due to
the virus-host interaction. Two main differences have been found between lentivirus
and classical retrovirus replication (Narayan and Clements, 1990a);
1. Lentiviruses replicate efficiently in non-dividing end-stage cells, both in the
host animal and in cell cultures, while other retroviruses require dividing cells for
replication (Weiss etal, 1982).
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2. Lentiviruses replicate their proviral DNA almost exclusively in the nucleus
(Haase et al, 1982), while the synthesis of proviral DNA in oncogenic retroviruses
takes place in the cytoplasm of the infected cell (Weiss et al, 1982).
Two types of clinical disease related to viral replication have been described
(Narayan and Clements, 1989);
a) A primary disease caused directly by the Lentivirus and associated with the
activation of virus replication in selective populations of macrophages. Primary
lesions in this case would be due to the altered production of cytokines that are
produced partly by the macrophages and partly by the lymphocytes as a response to
antigen presentation by the immunologically activated, infected macrophages.
b) A secondary disease caused by opportunistic agents which proliferate as a
result of the loss of function of activated helper T lymphocytes, which leads to a
severe immunosuppression.
1.1.2 AN INTRODUCTION TO THE DISEASE
'Maedi' and 'visna', (Icelandic names, 'maedi' meaning dyspnoea and 'visna'
meaning wasting) are considered as two histopathological and clinical forms of
disease caused by MVV (Palsson, 1976; Dawson et al, 1979) which involve the lungs
and the brain, respectively.
Morphological, biochemical and immunological studies of the causal agents of
maedi and visna have proved that both nosological entities are caused by the same
virus (Thormar, 1965, Thormar and Helgadottir, 1965; Mehta and Thormar, 1975;
Weiss et al, 1976; Stowring et al, 1979) and hence, the term MVV is now widely
accepted to designate this virus (De Boer, 1975; Nathanson et al, 1976; Dawson,
1980; Martin and Stamp, 1980).
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Progressive pneumonias of sheep resembling the Icelandic maedi/visna
complex have been described under various names in different countries (Palsson,
1976), namely Montana progressive pneumonia or ovine progressive pneumonia
(OPP) in the United States (Marsh, 1923), Graaf Reinet in South Africa (Mitchell,
1915; De Kock, 1929), La Bohuite in France (Lucam, 1942) and Zwoegerziekte in the
Netherlands (Koens 1943; Ressang et al, 1968; De Boer, 1970). Histopathologically
all these diseases are indistinguishable from maedi, and in the case of OPP and
Zwoegerziekte they are virologically indiscernible. Although minor differences have
been described in nucleic acid sequence and cross reaction of the internal protein of
MVV and OPP viruses (Ressang et al, 1968; De Boer, 1970; Stone et al, 1971;
Takemoto et al, 1971; Palsson, 1976; Weiss et al, 1976; Cutlip et al, 1979) they are
closely similar in their physicochemical, morphological and immunological properties
(De Boer, 1975; Cutlip et al, 1988).
1.1.3 HISTORICAL BACKGROUND
Loman (1862) first mentioned an ovine chronic respiratory disease in Dutch
sheep from the island of Texel. In 1915 Mitchell described in South Africa a chronic
ovine progressive pneumonia with similar characteristics to maedi. De Kock in 1929,
reported as well in South Africa in the 'Graaf-Reinet' Experimental Station a disease
very similar to the earlier one.
Marsh (1923) described in the United States another chronic progressive
pneumonia, Montana disease', similar to that mentioned by De Kock, that he had
observed in Moniana and other north-western states since 1915. Some similarities
between this pneumonia and the one described by Mitchell in 1915 were established
later (Cowdry and Marsh, 1927).
23
Sigurdsson, Grimsson and Palsson first detected this nosologic entity in 1939
in Icelandic flocks and subsequently contributed much to the knowledge of MVV. The
disease was introduced to Iceland by the importation of 20 Karakul rams from Halle,
Germany in the summer of 1933 in an attempt to improve the productivity of Icelandic
sheep and to promote production of Astrakhan coat (Gislasson, 1947; 1966).
Following a quarantine period of eight weeks, the imported sheep were distributed to
14 farms throughout the island (Perk, 1982). Epidemiological studies showed that two
of the imported rams were earners of MVV and one of them was also a carrier of
sheep pulmonary adenomatosis (SPA). This latter animal died during the summer of
1934 showing symptoms of respiratory disease. The following winter SPA appeared
on the farm where this ram had been kept, and on neighbouring farms and
subsequently spread to many other farms causing heavy economic losses (Gislasson,
1947). Maedi and SPA were commonly observed in the same flock and even in the
same animal. Paradoxically, in the original flock of Karakul sheep no losses due to a
disease resembling-maedi were detected (Palsson, 1976).
In 1937 an eradication program against SPA established by the Icelandic
government managed to significantly reduce the incidence of this disease by slaughter
in only two years. Only when the incidence of SPA diminished were two new
conditions namely maedi and visna detected although, unfortunately, they had already
extended to many flocks due to their insidious onset and to the concurrent infection
with SPA. In 1941 the Icelandic government concentrated its eradication program on
maedi and visna, managing to virtually eradicate visna in 1951 and maedi in 1954,
although some sporadic outbreaks occurred until 1965 necessitating regular checking
and control of the flocks until the middle seventies. Today Iceland is considered as a
MVV-free country although this eradication policy proved expensive (Palsson, 1976;
1985; 1990).
MVV infection also occurs in Algeria (Achour et al, 1984), Belgium (Biront et
al, 1981), Bulgaria (Pavloff, 1963), Canada (Bellavence et al, 1974), China (Deng et
al, 1989), Denmark (Hoff-Jorgensen, 1971), France (Cottereau et al, 1977), Greece
(Papadopoulos et al, 1971; Seimenis et al, 1985), Hungary (Suveges and Szeky,
1973), India (Rajya and Singh, 1964), Ireland (Guven, 1985), Israel (Nobel et al,
1973), Italy (Foglini et al, 1985), Kenya (Wandera, 1970), Mexico (Molina et al,
1986), Morocco (Mahin et al, 1984), Norway (Krogsrud and Udnes, 1978), Peru
(Snyder et al, 1983), Sweden (Hugoson, 1978), Switzerland (Tontis, 1981), United
Kingdom (Dawson et al, 1979) and USSR (Mitofanov and Yartsev, 1973).
1.1.4 THE VIRUS
MVV is a non oncogenic exogenous retrovirus belonging to the subfamily
Lentivirinae ('lenti' is latin for 'slow') (Fenner, 1976), which exhibits a great tropism
for the lymphoreticular and nervous system, where it replicates persistently but at a
remarkably slow rate (Gudnadottir, 1974).
Despite the fact that MVV is morphologically similar to C-Type
Oncornaviruses, antigenic and genetic criteria show them to be different (Haase,
1975). There is no evidence of oncogenic action of this lentivirus in the natural host
(Petursson et al, 1979) although some tumoral transformations in murine cells have
been described (Takemoto and Stone, 1971). As these transformations were not
always observed (Brown and Thormar, 1975), it seems quite likely that those changes
detected in the murine cells were due to spontaneous transformations of the infected
cells or to the interaction of MVV with an endogenous oncovirus from the mouse
(Teich, 1982).
1.1.4.1 Structure of MVV
The virus contains an enveloped, spherical, single stranded 60-70S RNA
genome (Lin and Thormar, 1970a; Harter, 1976), characterised, as are all retroviruses,
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by the presence of a RNA-dependent DNA polymerase (reverse transcriptase) which
allows the virus to copy a DNA strand directly from the RNA genome in the virus
particle (Bishop, 1978; Varmus, 1982; Stevenson and Bouffard, 1984). The viral
nucleoid is closely juxtaposed to the outer membrane. The mature virion is
approximately 80-120 nm in diameter. It contains a dense nucleoid (about 40 nm in
diameter) and small spikes (about 8 nm long) project from the viral envelope. The
virion matures by budding from the cytoplasmic membrane of the infected cells
(Thormar, 1961; Filippi et al, 1982). Extracellular mature virions have a distinct
intermediate layer and condensed electron-dense centrally located core with a
characteristic shape, often forming a bar-shaped nucleoid (Coward et al, 1970;
Dubois-Dalq et al, 1976).
1.1.4.2 Biochemical and biophysical properties
The virus contains approximately 60% proteins, 35% lipids, 3% carbohydrates
and 2% RNA (Haase, 1975). Infective MVV particles sediment at a density of
approximately 600S, similar to that of other retroviruses (Lin and Thormar, 1970a;
Haase and Baringer, 1974). The virus can be maintained at -5CPC and may withstand
repeated freezing and thawing without appreciable loss of infectivity (Thormar, 1965;
Sharma, 1982). MVV is inactivated by heat at 56°C for 10 min, diethyl alcohol for 20
h and by 0.04% formaldehyde, ethyl ether, chloroform, phenol, metaperiodate,
oxidised spermine and trypsin (Thormar, 1965; Kennedy et al, 1968; Takemoto et al,
1971; Harter, 1976). The virus is stable in media with a pH between 5.1 and 10.
1.1.4.3 Substructure ofMVV
a) Nucleic acid
A 60-70S single stranded RNA with a complex secondary structure and a
molecular weight of 10-12 x 106 Da (Lin and Thormar, 1970a; Stone et al, 1971;
Haase and Baringer, 1974; Brahic and Haase, 1981) constitutes 90-95% of the viral
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genome, the rest being double-stranded DNA (Harter, 1976; Thormar, 1976). Two
precursor units of 30-40S combine to form this nucleic acid (Brahic and Vigne, 1975),
a process that takes place within the virion.
Heat denaturation divides the 70S RNA into two initial subunits of 35S.
Apparently these subunits, whose molecular weight is 3.6 x 106 (Guillespie et al,
1973), have the same genetic information and hence the genome is often diploid and it
could even be polyploid (Vigne et al, 1978). These subunits constitute the basic units
for the performance of the reverse transcriptase in the viral replication (Haase and
Baringer, 1974; Harter, 1976).
Three main regions containing the genes env, gag and pol have been
differentiated in the viral genome, these genes coding respectively for the
glycoproteins, the viral core proteins and the reverse transcriptase (Vigne et al, 1985).
The genes are organised in the genome (5'-3s) gag-pol-env according to a genetic
structure similar to other retroviruses. Recent studies have shown a 9,202 nucleotide
sequence (Sonigo et al, 1985), with a global composition as follows (Vigne et al,
1977); 21.4% uracil, 15.4% cytosine, 26.1% guanine and 37.1% adenine.
MVV genome presents seven 'open reading frames' (ORF), potential regions
coding for proteins (Davis and Clements, 1989; Sargan and Bennet, 1989). These
ORF are designated regions 'Q' and 'S' and their protein products could play a role in
the regulation of the molecular events implied in the replication of the virus (Sonigo et
al, 1985).
b) Viralprotein
The exact number of proteins comprising the mature virion is not yet clear
although between 10-25 of them have been identified (Haase and Baringer, 1974; Lin
and Thormar, 1974). Only four of them: p25, pl6, pl4 and gpl35 account for 90% of
the total viral protein content, excluding the reverse transcriptase (Brahic and Haase,
1981). The main constituent of the spikes seems to be gp 135, a surface glycoprotein.
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Antibodies against this glycoprotein have a neutralising activity and are type-specific
(Narayan et al, 1981; Scott et al, 1984). The three major structural proteins p25 (p30),
pl6 and pl4 have been called 'gag proteins' as they are encoded by this gene (Haase
and Baringer, 1974; Lin and Thormar, 1979; Brahic and Haase, 1981; Perk, 1982;
Vigne et al, 1985). p25 is the main viral core constituent representing about 40% of
the total virion protein; pl6 is related to the N-terminal extreme from the gag
precursor and pl4 seems to be a nucleic acid related protein (Sonigo et al, 1985).
c) Reverse transcriptase (DNA-polymerase-RNA dependent)
Reverse transcriptase is present in all retrovirus nuclei and is encoded through
the gene 'pol' (Lin and Thormar, 1970b; Stone et al, 1971; Vigne et al, 1985). Two
different forms of this enzyme have been described, with sedimentation coefficients of
6.9S and 6.3S and MW of 135,000 Da and 118,000 Da respectively (Sonigo et al,
1985).
1.1.4.4 MVV in cell cultures
MVV has been isolated by cultivation in cell cultures derived from ovine
choroid plexus, lung and kidney (Gudnadottir and Palsson, 1967; Kennedy et al,
1968), testes (Takemoto et al, 1971), adrenals (Straub, 1970), ovine foetal lung,
cornea and kidney (Thormar, 1976; Sharma, 1982), macrophages (Narayan et al,
1982) and cells derived from the synovial membranes from newborn kids (Narayan et
al, 1980). Bovine, porcine and human cells can provide an optimum culture medium
for MVV (Harter et al, 1968; Maclntyre et al, 1972), while cells from other species
have failed to support viral production (Thormar and Sigurdadottir, 1962), except for
Himalayan tahr ovary cells (Perk, 1988).
Viral attachment to cells in culture takes place after two hours of incubation at
37°C. Depending on the amount of initial inoculate the eclipse phase will oscillate
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between 20-24 h (Petursson, 1990). During the next 15 h there will be an exponential
increase, reaching a maximum titre 50 h post-infection (Harter and Choppin, 1967).
Infection of cell cultures with MVV is usually followed by a localised
cytopathic effect within 24-36 h (Thormar, 1963; Sigurdadottir and Thormar, 1964;
Harter and Choppin, 1967; Brahic and Haase, 1981; Caporale et al, 1985) consisting
of cell fusion into giant syncytia, containing clusters of nuclei, formation of refractive
mononucleated and giant stellar cells and, as the infection progresses, cytolysis. Due
to all these changes there is a destruction of the cell culture in one or two weeks, with
high titres of the virus in the culture supernatant (Thormar, 1963). The prototype
Icelandic MV and OPP viruses are also cytolytic in vitro (Sigurdsson et al, 1960;
Cutlip and Laird, 1976; Narayan et al 1977).
Ovine and caprine lentiviruses may also establish a prolonged productive
infection in macrophages with minimal cytopathic effect (Klevjer-Anderson and
McGuire, 1982; Narayan et al, 1982; Gendelman et al, 1984; Anderson et al, 1985)
and furthermore, lentivirus-host cell interactions without apparent cytopathic effect
have been described (Narayan et al, 1982).
1.1.4.5 In vivo cell tropism of MVV
The main targets of MVV infection in vivo are those cells from the monocyte-
macrophage lineage (Narayan et al, 1982; Gendelman et al, 1985; Peluso et al, 1985).
A selectivity in the macrophage populations which are infected by MVV is observed,
with no reports of infection of liver Kupffer cells or histiocytes.
In vivo infection of peripheral blood dendritic cells has also been recently
suggested (Gonell et al, 1992). There is no substantiated evidence of MVV infection
of lymphocytes (Carey andDalziel, 1993).
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1.1.4.6 Viral replication
The virus penetrates within the cell cytoplasm by fusing its envelope with the
cell membrane (Harter, 1969; Brahic and Haase, 1981). Each virion contains two
copies of viral RNA and both copies will be used by the 'reverse transcriptase' (Pyper
et al, 1990). The transcription of the viral RNA to double stranded DNA starts within
the cell cytoplasm and finishes within the nucleus (Haase and Varmus, 1973;
Thormar, 1976; Brahic et al, 1977; Brahic and Haase, 1981). This DNA synthesis
carries on during all the replication cycle giving rise to several copies per cell (Haase,
1986a), copies that will ensure the conservation of the viral genetic information for the
production of the viral RNA and the viral progeny (Haase et al, 1982). A small
fraction of this DNA is integrated within the cell genome (Clements et al, 1979),
while a greater number of copies stay in the cell nucleus as 'free' DNA (Haase and
Varmus, 1973; Haase et al, 1982). The synthesis of the viral RNA begins within the
nucleus of the infected cell 5-7 h after infection and takes place in an exponential way
until several thousands RNA copies per cell have been produced (Brahic et al, 1977).
The exact mechanisms for the attachment of the different viral components are still
unknown, but some complexes composed of RNA and several other polypeptides, that
have been demonstrated to be infectious for ovine cells, have been detected (Filippi et
al, 1982). These complexes would presumably give rise to viral particles by acquiring
some material from the cytoplasmic cell membrane during the 'budding process'
(Filippi etal, 1982).
1.1.4.7 Host range
Sheep and goats are the only species known to be susceptible to this disease
(Banks et al, 1983). The disease in goats has been mainly reported in India (Rajya and
Singh, 1964) although serological evidence of MVV infection in goats has also been
recorded in Germany (Weinhold and Triemer, 1978) and in Norway (Krogsgrud and
Udnes, 1978).
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Several attempts to experimentally infect a number of laboratory and other
domestic animals have failed (Palsson, 1976) and, although MVV can replicate in
cultures of bovine or human cells, no evidence of in vivo infection in these species has
been shown (Thormar, 1976).
1.1.5 PATHOGENESIS
MVV presents a complex biology and disease pathogenesis, as do all the
viruses belonging to the Lentivirus subfamily. MV is a multi-systemic disease;
following infection of the target cells there is a leukocyte-associated viremia
(Gudnadottir, 1974; Nathanson et al, 1976) and the virus spreads to different organs
including lungs, bronchial and mediastinal lymph nodes, spleen, kidneys, joints,
salivary glands, mammary gland and choroid plexus (Gudnadottir and Palsson, 1967).
The virus is also found in the milk of infected ewes (De Boer, 1970; Sihvonen, 1980).
MVV infection provokes both an humoral and a cellular immune response, in spite of
which the virus persists. The role of humoral and cellular immune responses in the
development of MVV lesions is not known (Gudnadottir, 1974), but it has been
reported that infection is not necessarily followed by the development of lesions
(Sharma, 1982), and the typical MVV lesions characterised by mononuclear cell
infiltration and lymphocytic hyperplasia may be immunologically mediated, as
immunosuppression inhibits development of lesions in experimental visna (Nathanson
et al, 1976; Panitch et al, 1976) while hyperimmunisation enhances the severity of the
lesions (Nathanson et al, 1981).
As a compensation for their narrow host range and inefficient mechanism of
transmission (depending almost exclusively on exchange of body fluids) the
lentiviruses have elaborated complicated strategies for their constant replication in the
immune competent host, the most remarkable being the integration of their genome
into the host cell, which permits a latent infection without any expression of the viral
genome even for years (Narayan and Clements, 1990a). Replication of lentiviruses in
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vivo is maintained at a restricted level throughout the infection due to the virus-host
interaction (Narayan and Clements, 1990a), and host susceptibility and virulence of
the viral strain seem to play an important role in the severity of lesion development
(Cheevers and McGuire, 1988).
Pathogenic mechanism of the lesions are not completely understood (Haase,
1986b). Viral persistence, the survival of the virus or latently infected cells even in the
presence of antiviral immune responses, is fundamental to the pathogenesis of all
lentiviral diseases, and in the case of MVV infection, accounts for the chronicity,
progressive course and recrudescence of the disease (Cheevers and McGuire, 1988).
Two basic mechanisms have been suggested to explain this feature;
1) Antigenic drift or antigenic variation of neutralisation epitopes of virion
surface glycoproteins. Under the pressure of circulating antibodies some mutant
strains can develop (Gudnadottir, 1974; Nathanson et al, 1976), which will not be
neutralised by early sera (Narayan et al, 1987).
2) Host restriction of viral gene expression. This hypothesis states that the
synthesis of viral antigen is restricted by suppression of viral gene expression and
hence, virus infected cells are not eliminated by humoral or cell-mediated immune
responses. Two mechanisms at least could contribute to this regulation, namely
restricted expression of viral antigen by circulating monocytes and the generation of a
soluble interferon-like factor (LV-EFN) by T cells during their interaction with MVV-
infected macrophages (Narayan et al, 1985);
Restricted expression of the virus by circulating monocytes also plays a major
role in the pathogenesis ofMVV infection. Viral nucleic acid resides in a quiescent or
proviral form in circulating monocytes (Narayan et al, 1982; Geballe et al, 1985;
Gendelman et al, 1986). During monocyte maturation the virus is activated, leading to
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a permissive infection (Narayan et al, 1982; Gendelman et al, 1986). Restricted viral
antigen expression in the monocyte-macrophage series permits covert circulation of
the virus throughout the body without inducing an immune response, a phenomenon
that has been referred to as 'Trojan Horse' (Peluso et al, 1985), thus ensuring
persistence and dissemination of the virus.
A final pathogenic mechanism is mediated by LV-IFN released from T
lymphocytes during interaction with MVV-infected macrophages (Narayan et al,
1985). This LV-IFN not only delays maturation of monocytes to macrophages causing
a reduction in virus production, but also induces the expression of MHC Class II
antigens on the surface of local macrophages, so setting the stage for abnormal
proliferation of lymphoid cells (Cheevers and McGuire, 1988), inducing production of
PGE2 by the macrophages (Narayan, 1988) and preventing virus-induced fusion (Zink
et al, 1990).
1.1.6 MAEDI OR RESPIRATORY FORM
Maedi has been defined as a highly infectious, invariably fatal, insidious but
continuously progressive interstitial pneumonia with a variable long incubation period
(Sharma, 1982).
1.1.6.1 Clinical signs
Progressive emaciation despite a normal appetite, listlessness, physical
weakness and exertional dyspnoea (with an increase in the respiratory rate up to 80-
120/min) (Sigurdsson, 1954; Palsson, 1985; Brahic and Haase, 1981) are usually the
earliest signs of the disease (Cutlip et al, 1988).
The main symptom in maedi is laboured breathing or 'dyspnoea' (Sigurdsson et
al, 1952; Gonzalez, 1989) being barely perceptible at the beginning (only observed
during exercise or physical stress), but as the disease progresses the dyspnoea
increases and is present even at rest (De Boer et al, 1978; Dawson, 1980). At this
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stage the animal displays dilated nostrils, flank breathing or 'pumping' (controlled by
the accessory respiratory muscles), rhythmic jerk of the head (usually held high) and
occasional mouth breathing. In the final stage of the disease, animals tend to lay on the
floor first on sternal recumbency and finally in lateral recumbency until death occurs.
Dry coughing and nasal discharge, although not constant features, could appear at any
time during the course of the disease (Dawson, 1980).
Auscultation of the thorax, though seldom characteristic, can aid diagnosis,
with vesicular breathing, crepitations and dry and moist rales being reported (Ressang
et al, 1968).
A tendency to lag behind the flock and decreased milk production are also
suggestive of maedi. Advanced cases may occasionally abort or produce small weak
lambs (Dawson, 1980). Uncomplicated cases of maedi show a normal pulse rate and
body temperature (Sigurdsson et al, 1952; Dawson, 1980; Palsson, 1985). Deaths
(when no other complications supervene) occur in several months due to anoxia,
although usually a secondary bacterial infection shortens the course of the disease in
field conditions (Palsson, 1985). Though some animals may appear to recover
temporarily, this entity is invariably fatal (Ressang etal, 1968; Dawson, 1980).
Stress factors such as pregnancy, bad weather, worm infestation, lactation,
excessive physical exercise or shearing can precipitate the clinical phase of the disease
(Sigurdsson, 1954; Palsson, 1976; Palsson, 1985; Cutlip et al, 1988) which,
conversely, might be prolonged with good nursing (Dawson, 1980; Jones et al, 1982).
However, according to Houwers and Van der Molen (1987), stress does not play such
an important role in the onset of the disease. Slaughter of the diseased animals while
still remaining in a moderately a good physical condition is a common practice.
1.1.6.2 Haematological findings
Sheep may show hypochromic anaemia, a significant increase in erythrocyte
sedimentation rate, anisocytosis and poikilocytosis, persistent lymphocytosis,
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individual variations in the haeraatologic results, slight increase of plasma fibrinogen,
an increase in levels of serum immunoglobulins, significantly reduced average total
protein in plasma (usually associated with hypoalbuminemia) and respiratory acidosis
(Sigurdsson et al, 1952; Sigurdsson, 1954; Chauhan and Singh, 1970; Palsson, 1976;
Molitor et al, 1979; Perk, 1982; Jones et al, 1982; Gonzalez, 1989).
1.1.6.3 Lesions in maedi
Macroscopic and microscopic lesions have been described by numerous
authors (Sigurdsson and Palsson, 1958; Sigurdsson et al, 1962; Ressang et al, 1968;
Georgsson and Palsson, 1971; Georgsson et al, 1976; Grimshaw et al, 1981; Van der
Molen et al, 1985).
In maedi the gross pathological changes are confined to the thorax, except for
those lesions arising secondary to emaciation. Histopathological lesions in maedi are
not pathognomonic (Cutlip et al, 1978; De Boer et al, 1978), and because of that the
diagnosis cannot be based solely on histopathological examination, both virological
and/or serological methods being required. The histological changes in maedi are
usually complicated by lesions caused by lungworms, and signs of terminal acute
bronchopneumonia are often found.
Grossly, affected lungs are usually enlarged in size and are 2-4 times heavier
than normal (from the normal range of 300-500 g to an average of 1200 g), remaining
normal in shape (except for slightly rounder edges) but firm on palpation. On opening
the thoracic cavity they collapse less than normal lungs. In uncomplicated cases rib
impressions are evident on the surface of the caudal lobe. The consistency of affected
lungs is diffusely rubbery and less elastic than usual, and occasionally adhesions may
unite one lobe with another and connect the lung to the thoracic wall, although the
general pattern is a smooth and shining pleural surface without fibrous adhesions
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(Sheffield et al, 1980). The cut surface of affected lungs is dry. Although there is no
sharp demarcation of lesions, diaphragmatic lobes may appear more severely affected.
Alteration of the lung colour is another consistent finding, usually being paler
or greyish but ranging from gray-blue to gray-yellow or gray-brown. Occasionally,
grey nodules may be observed. The presence of a subpleural grayish fine stippling
homogeneously distributed through all the pulmonary parenchyma and constituted by
small foci of 0.5-1.5 mm in diameter is also quite characteristic of maedi (Badiola,
1990).
In advanced cases, areas of red-grey consolidation (Badiola, 1990) may be
observed, mainly in cranioventral areas, and on their cut surface a mucopurulent
exudate often is present in the airways. These consolidated areas may be slightly
elevated above the level of the surrounding tissue, associated with a diffuse fibrous
pleuritis. When pulmonary oedema and congestion are extensive, areas of
consolidation are difficult to detect.
Histopathologically, the interstitial pneumonia of maedi is characterised by:
1) Lymphoid tissue hyperplasia. This lymphoid proliferation was especially
emphasised by Lucam (1942) in France who termed it 'lymphomatose pulmonaire
maligne du mouton' describing it as being malignant. Today, it is accepted that the
lymphoid proliferation is a reactive hyperplasia in response to the infective process,
although is not pathognomonic of maedi or other viral pneumonias, as it seems to be a
non specific response to various agents. The lymphoid tissue hyperplasia is the most
consistent and prominent finding in maedi (Rajya and Singh, 1964; Gupta and Rajya,
1968; Sharma et al, 1974; Georgsson et al, 1976) and also one of the earliest
histopathological signs (Sigurdsson et al, 1953). The lymphoid tissue hyperplasia is
usually associated with formation of lymphoid follicles with active germinal centres in
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peribronchiolar, perivascular or interstitial locations. Some foci of lymphocytes
without arrangement into follicles may also be found.
Small greyish-yellow foci (seen on gross examination) are accumulations of
proliferative lymphocytic cells with some of the lymphocytes infiltrating the
interalveolar walls (Sigurdsson et al, 1952; Sigursson, 1954). In the early cases these
foci are scattered but in the advanced cases they are extensive and prominent
throughout the lungs.
2) Diffuse thickening of the interalveolar septae (Sigurdsson et al, 1952;
Georgsson and Palsson, 1971). This is often quite pronounced, leading in some
regions to a total obliteration of the alveoli and consolidation with practically no
patent alveoli. This thickening of the interalveolar septae is mainly due to:
a) Mononuclear cell infiltration (Sigurdsson et al, 1952; Gislasson, 1966)
mainly with large mononuclear cells and to a lesser extent with lymphocytes,
occasionally plasma cells and practically no polymorphonuclear leukocytes except in
those areas of terminal acute bronchopneumonia.
b) Smooth muscle hyperplasia or hypertrophy with a diminished elasticity
(Sigurdsson et al, 1952); there is a proliferation of smooth muscle fibres that may
represent a compensation for the chronically diseased lung. It is usually more
pronounced in bronchial and bronchiolar musculature, although the interalveolar septa
may also be affected.
c) Existence of numerous histiocytes and fibrocytes and collagenous and
reticular fibres, and in some lungs areas cuboidal epithelialisation of alveoli
(Sigurdsson et al, 1952; Ressang et al, 1968; Georgsson and Palsson, 1971). All
consolidated lung has atelectasis.
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3) Hyperplasia of the epithelium in small bronchi and bronchioles. Due to this
change the smaller bronchi display a hyperplastic appearance with a mucoid
metaplasia and preponderance of goblet cells. Bronchial mucous glands may be
widened and filled with mucus, and the bronchi also frequently contain mucus. This
hyperplasia of epithelium in the terminal air passages is not specific to maedi as
similar changes are observed in various viral pneumonias in man and in lambs
infected experimentally with parainfluenza virus (Spencer, 1963).
This lesion is sometimes accompanied by disorganisation and epithelialisation
of adjacent alveoli. Alveolar epithelialisation, also called 'foetalisation', consists of a
partial transformation of the lining squamous epithelium of the alveoli into a cuboidal
epithelium, and it takes place principally where the thickening and fibrosis of the
interalveolar septa is most pronounced.
4) Vascular changes. Quite rare, they are only found in far advanced cases of
maedi, being always of a moderate degree (Ressang et al, 1968; Georgsson and
Palsson, 1971). They consist of an acute arteritis and peri-arteritis with a lymphocytic
infiltration of the adventitia and media and endothelial proliferation. Hyalinisation of
the media can occur, although it is exceptional. In addition, muscular hyperplasia and
hypertrophy reduce the size of the lumen.
5) Intra-alveolar exudate (Georgsson and Palsson, 1971). In the absence of
secondary bacterial infection there is seldom evidence of exudative or necrotising
bronchitis or bronchiolitis, but in those cases in which such infection occurs, dense
cellular exudates can be found in the alveoli. This intra-alveolar exudate consists
mainly of desquamated macrophages, neutrophils and sporadic eosinophilic materials.
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Alveolar macrophages may exhibit fusions, forming bi- and tri-nucleated cells,
although the typical giant multinucleated cells which are present in MVV-infected
tissue cultures are not found.
Regional lymph nodes (mediastinal and tracheobronchial) are also affected in
maedi (Ressang et al, 1968; Georgsson and Palsson, 1971). Macroscopically, they
appear swollen, markedly enlarged (from a normal weight of 10 to 15 g to an average
of 40 g) and oedematous (slight to moderate oedema), without clear demarcation
between cortical and medulla. This enlargement is mainly due to hyperplasia of the
cortical lymphoid elements. Microscopically, lesions are characterised by a diffuse
lymphoid hyperplasia. Some swelling and desquamation of the reticuloendothelial
cells may be observed with accumulations of mononuclear cells in the medullary
cords and of plasma cells and eosinophils in the sinuses. Neutrophils are rarely found.
1.1.7 VISNA OR NEUROLOGICAL FORM
Visna, the nervous form of the disease, was originally described by Sigurdsson
and others (1957) as a slow, progressive disease of the central nervous system of
sheep characterised by inflammation and demyelination. The first isolation of the
causal virus took place in 1960 (Sigurdsson et af). Visna, as Cheevers and McGuire
(1988) reported, was originally recognised as a complication of maedi in Icelandic
sheep (Sigurdsson and Palsson, 1958) and occurs with low frequency in other breeds
of sheep (Ressang et al, 1968; De Boer, 1975; Cutlip et al, 1979; Sheffield et al, 1980;
Oliver et al, 1981a) and in other parts of the world (Foglini et al, 1985; Gonzalez et al,
1992). A possible explanation for the rare occurrence of visna in field cases of maedi
could be the fact that virus-infected monocytes do not, under most circumstances,
cross the blood-brain barrier or, if they do, they do not remain there (Narayan et al,
1984).
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The incubation period is shorter than that for maedi (Dawson, 1980) and the
clinical disease can be seen in animals over two years old. Experimentally, it can be
transmitted by intracerebral inoculation of cell-free filtration of brain tissue and by
intrapulmonary inoculation, although its mode of transmission in the field is still
unknown (Gudnadottir and Palsson, 1965). The disease is invariably fatal, though
during its clinical course some periods of relative normality or remission may occur.
Its clinical course varies in length from a few weeks to several months or even a year.
1.1.8 OTHER CLINICAL FORMS OF MAEDI-VISNA
Chronic indurative mastitis
Although this clinical form of the disease has been recognised only recently, it
is of great importance due to its high incidence being even more frequent than the
respiratory form (Cheevers and McGuire, 1988; Lujan et al, 1991).
Arthritis
A chronic non suppurative arthritis, usually bilateral, has been described in
carpal and tarsal joints of animals affected with MVV in USA. Although rare in
presentation, it closely resembles that affecting the joints of goats with caprine
arthritis-encephalitis (CAE) (Cutlip et al, 1985a; Narayan and Cork, 1985). Although
naturally it occurs in animals over two years, experimentally it can appear within one
year.
Vasculitis
Degenerative changes in blood vessels of MVV-infected animals have been




Although few data have been published on changes produced by viruses in
genital infections (Watt, 1972), the testicular lesions found in rams infected by MVY
suggest that the virus can be transmitted with semen (Palfi et al, 1989), in addition to
respiratory secretions and saliva and so, infected rams probably play a role in
transmitting infection (Suveges and Szeky, 1973).
Lesions in other organs
Spleen: An acute splenitis has been described (Sheffield et al, 1980) where lymphoid
follicles were consistently large and had prominent germinal centers.
Liver: Sigurdsson and others (1952), reported inflammatory changes consisting of
small scattered infiltrates of lymphocytes and plasma cells without apparent
connection with the vessels of the liver.
Kidneys: There may be infiltration of large proliferating lymphocytes at the cortico-
medullary junction, spreading both into the medulla and cortex (Georgsson et al,
1976).
Heart: A generalised acute endocarditis, focal myocardial degeneration and slight
hypertrophy of the right side of the heart have been found (Ressang et al, 1968).
1.1.9 EPIDEMIOLOGY AND CONTROL
1.1.9.1 Geographic distribution
Geographically, maedi has been detected in most major sheep producing areas
of the world except for Australia and New Zealand (Jensen and Swift, 1988). Very
high prevalence rates are observed in the western range flocks of the United States
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where 50% of the total sheep population may be infected (Cutlip et al, 1977; Gates et
al, 1978; Huffman et al, 1981).
1.1.9.2 Maedi/Visna in Great Britain
Although Jones and others (1982) first reported the clinical disease in the
United Kingdom (UK), serological evidence of infection was first detected by Dawson
and others (1979) in a flock intending to export rams.
It is thought that the importation of exotic breeds of sheep during the 1970s
could have introduced the disease into the country as the first clinical cases were
imported sheep, their progeny and those animals reared in contact with them. Today,
however, the disease is spreading among commercial sheep flocks which have no
connection with imported breeds (Pritchard et al, 1984; Pritchard and Spence, 1984;
Pritchard and Dawson, 1987).
Maedi and SPA have been reported to co-exist in British flocks (Pritchard and
Done, 1990; Watt et al, 1990; 1992a; Gunning and Shaw, 1993). Visna has also been
reported in the UK (Pritchard and Done, 1990; Watt et al, 1990).
1.1.9.3 Economical losses
MVV infection causes heavy economic losses to the farmers (Sigurdsson et al,
1952), not only because of mortality and unthriftiness during the long course of the
disease but also due to reproductive inefficiency and significantly reduced longevity
(Blood and Henderson, 1983; Houwers, 1990).
The reports of subclinical MVV infections causing indurative mastitis (Van
der Molen et al, 1985) and other deleterious effects on productivity (Dohoo et al,
1987) must also be of concern to the sheep industry.
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1.1.9.4 Susceptibility to MVV
1.1.9.4.1 Breed susceptibility
Different authors have different points of view concerning this subject:
Cutlip and others (1988) and Jensen and Swift (1988) indicated that all breeds
of sheep are susceptible to MVV infection, although some breeds are more resistant
than others to the development of the disease after the infection (Cutlip et al, 1986).
Palsson (1976) considered genetic predisposition to be the most important
factor and hence, certain strains of sheep within the same breed will be more resistant
to clinical disease than others.
Finally, Gates and others (1978) and Narayan and Clements (1989) believe in
breed susceptibility, reporting that Border Leicester sheep in the USA and Texel sheep
in Holland are more susceptible to infection. Serological studies on field samples in
USA have also shown a higher prevalence of infection in some breeds than in others
(Gates et al, 1978; Light et al, 1979).
1.1.9.4.2 Age susceptibility
Although the age-specific prevalence shows that the proportion of infected
animals increases with age (Jensen and Swift, 1988), which could indicate either
lateral transmission of the virus or delayed seroconversion after infection at birth,
some other authors have reported that natural disease may occur at any age in adult
sheep (Cross et al, 1975). Though more common in 2-3 year old sheep, disease has
been described in lambs from infected sheep (Cross et al, 1975) and pulmonary
lesions have been described in foetuses after the intrauterine inoculation of the virus
(Cutlip et al, 1982) and in young lambs after intratracheal inoculation of low-passage
virus (Lairmore et al, 1986).
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1.1.9.5 Concurrent infection with MYV and Sheep Pulmonary Adenomatosis
MVV spreads more quickly and produces more severe losses in those flocks
that are affected with SPA (Houwers and Terpstra, 1984; Dawson et al, 1985; 1990).
The possible explanations for this synergism between infection with SPA and MVV
are: firstly, the increased numbers of alveolar macrophages present in SPA lungs,
particularly adjacent to the tumour tissue (Hunter and Munro, 1983) may provide
optimal conditions for effective MVV replication; secondly, typical SPA bronchial
secretions and subsequent coughing may increase the number of airborne MVV
droplets; and thirdly, MVV seems able to integrate into the tumour cells' genome,
helping the simultaneous transmission of both viruses from infected to healthy
animals.
In advanced mixed infections it can be difficult to distinguish between the
lesions due to MVV and those due to SPA.
1.1.9.6 Transmission
The virus is transmitted primarily from dam to lamb through the colostrum and
milk (De Boer, 1970; Palsson, 1976; De Boer et al, 1979; Dawson, 1987; Narayan and
Clements, 1989) and isolation of MVV from milk has been reported up to 5 months
after lambing (De Boer, 1970). The proviral state ensures that the virus remains
closely cell-associated, thus the transference of infected cells between animals is
necessary for transmission. Differentiated macrophages from the mammary gland,
present both in colostrum and milk are the target cell for viral replication (Narayan
and Clements, 1989) and because of this, any concurrent infection leading to an
increase in the extrusion of macrophages into the milk (such as mastitis) will increase
the load of lentivirus in the milk (Kennedy-Stoskopf et al, 1985a). Infected
macrophages probably pass through the intestinal epithelium of the neonate to
establish infection.
The longer a dam has been infected, the sooner infection can be detected in her
lambs after birth, as lambs will be exposed to higher numbers of virus (Sihvonen,
1981).
Horizontal or contact transmission. Droplet infection via the respiratory route
was the most likely method of transmission during the epidemics of the disease in
Iceland (Palsson, 1976). However, under experimental conditions it has been difficult
to prove respiratory transmission, and very close contact between affected and
unaffected animals seem to be necessary (Sigurdsson, 1954; Gislasson, 1966; Blood
and Henderson, 1983) although infection can also become well established among
traditionally managed unhoused sheep (Pritchard et al, 1984; Houwers and Van der
Molen, 1987). Overcrowding and close housing of the animal for a long period
facilitates the spread of the infection (Sharma et al, 1975). Some authors, however,
consider that respiratory transmission is less important than milk transmission
(Sigurdsson et al, 1953).
Saliva has been reported to be another possible source of virus (Straub, 1970;
Narayan and Cork, 1985).
Although epizootiological data implicate rams as sources of infection
(Suveges and Szeky, 1973), no data has been published on the mode of spread (Palfi
et al, 1989). It is believed that two rams were implicated in introducing the disease in
Iceland (Palsson, 1976) and in Norway (Krogsgrud and Udnes, 1978). However,
experiments to date have failed to demonstrate that semen from MVV infective rams
is infective (Dawson, 1987).
Blood does not seen to be particularly infective in spite of the persistent
viraemia during MVV infection (Dawson, 1987). The low infective capacity of blood
could be due to the fact that the virus is only present in one in 1$ to 107 leukocytes
and only as dormant proviral DNA (Peluso et al, 1985).
No evidence has been found to suggest that sheep lungworm Muellerius
capillaris (De Boer et al, 1979) or the sheep ked Melophagus ovinus (Sigurdsson et al,
1953) were implicated in the transmission ofMVV infection.
Indirect transmission is probably uncommon (Dawson, 1980, 1987; Straub,
1985; Palate and Koenen, 1987; Sharp, 1988).
Experimental studies have demonstrated transmission via drinking water
contaminated with faeces from infected sheep (Sigurdsson et al, 1953). Nevertheless,
the infectivity of faeces and urine has not been examined thoroughly enough to allow
generalisation (Gudnadottir, 1974).
Opinions regarding the importance of vertical transmission differ. Cross and
others (1975) and Cutlip and others (1981) believe that transmission in utero, although
rare, can occur either through the uterine wall or via the germ cell. Hoff-Jorgensen
(1977) isolated MVV from three lambs delivered close to term from infected dams by
caesarian section. However, the epidemiological study by De Boer and others (1979)
failed to demonstrate evidence for transplacental infection and transplacental
transmission could not be demonstrated in the experiments of Sihvonen (1980).
Cross and others (1975) described interstitial pneumonia in four months old
lambs which were hysterectomy-'derived from sheep suffering from maedi, but some
other authors (De Boer et al, 1979), consider that those observed changes in lungs are
not conclusive for vertical transmission, and claim that the diagnosis was not
substantiated by serological investigation and virus isolation. Furthermore, the virus
could have been transmitted into the foetuses during the surgical manipulation.
The difficulty in isolating virus from the foetuses taken by caesarian section
from MVV-infected sheep could be explained by considering the particular mode of
replication of lentivirus rather than a lack of foetal susceptibility. Hence, virus might
exist in the foetuses as a provirus (in a non-infectious, non recognisable state) and
only under certain conditions, or after the animals have reached a certain age, would
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infectious viral particles be produced. The presence of the provirus could be shown by
using a hybridisation technique.
1.1.9.7 Control
There is no effective treatment for this disease, nor is there any available
vaccine (Cutlip and Lehmkuhl, 1986). Vaccines would be expensive and not too
efficient (Narayan and Clements, 1989) due to the antigenic variation of the virus
(Stevenson and Bouffard, 1984). Moreover, vaccinated sheep, although producing
complement-fixing antibodies, are not protected (Haase, 1986b). Hence, vaccination at
the outset of infection might reduce the number of potential cells involved in the
pathological changes, but will not prevent lentivirus infection (Haase, 1986b).
Experimentally, however, inhibition of viral DNA synthesis (Haase and Levinson,
1973), intracellular action with interferon (Carroll et al, 1978; Narayan et al, 1985),
control of the transcription and translation of the lentiviruses genome (Haase, 1986b)
and the development of a defective virus vector which would stabilise the dormant
state of infection (Staskus, unpublished) are the main points of interest for therapy,
although still without practical applications. Treatment must be symptomatic;
antiinflammatory drugs can be used to reduce joint pain and antibiotics to prevent
secondary infections of the lungs.
The addition of clinically normal infected animals into a flock is the major
route for the introduction of the disease. Even the negative serological testing of such
animals does not guarantee that they are free from infection as the development of
detectable antibodies following infection can take several months and also some
infected animals fail to produce detectable antibodies (De Boer et al, 1979).
In the past, the only control attempted for the eradication of the disease was the
slaughter of all sheep in the area and a subsequent restocking policy. These
approaches are extremely expensive and may not be cost effective as strict quarantine
measures must be applied to avoid reintroduction of the disease. Lambing is thought
to contribute to spread of the disease and its discontinuance is recommended in
infected flocks. In those countries where MVV is enzootic, severe restriction of inter-
farm movement and outdoor housing are obvious aids for limiting the dissemination
of the infection.
Today, control of MVV is based upon early identification of infected animals
by periodic serological 'testing and culling' of these reactors and their offspring, even
if the latter are negative at the time of the test (De Boer et al, 1979; Houwers et al,
1983). The recommended frequency of the serological tests is every 6 months, but
may be reduced to once a year after two negative tests (Jensen and Swift, 1988). This
method does not guarantee the complete elimination of all infected animals as a few
may not seroconvert even if they harbour the virus, but at least it reduces the rate of
infection to a minimum.
Prevalence of the disease may also be reduced by avoiding exposure of healthy
animals to infected ones (Sharma, 1982). The progeny from infected dams should be
weaned at birth and separately reared by artificial feeding. Either pasteurised milk or a
milk substitute can be used for this purpose (Light et al, 1979; Houwers et al, 1983)
and colostrum from infected dams is suitable after heat-treatment to destroy the virus
infected cells (Lerondelle and Ouzrout, 1990).
Slaughtering of animals at an earlier age (Hugosson, 1978), in combination
with the 'test and culling' policy could help to reduce losses in commercial breeding
flocks, while mass hysterectomy of the flock with artificial rearing of the lambs or
embryo-transfer technique needs to be evaluated more thoroughly before
recommending their use.
Once a flock is declared free of MVV, care must be taken to avoid its
reintroduction as this virus is a constant threat to the maintenance of free flocks.
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1.1.10 DIAGNOSIS
Diagnosis ofMVV infection may be complex due to the insidious nature of the
disease, the likelihood of it being masked by other pulmonary diseases (such as
pasteurellosis and SPA) or by other debilitating and wasting diseases, and finally
because changes produced by the virus might be masked by invasion of lungs by
multiple pathogens (Pritchard etal, 1984).
Pathological changes, although highly suggestive for MVV infection both
macro- and microscopically, are not pathognomonic.
Cultivation of virus can be used for diagnostic purposes, but it takes a long
time and cannot be used as a routine test. Viral isolation can be attempted from live
animals by cocultivation of peripheral blood leukocytes usually on cell cultures of
sheep choroid plexus, lung, testis or spleen (Dawson, 1980).
One of the characteristic features of this infection is the persistence of the virus
in infected animals and, once developed, a permanent detectable humoral response.
The persistence of the virus in the presence of circulating antibodies allows a
diagnosis of MVV infection to be made by identifying either virus or specific
antibodies in the blood (Cutlip et al, 1978, 1986). Examination of serum samples
searching for specific antibodies can be used for diagnostic purposes both during the
incubation period and in the clinical phase. Several serological methods can be used to
identify virus carriers (Thormar et al, 1966; De Boer, 1970; Cutlip et al, 1977;
Dawson et al, 1979; Houwers and Gielkens, 1979; Molitor et al, 1979; Winward et al,
1979; Biront et al, 1981; Cutlip and Lehmkuhl, 1986). Currently, the most frequently
used techniques are the agar-gel-immunodiffusion test (AGIDT) and an enzyme
linked immunosorbent assay (ELlSA); both are equally specific for detecting
antibodies to MVV in ovine sera after a comparative trial (Dawson et al, 1982). The
simplicity of the AGIDT makes it the test of choice for most surveillance or control
programs (Dawson et al, 1982), but the indirect ELISA developed by Houwers and
Gielkens in 1979, seems to be slightly more sensitive than the AGEDT (Houwers et al,
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1982) being able to detect infected sheep at an earlier stage post-infection. An indirect
immunofluorescence test is also available (Dawson et al, 1982), but has not been
widely used. Other serological tests that have been used are the complement fixation
test (Larsen et al, 1982a), serum neutralisation test (Sigurdsson et al, 1960),
microimmunodiffusion test (Cowan and Wagner, 1970), immunoelectro-osmophoresis
(Pan et al, 1972) and a radial immunodiffusion test.
Serology, however, has some limitations. Passively acquired antibodies
obtained through the colostrum are lost by six months of age making serological tests
uninterpretable during the first six months of age. Due to this, the best application of
serological testing will be on a herd basis.
Summarising, a definitive diagnosis depends upon finding characteristic
lesions at necropsy in conjunction with clinical signs, information about the spread of
the disease (Sharma, 1982) and demonstration of virus by either serology or isolation.
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1.2. PULMONARY IMMUNE RESPONSE DURING LENTIVIRAL
INFECTION: HIV AS A MODEL
1.2.1 HUMAN RETROVIRUSES AND LUNG DISEASES
In the last few years a wide spectrum of human pulmonary diseases has been
associated with the local immunodeficiency induced by retroviruses (Rankin et al,
1988; Semenzato and Agostini, 1989).
At least three human retroviruses belonging to the Oncovirinae subfamily are
currently known, namely human T-cell leukemia virus type I (HTLV-I) (Poiesz et al,
1980), HTLV-H (Rosenblatt et al, 1986) and HTLV-V (Manzari et al, 1987). HTLV-I
infection accounts also for some neurodegenerative disorders; in the lung this virus
shows a peculiar tropism for helper-related CD4+ T cells in which it produces partial
activation of the interleukin-2 receptor (IL-2R) and interleukin-2 (IL-2) gene
expression, this probably leading to a period of autocrine T-cell growth and finally to
the ultimate leukemic transformation (Leung and Nabel, 1988).
Besides oncoviruses, two other human retroviruses evolutionarily related to the
lentivirus family have recently spread across many parts of the world, becoming a
dramatic threat to public health, i.e. HIV-1, the etiologic agent of acquired immune
deficiency syndrome (AIDS) (Barre-Sinoussi et al, 1983) and the more recently
isolated HIV-2 (Clavel et al, 1986).
HIV-1 shares morphology (Gonda et al, 1985), genomic sequence homologies
(Gonda et al, 1985; Sonigo et al, 1985) and replication mechanisms (Hess et al, 1985;
Davis et al, 1987) with the ungulate lentiviruses. Lung pathology is also similar in
both viral infections, neonatal lambs inoculated with ovine lentivirus developing a
lymphoid interstitial pneumonia which is morphologically and clinically similar to
that of juvenile and adult AIDS (Lairmore et al, 1986). Furthermore, related
pulmonary complications in both diseases are associated with similar abnormalities of
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the BALF cellular constituents. This review will focus on what is currently known
about the effects of HTV-1 infection on host lung defences, aiming to provide some
insights into the mechanisms by which MVV operates in the ovine lung during MVV-
infection.
1.2.2 PULMONARY IMMUNE RESPONSE AGAINST HIV-1
Studies performed on cells recovered by BAL, combined with the availability
of monoclonal antibodies (MAbs), cell culture and recombinant cytokines and
molecular probes, have allowed the investigation of those events leading to the
progressive impairment of pulmonary defence mechanisms during HIV-1 infection.
In HIV-1 infection, pulmonary immunologic alterations are an early
phenomenon. The main immunocompetent cell types usually found within alveolar
spaces of patients with HIV are lymphocytes and alveolar macrophages (Venet et al,
1983; Agostini et al, 1988; Nowakowski et al, 1992). Polymorphonuclear leukocytes
(PMNs), although present in normal numbers in asymptomatic patients, can be
increased during concurrent opportunistic infection (Agostini et al, 1991a;
Nowakowski et al, 1992).
1.2.3 ROLE OF PULMONARY LYMPHOCYTES
Lymphocytes participate in host defences by regulating other immune
mechanisms (helper and suppressor T cells), by producing antibodies against
pathogens (B cells) and by participating in killing of target cells (cytotoxic T
lymphocytes (CTL) and natural killer (NK) cells).
1.2.3.1 T lymphocytes
In contrast to the lymphopenia usually observed in PB, which mainly reflects a
depletion of circulating CD4+ cells, pulmonary lymphocytes are increased in patients
with AIDS. The phenotypic evaluation of BALF T cell subpopulations shows an
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increase in both the percentage and total number of lymphocytes, with alterations in
lymphocyte subsets. The lymphocytic alveolitis in AIDS comprises mainly CD84"
cytotoxic T cells (Venet et al, 1983; Young et al, 1985; Agostini et al, 1988;
Nowakowski et al, 1992). The pulmonary helper CD4+ lymphocytes are virtually
absent, resulting in a marked decrease in the CD4+/CD8+ ratio.
Two different hypotheses have been proposed to account for the accumulation
of lymphocytes within the lung during the course of HIV-1 infection, either a
recruitment of these cells from the PB to the lung, or an IL-2 driven proliferation of
preexisting T cells (Hunninghake et al, 1983; Pinkston et al, 1983; Semenzato, 1991).
BALF T lymphocytes of HIV-1 seropositive patients, apart from expressing the IL-
2R, (Zambello et al, 1992) bear some other activation markers on their surface such as
MHC Class II antigens (HLA-DR) (Agostini et al, 1993b).
In addition to increased lymphocyte populations in the alveolar space, open
lung and transbronchial biopsies from HIV-positive patients have shown that CD8f T
cells also infiltrate the pulmonary parenchyma (Beck and Shellito, 1989) and
interstitium (Solal-Celigny et al, 1985). Peribronchiolar lymphocyte infiltration has
also been observed (Ettensohn et al, 1988).
Lung CD8+ T cells of HTV-1-infected patients are represented by two different
subpopulations of cytotoxic T lymphocytes: CD3+/CD8+/S6F1 bright qyL restricted
by the MHC and CD3+/CD8+/S6F1 bright x-cells bearing NK markers (Agostini et al,
1990; Plata et al, 1990). While the former CD8+ T cell subpopulation is involved in
the host defence mechanisms against HIV-1 (being able to recognise and attack HIV-1
antigens on the surface membrane of infected cells), the MHC-unrestricted
subpopulation does not seem to take part in host defence mechanisms against HIV-1,
such cells being likely to contribute to the resistance against the development of
AIDS-related opportunistic infections (Rankin et al, 1988; Beck and Shellito, 1989;
Semenzato, 1991).
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Only in the more advanced phases of the syndrome is the absolute number of
CD4+ cells severely reduced (Semenzato and Agostini, 1989), the number of CD4+
cells being higher in those patients with recent infection than in those with concurrent
opportunistic infections.
Although the majority of cytotoxic cells in the HIV-1 infected lung coexpress
the CD3 antigen and the a(3 TCR, some y8 TCR cells are also found within the lung.
These yd TCR lymphocytes differ phenotypically from those in PB, as a high
proportion of them coexpress the CD8 antigen (Agostini et al, 1990, 1994). These yd
TCR cells seem to play a cytolytic role in the lung (Spits, 1991), however, their exact
functional role is still unknown. It is speculated that, by recognising different sets of
HIV-1 antigens from those recognised by a(3 TCR cells, they could play a major role
during the pulmonary immune response in AIDS (Agostini et al, 1993a, 1994).
Pulmonary NK cells from AIDS patients are quantitatively increased and
maintain the capacity to bind sensitised targets (Agostini et al, 1988). However, they
are defective, as they lose the ability to release the cytotoxic factor involved in the NK
lytic machinery (Semenzato, 1991).
1.2.3.2 B lymphocytes
Humoral immunity may also be abnormal in pulmonary AIDS. BALF from
AIDS patients shows increased total amounts of IgG, IgM and IgA (Young et al,
1985). The presence of increased quantities of albumin (a protein only synthesised in
the liver) in BALF of patients with AIDS suggests that the integrity of the alveolar-
capillary membrane is compromised and some serum proteins are passing into the
pulmonary epithelial lining fluid (PELF) (Beck and Shellito, 1989). Although it is
likely that some of the increase in BALF Ig is due to transudation from the
intravascular space, local production by pulmonary plasma cells is also a probable
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additional source (Young et al, 1985). This is supported by the finding of increased
numbers of IgG, IgM and IgA secreting cells in AIDS patients (Rankin et al, 1983).
1.2.4 ROLE OF ALVEOLAR MACROPHAGES
Alveolar macrophages are important elements in host defence against
pulmonary infection as they possess phagocytic and microbicidal properties. These
cells can be infected in vitro by HIV-1 (Clarke et al, 1990; Plata et al, 1990; Rose et
al, 1991). They also contain HIV-1 RNA (Plata et al, 1987), suggesting that they
might serve as a reservoir for the virus and therefore, perpetuate the infection in vivo.
Most of the alveolar macrophages within the lung from HIV-1 infected subjects derive
from circulating monocytes (Holian and Scheule, 1990), although some of them can
also replicate in the normal lung.
Apart from being a target for HIV-1, in the early stage of AIDS, alveolar
macrophages could be involved in the host defence mechanisms against HIV-1 and
against opportunistic infections (Reynolds, 1987; Agostini and Semenzato, 1990), and
a macrophage alveolitis has been reported in some HIV-1 patients (Agostini et al,
1991a). Interesting phenotypic features are found in alveolar macrophages from HIV-
infected patients. They appear to be in a permanent state of activation showing
upregulated surface expression of CD25 antigen (p55 chain of the EL-2R) (Agostini et
al, 1993b), MHC Class II (HLA-DR) antigens, adhesion molecules (CD44, CD54)
and CD4 determinants. As CD4 is the receptor for HIV-1, its increased expression on
alveolar macrophages could contribute to the HTV-1 infection of these cells. Reduced
expression of some specific alveolar macrophages markers has also been reported
(Bray et al, 1991).
Alveolar macrophages isolated from patients with AIDS release a series of
cytokines. They constitutively release tumour necrosis factor a (TNF-a), a
proinflammatory cytokine which might play a role in the pathogenesis of AIDS-
55
related pulmonary complications (Semenzato, 1990) and favour viral spread (Osborn
et al, 1989; Krishnan et al, 1990; Agostini et al, 1991b; Israel-Biet et al, 1991; Millar
et al, 1991a). However, the function of TNF as an inflammatory mediator can also be
beneficial as it promotes endothelial adhesion by PMNs, induces the synthesis of IL-1
by macrophages and may have antiviral properties (Beutler and Cerami, 1987).
Alveolar macrophages from HIV-1 patients also secrete increased amounts of IL-6
and IL-6 inhibitor (Millar et al, 1991b; Trentin et al, 1992) and of granulocyte
macrophage-colony stimulating factor (GM-CSF) (Agostini et al, 1992). The
regulatory network between HIV-1 and cytokines in the lung seems to be essential for
the regulation of the HIV-1 production, latency and reactivation.
Reports about the effect of HIV-1 infection on the antimicrobial faculty of
alveolar macrophages are contradictory. Hence, while some authors claim that HIV-1
does not affect the killing capacity of these cells (Murray et al, 1985), others have
demonstrated some decrease in the microbicidal functions of alveolar macrophages
from those ADDS patients who developed pneumonia (Musher et al, 1990); such an
impairment might explain the spectrum of pulmonary pathogens encountered in AIDS
patients (Beck and Shellito, 1989).
1.2.5 ROLE OF POLYMORPHONUCLEAR LEUKOCYTES (PMNs)
Like alveolar macrophages, PMNs, contribute to host defence by intracellular
killing of organisms through chemotaxis, phagocytosis and subsequent generation of
toxic metabolites. Their number increases in the last phase of AIDS when
opportunistic infection of the respiratory tract occurs. Neutrophils are the main cell
type which accounts for this increase (Agostini et al, 1991a), while eosinophils are
only occasionally increased (Fleury-Feith et al, 1989). The increased lung neutrophils
seems to be directed to the clearance of pulmonary pathogens, although the
mechanisms for the recruitment of these cells into the lung of HIV-1 infected patients
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is not yet fully understood. The macrophage-derived EL-8 seems to initiate and direct
the migration of PMNs into the lung (Basha et al, 1991), while some other cytokines
such as IL-3, granulocyte-colony stimulating factor (G-CSF) and granulocyte
macrophage-colony stimulating factor (GM-CSF), by promoting bone marrow
differentiation and proliferation of neutrophil precursors, would enhance neutrophil
accumulation.
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1.3. BRONCHOALVEOLAR LAVAGE (BAL)
1.3.1 INTRODUCTION
The importance of the lung as a target organ in several infections and allergic
diseases has focussed attention on the immune responses of the lower respiratory tract.
The inflammatory states that can be found in the lungs are the result of the humoral
and cellular interactions during the immune response. A much better understanding of
the inflammatory processes occurring in human chronic lung diseases has been
achieved by the use of the bronchoalveolar lavage (BAL) (Crystal et al, 1984).
BAL performed using a fibreoptic-endoscope has enabled sampling of the
airway lumen cell population which consists mainly of macrophages and
lymphocytes. The BAL sample represents principally an alveolar lining sample as the
alveolar surface area is approximately 100 times greater than that of peripheral
airways. The lymphocyte cell population harvested by this procedure correlates fairly
well with cell populations obtained by lung biopsy and necropsy samples, and it has
even been reported that the effector cells recovered by BAL are a more accurate
reflection of the cell population in the lower respiratory tract than that obtained from
biopsy tissue (Haslam et al, 1980).
1.3.2 BAL APPLICATIONS IN MAN: ROLE AS A CLINICAL, DIAGNOSTIC
AND RESEARCH TOOL
BAL has been commonly used for the study of interstitial lung diseases, which
are characterised by diffuse inflammation of the pulmonary parenchyma and
interstitium. Since its introduction there has been debate regarding the application of
BAL, as the boundary between its clinical and research function is not yet clear.
Daniele and others (1985) examined this technique, concluding that the BAL is
primarily a research procedure, having several limitations in the clinical site.
There are few complications associated with fibreoptic bronchoscopy (its ease
and safety and the benign nature of lavaging different subsegments of pulmonary
lobes) hence, BAL has become a widely acceptable means for recovering cells and
proteins from the lower respiratory tract of subjects with many different respiratory
diseases.
1.3.2.1 BAL AS A CLINICAL TOOL
The cell population recovered by BAL resembles in proportion, function and
type that found in the alveoli regardless of the lobe lavaged. Because of the possibility
of estimating the number of free cells in the lungs, BAL constitutes a very sensitive
method for the detection of early pulmonary cellular responses, and for helping to
stage and monitor the progress of the pulmonary disease. Other respiratory tract
sampling procedures have more disadvantages than BAL and therefore, repeated open
lung biopsy is unsuitable, associated with some morbidity, limited to the sampling of
few alveoli, and presenting some difficulties in the specific identification of
infiltrating cells; transbronchial biopsy, apart from its significant sampling error is
contraindicated in some patients, because of the risk of causing pneumothorax,
haemorrhage and even death; chest radiographs and standard pulmonary function
tests are not completely satisfactory for monitoring disease evolution.
1.3.2.2 BAL AS A DIAGNOSTIC TOOL
By permitting the exploration of previously inaccessible distal airways BAL
has made possible the diagnosis of respiratory processes by identification of cellular
constituents, recognition of inorganic molecules inside alveolar macrophages and
detection of abnormalities in local cellular immune responses. It has also proved to be
particularly useful for the diagnosis of opportunistic infections (for instance the
diagnosis of pneumonia due to opportunistic infections such as Pneumocystis carinii,
especially in patients with AIDS.
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However, it does not constitute a very valuable aid for the diagnosis of
bacterial respiratory infection as it is technically difficult to collect BALF without
oropharyngeal bacterial contamination.
1.3.2.3 BAL AS A TOOL FOR PULMONARY RESEARCH
Knowledge about the role of airway cells and secretions in the
immunopathogenesis of lung diseases has improved and, hence, BAL has recently
acquired a crucial importance in pulmonary research.
It enables study of the immune properties and functions of the harvested cells;
MAbs have been used to characterise antigens on the surface of these cells, permitting
flow cytometric analysis for assessing the subpopulations of the recovered cells.
Furthermore, it also allows a qualitative and quantitative study of the lavage
supernatant components, as a single analysis of lavage is quite representative of all the
cells and acellular constituents throughout the lung (Crystal et al, 1986).
1.3.3 STANDARD METHOD
Optimally, sampling procedures should meet the following criteria (Saltini et
al, 1984): they should be easy to perform, produce a reliable recovery and precise
quantification of all the cell types present, allow routine histological and
histochemical staining procedures, yield specimens that can be stored indefinitely and
provide cells in good morphological condition.
BAL, usually performed by fibreoptic endoscopy, meets all these
requirements. To avoid blood contamination, which could modify cell and protein
values, the lavage must be done prior to any bronchial brushing or transbronchial
biopsy.
It is desirable to lavage multiple lung areas as there may be slight lobar
differences in cell counts. In human patients one wash from each lung is usually
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performed and the respective specimens are assayed independently. Although usually
both samples are quite similar in normal patients, in the diseased lungs some
variations may be appreciated (Nugent et al, 1984).
Physiological sterile saline solution is infused through the channel of a
fibreoptic endoscope (previously wedged into a midsized bronchus). A medium
without Ca++ and Mg++ ions is preferred for the washing as it decreases cell
clumping and provides a better yield of cells and proteins.
Warming the saline to 37°C will slightly increase the harvest of respiratory
cells (Pingleton et al, 1983) and may reduce coughing.
The saline solution 'washes out' the material lining the epithelial surface of the
bronchial tree and alveoli distal to the bronchoscope, termed the PELF, which is then
recovered by gentle suction. Excessive suction will reduce cell viability (by damaging
the recovered cells) and could also cause a collapse in the airways distal to the tip of
the bronchoscope, decreasing the effective return of the fluid.
The time the lavage fluid must remain in the lung before aspiration (termed the
'dwell time') has not been well established, but it seems that a better sample is
obtained when the patients breathe once or twice before the extraction of the fluid.
Rennard and others (1986), however, have shown that as the 'dwell time' increases the
diffusion of molecules, i.e.. histamine, urea, albumen from the blood and lung into the
BAL fluid also increases and may lead to incorrect measurement of these molecules.
The frequent presence of foam in the later samples denotes that surfactant is
present, indicating therefore that the site where the recovery is taking place includes
the alveoli.
It is advisable to discard the first wash as it differs from all the other
subsequent washes, not only because of its smaller volume but also because of the fact
that it represents more a bronchial than an alveolar sample. Besides, the content of
epithelial cells in this first fraction is usually relatively high.
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Any mucus or debris recovered with the fluid can be easily eliminated along
with some of the surfactant froth by filtering the specimen through a single layer of
loose cotton gauze.
1.3.4 ANALYSIS OF RECOVERED CELLS
Firstly, the number and type of the recovered cells are determined. For this,
cells in the neat lavage fluid (without any previous dilution or concentration) are
counted in either an haemocytometer chamber or in a Coulter counter and expressed
as cells per millilitre or (il of solution. Differential cell counts are performed on
cytocentrifuged preparations stained with Leishman's stain or any other analogous
stain (i.e. Wright Giemsa). Occasionally special staining techniques may be required
to assess the identity of certain cell types.
1.3.5 PROBLEMS ASSOCIATED WITH BALF PROCESSING
Different methods for processing BALF samples can induce variations in the
results of lavage analysis (Mordelet-Dambrine et al, 1984; Daniele et al, 1985) and
therefore, these technical problems must be considered when comparing BAL cell
counts published by different groups.
By analysing several criteria, Mordelet-Dambrine and others (1984),
concluded that the centrifugation speed and the number of cell washes were the main
parameters influencing differences in cell count. The reading of the preparations by
different investigators along with the utilisation of different haemocytometers did not
cause a significant variation in the cell counts. On the other hand, the absolute cell
count was higher before washing and higher centrifugation speeds led to a loss of
macrophages.
Due to the inevitable loss of cells during centrifugation (affecting all the cell
types) the quantification should be performed on the neat lung fluid prior to
centrifugation. Discrepancies in the number of cells recovered will also depend on the
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volume of fluid instilled and recovered (Daniele et al, 1985). Another feature to be
considered is that different fractions of lung fluid always differ in their predominant
cell types (Davis et al, 1982; Martin et al, 1987); the first fraction containing more
PMNs and fewer macrophages, while the later fractions will be richer in lymphocytes.
Saltini and others (1984) and Walters and Gardiner (1991) have reported that
the cytocentrifuge technique underestimates the percentage of recovered lymphocytes.
In order to prevent this lymphocyte loss and whenever a very accurate quantification
of cells is required, the same authors have described a filter preparation technique
which also provides a good morphologic detail of cells; this procedure tends to collect
all the cell populations prior to staining. This technique however is much more time-
consuming.
Additionally, coughing or expectoration during the performance of the BAL
could affect the results.
1.3.6 BAL IN SHEEP
The sheep lung, due to its anatomical features, has been proposed as an
excellent model for the study of pulmonary immune responses (Joel and Chanana,
1985). Most studies on immunity of the respiratory tract of sheep had been limited to
the upper respiratory tract. The use of the fibreoptic endoscope has allowed the study
of the immunity of the lower respiratory tract in normal sheep (Gorin and Steward,
1979; Rola Pleszczynski et al, 1981). Some work has also been done in diseased
sheep; Burrells (1985a) reported quantitative, qualitative and functional differences in
BALF from sheep inoculated with Mycoplasma ovipneumoniae, Pasteurella
haemolytica and parainfluenza-3 virus, when compared with control animals. Cordier
and others (1990) described increased BALF cellularity, increased percentage of
neutrophils and activation of alveolar macrophages in BALF from MVV-infected
sheep.
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Although BAL has been used in unsedated cattle (Fogarty et al, 1983) and
sheep (Begin et al, 1981), the introduction of catheters or of the fibreoptic
bronchoscope into the airways of conscious sheep is not well tolerated (Rola
Pleszcynski et al, 1981; Williams and Burrells, unpublished observations), since it is
invariably associated with marked spontaneous coughing. This cough could lead to
small capillary blood vessel rupture and hence to blood contamination of the lung
fluid recovered making it inappropriate for humoral or cellular studies. Due to the
disadvantages of performing the lung lavage in conscious animals, two alternative
methods for the recovery of respiratory fluid in sheep have been described (Burrells
and Williams, 1986), namely gross lavage of excised lungs and segmental lavage on





The flow cytometer is a sophisticated apparatus for cell analysis. It uses laser
light sources and sensitive optics that can analyse cells on the basis of light scattering
and fluorescent properties and thus, improve the degree of accuracy with which cells
from lavage fluid are identified. A suspension of cells appropriately labelled with
fluorochrome conjugated antibodies to cell surface antigens is projected through the
nozzle of the machine under pressure. Each cell, on passing the light beam, generates
optical signals by scattering the light or emitting fluorescence and these optical signals
are detected by photodetectors (lenses and optical filters) which convert them into
electrical signs relating cell volume to its electronic impedance. These electronic
signals are then stored and processed by a computer.
Three different parameters are usually recorded for each cell: forward angle
light scattering or forward scatter (FSC), which represents the light that is deflected
out of the laser beam through a small angle (0-1 CP) and is related to cell diameter;
right angle light scattering or side scatter (SSC), which is the light that is deflected by
the cells through a wide angle (70-110°) and gives information about the internal
structural properties of the cells (i.e. those cells with large number of cytoplasmic
granules or other organelles scatter more light than erythrocytes or lymphocytes); and
fluorescence, related to binding of fluorochrome.
The simultaneous analysis of two of the variables, FSC and SSC, permits the
rapid identification and selective analysis of the particular population of cells one
wishes to analyse. Furthermore, the use of tire FSC allows discrimination between
viable and non-viable cells since dead cells give rise to a smaller forward scatter signal
than live cells (Loken and Stall, 1982). By using a third parameter, the binding of
fluorochromes, the phenotypic expression of the cells can be identified.
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1.4.2 ANALYSIS AND DISPLAYS
The most common and useful forms of display are the 'frequency histogram'
and the 'dot plot' or dual parameter correlated dot plot. Data can also be presented in
other forms such as the 'three-dimensional histograms' (contour maps or contour
plots).
The frequency histogram or single parameter histogram is the simplest form of
data display available. In this histogram either units of fluorescence intensity or light
scattering per cell are plotted on the horizontal axis which usually consists of 256
channels, and frequency or number of cells on the vertical axis. The conventional
manner for analysis of an immunofluorescence histogram is to separate positive and
negative populations and to set a threshold or gate, those cells with fluorescence
intensity above the threshold being considered to show positive labelling. To set this
'fluorescence threshold' an appropriate control is used as reference; this gate is usually
selected such that only a small percentage of control cells are scored as positive.
In the dot-plot each cell appears on the screen as a dot whose X and Y axis
coordinates represent the light scatter and fluorescence signal for the cell. By
inspection of such a plot it is easy to gain an impression of which size of cells bears
the fluorescent label. However, by using the dot-plots is not possible to assess visually
the quantitative distribution of the various cell populations as all cells that fall in a
particular location will be represented only by a single dot. Three dimensional
histograms show frequencies of cells for all pairs of red and green intensities
(Herzenberg, 1978).
1.4.3 POTENTIAL ADVANTAGES OVER METHODS EMPLOYING
FLUORESCENCE MICROSCOPIC ANALYSIS
Flow cytometry enables rapid, multiparameter analysis of much larger
numbers of cells than fluorescence microscopy, avoiding tedious visual counting. It
provides quantitative data, allowing an accurate measure of the relative amount of
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antibody bound to each cell (this is of great relevance as a cell population is often
identified on the basis of the amount of a particular marker rather than simply on its
presence or absence). It is also much more sensitive, being able to detect very low
levels of fluorescence. Finally, it offers the possibility of characterising cell




1.5. SHEEP LEUKOCYTE MOLECULES IDENTIFIED BY SPECIFIC
MONOCLONAL ANTIBODIES
1.5.1 INTRODUCTION
Most of the molecules on the surface of ovine leukocytes and defined by
MAbs, are homologous to human or rodent molecules; many mammalian leukocyte
molecules have conserved their structure, function and tissue distribution during
evolution (Mackay et al, 1988b). The review below is a summary of those sheep
leukocyte molecules most relevant to this study.
1.5.2 CD45 (LCA)
The CD45 molecule of mammals (formerly LCA or T-200) is a panleukocyte
marker. It consists of a group of integral membrane glycoproteins, ranging in
molecular weight from 180 to 220 kDa, which are expressed only on cells of the
haematopoietic lineage (either immature or mature), including T and B cells,
thymocytes, mononuclear phagocytes and PMNs. Isoforms of CD45 proteins that are
expressed on a restricted group of cell types are designated CD45R. CD45R
expression on T cells is of interest because it is developmentally regulated during the
maturation process of T cells and hence, naive T cells express a form of CD45R called
CD45RA, while memory T cells express a different isoform called CD45RO.
In sheep, CD45 is expressed on the surface of all lymphocytes of the thymus,
spleen, lymph nodes, ileal Peyer's Patches and PB, as well as being found on
macrophages and PMNs (Maddox et al, 1985a). Three different epitopes of the LCA
of sheep have been characterised, one of which is expressed only by B cells and a
unique lymphocyte subset (Mackay et al, 1987). The MAb 1-11-32 identifies a
determinant present on all sheep leukocytes which had the molecular characteristics
expected of the sheep analogue of rat, human and mouse LCA. Another MAb 20-96,
produced against the p220 component of sheep CD45, revealed a restricted tissue
distribution, reacting with all B cells and a subpopulation of CD4", CD8", T19" and
slg" lymphocytes (Mackay et al, 1987). Different cell lineages or cells at various
differentiation stages express different molecular forms of LCA, which result from
differential processing of a primary mRNA transcript from one LCA gene (Saga et al,
1986). The sheep CD45 presents a 190 kDa molecule on B cells from ileal Peyer's
Patches in contrast with peripheral B cell CD45 which is 220 kDa (Mackay et al,
1987).
The precise function of this molecule is still unknown, although MAbs reactive
with LCA inhibit B cell differentiation (Yakura et al, 1983), accessory cell function
(Mairo et al, 1981), NK cell lysis (Newman et al, 1983) and lysis by cytotoxic T
lymphocytes (Harp et al, 1984).
1.5.3 CD2 AND LFA-3
CD2 (also referred to as Til, Leu-5 or Tp50) is the sheep erythrocyte receptor
(Hunig et al, 1986). It is a 40 kDa surface glycoprotein that is present on
approximately 90% of mature T cells, 50-70% of thymocytes (appearing early on
stage I thymocytes) and on NK cells
CD2 functions as an intercellular adhesion molecule, and an identified ligand
for CD2 is the structurally similar molecule called leukocyte function associated
antigen-3 (LFA-3) or CD58 (Denning et al, 1988). LFA-3 is a 55 to 70 kDa surface
glycoprotein expressed on a wide variety of haematopoietic and nonhaematopoietic
cells. CD2 binding to LFA-3 promotes cell-cell adhesion. In addition to its adhesive
function, CD2 is also a signal-transducing molecule, being able to facilitate T-
lymphocyte target cell interactions and to activate resting T-lymphocytes (Hunig et al,
1987). CD2 may activate T cells without MHC and antigen interaction, which might
potentiate immune responses in the absence of additional antigen stimulation (Meuer
etal, 1984).
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Only one MAb, namely 36F, is specific for ovine CD2 (Mackay et al, 1988a;
Hein etal, 1991).
1.5.4 LFA-1 (CDlla/CD18!
Leukocyte function associated antigen-1 (LFA-1) is a member of the integrin
family of heterodimeric leukocyte surface proteins (Arnaout, 1990), which function
primarily as adhesion molecules. LFA-1 is expressed on virtually all bone marrow-
derived cells, including more than 90% of thymocytes and mature T cells, B cells,
PMNs and monocytes (Springer et al, 1987; Kishimoto et al, 1989).
Anti-LFA-1 antibodies inhibit a wide variety of adhesion-dependent
lymphocyte functions (Arnaout, 1990), including antigen and antigen presenting cell-
inducer helper T cell stimulation (Hildreth and August, 1985), CTL-mediated killing
of target cells (Arnaout et al, 1984), and lymphocyte adhesion to high endothelial
venules (Haskard et al, 1986). Intercellular adhesion molecule-1 (ICAM-1), an 80-114
kDa integral membrane glycoprotein is the specific ligand for LFA-1 (Springer et al,
1987).
Six MAbs have been described as CD1 la specific. All these MAbs react with a
180,000 MW a chain associated with the CD18 (3 chain (f^-integrin) (Hopkins et al,
1993a).
1.5.5 CD25 OR IL-2R
This single chain glycoprotein, often referred to as the a-chain of the
interleukin 2-receptor (IL-2R) or the Tac antigen, has a MW of 55 kDa (Robb et al,
1984), and is present on activated T (Yagita et al, 1989) and B (Waldmann et al,
1984) cells, activated macrophages (Hancock et al, 1986) and stimulated monocytes
(Holter et al, 1987; Allen et al, 1990), playing a key role in antigen-induced
proliferation. Together with the (3-chain of the EL-2R (p75, MW 75 kDa), the CD25
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antigen forms a high affinity receptor complex for EL-2 (Robb et al, 1984;
Teshigawara et al, 1987).
1.5.6 CD3 AND TCR
The CD3 molecule in man and mice is a pan T-cell antigen closely linked with
the T cell antigen receptor (TCR). It appears early and is retained throughout T-cell
maturation. The CD3 molecule seems to act as a signal transducer for the TCR,
leading the CD3/TCR interaction to a cascade of intracellular reactions that are
fundamental for cellular activation (Oettgen and Terhorst, 1987). Sheep CD3 has been
characterised using a rabbit anti-human CD3 antiserum which crossreacts with the
sheep molecule; however, no MAbs against this molecule have been raised so far.
1.5.7 CD5
CD5 (also referred to as Tl, Tp67 or Leu-1 in humans and Ly-1 in mice) is a
pan-T cell antigen which appears early on thymocytes and is retained throughout cell
maturation. In man, rat, mouse and sheep this antigen consists of a single
glycopolypeptide chain with a MW of 67 kDa (Mackay et al, 1985; Beya and
Miyasaka, 1986). The tissue distribution of ovine CD5 is analogous to that reported
for CD5 in other species (Mackay, 1988). All T cells, thymocytes and some B cells
express this molecule, medullary thymocytes expressing higher levels of CD5 than
most cortical thymocytes (Mackay et al, 1985). In sheep, CD5+ B cells are abundant
in adult spleen (representing up to 20% of B cells) but are not detected within lymph
nodes or efferent lymph, suggesting that these cells might not be recirculating
(Mackay, 1988).
The functional role of the CD5 molecule is still unknown, although MAbs
directed against the CD5 antigen potentiate T cell proliferation in response to antigens
and mitogens (Dallman et al, 1984) and cause an increase in the production of IL-2
(Ledbetter et al, 1985). CD5 has been associated with the execution of T helper
functions of CD4+ cells and with positive regulatory mechanisms involving T cell
proliferation (Srour et al, 1980). Although the ligand for CD5 has not yet been
determined, similar structural features to other human receptor molecules, such as the
insulin-receptor, IL-2R and transferrin receptor have been attributed to this ligand, due
to the high conservation of mammalian leukocyte molecules through evolution
(Mackay and Mackay, 1989). CD5, identified in sheep by the 25-91 MAb (Mackay et
al, 1985) is, so far, the best pan T cell marker for sheep (Mackay et al, 1987).
1.5.8 CD4 AND CD8
The primitive thymocyte acquires both CD4 and CD8 antigen. As the
thymocyte matures two separate T subpopulations emerge: one expressing CD4 but
not CD8 (T-helper cell) and the other expressing only CD8 (T-suppressor cell).
Double labelling of ovine T lymphocytes with SBU-T4 and SBU-T8 have shown that
the populations recognised are mutually exclusive (Bujdoso et al, 1989).
CD4: CD4 antigen is a 55 to 62 kDa single chain cell membrane glycoprotein
expressed on most thymocytes and on T cells in all mammalian species so far
examined (Crocker et al, 1987). In sheep and cattle, CD4+ cells are functionally and
structurally similar to those described in humans, rats and mice (Maddox et al, 1985b;
Baldwin et al, 1986; Lalonde et al, 1986). CD4 is a non-lineage restricted molecule
(Crocker et al, 1987), having been demonstrated on CD8" T cell, conical thymocytes,
most medullary thymocytes, some B cell lines (transformed B cells), glial cells,
dendritic cells and even on rat macrophages and human monocytes.
CD4 acts as a receptor for the invariable part of the HLA-class II antigens
(Maddox et al, 1985b) and is involved in the induction of T-lymphocyte helper
functions and T-proliferative responses to antigen stimulation. It also acts as a
coreceptor for TCR2 (a(3 T cell receptor) in T cell activation (Hopkins et al, 1993a).
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Additionally, the CD4 antigen is an important part of the receptor for HTV (Maddon et
al, 1986).
MAbs produced to the sheep CD4 molecule, namely 44.38 and 44.97, do not
crossreact with CD4 molecules in other species (Mackay et al, 1986).
In man, T cells expressing CD4 show restricted recognition of antigen in
association with MHC class II (Marrack et al, 1983) and have mainly helper/inducer
functions (Swain, 1983). Recent studies have discovered the functional heterogeneity
of the CD4+ T cell subset as it includes helper and inducer lymphocytes as well as
suppressor and cytotoxic cells (Thomas et al, 1983). On the basis of lymphokine
secretion patterns the CD4+ T cells subset has been classified into another two
categories, TH1 and TH2 (Janeway, 1975; Marrack and Kappler, 1975; Kim et al,
1985; Francien et al, 1988). The TH1 subset produces IL-2, y-IFN and lymphotoxin,
has cytotoxic capacity, suppresses some antibody responses, mediates macrophage
activation and may also present helper activity for polyclonal B cell differentiation.
The TH2 subset is mainly characterised by the production of IL-4, IL-5, IL-6 and IL-
10, is a potent B cell activator and provides antigen-specific help (Kim et al, 1985;
Tite et al, 1985; Mossman et al, 1986; Coffman et al, 1988).
CD8: CD8 in sheep is a glycoprotein which is a homodimer of 36 kDa on
peripheral lymphocytes, existing in two forms, 33 and 36 kDa, when isolated from
thymocytes (Maddox et al, 1985b). This molecule has a similar nature and tissue
distribution to that of other species (Maddox et al, 1985b; Ezaki et al, 1987). This
antigen is expressed on 10-25% of peripheral blood lymphocytes, 12-23% of efferent
lymphocytes, on most coitical thymocytes and on CD4" medullary thymocytes.
Although also expressed by some NK cells in humans and rodents, this has not yet
been investigated in sheep.
T cells expressing CD8 show restricted recognition of antigen in association
with MHC Class I (De Vries et al, 1989), and have mainly cytotoxic functions
although a CD8+ CD5" population clearly different from the classical
suppressor/cytotoxic T lymphocytes has been observed in sheep (Meeusen et al, 1988)
and also a subset of CD8+ T cells with an auxiliary role in adhesion has been
described (Manakata et al, 1988). The function of sheep CD84" T cells has also been
studied in vitro, resembling that of other species in that anti-CD8 MAbs are able to
block cytotoxic T lymphocyte function (Ezaki et al, 1987). Ovine CD8 also acts as a
coreceptor molecule in T cell activation (Hopkins et al, 1993a). Several MAbs in
sheep recognise CD8, namely 24.9 and 38.65 (Maddox et al, 1985b; Mackay et al,
1986), S-T8 (Ezaki et al, 1985; 1987), CC58 and IL-A51 (Keech and Brandon, 1991)
and CC63 and BAT82A (Hopkins et al, 1993a).
1.5.9 y5T CELLS
y5 T cells neither express B cell markers, nor are associated with B cell
lymphoid tissue. They show a marked variance in tissue distribution between different
species. In sheep, 30-60% of T cells express y8 TCR, the number and localisation of
these cells varying with age and appearing in the thymus during early foetal ontogeny
(Maddox et al, 1987). Some y5 T cells express a unique surface molecule termed Ti9
(Brenner et al, 1986; Weiis and Imboden, 1987; Janeway et al, 1988; Mackay et al,
1989) which is antigenically unrelated to either CD45 or the TCR and without a
known human or murine counterpart. The ovine T19 molecule is a 215 kDa single
chain polypeptide defining a lymphocyte subset which is CD2", CD3+, CD4", CD8",
slg", LFA-l+low, MHC Class I+ and CD5+low. T19 is a maturation marker for y8 T
cells, appearing on nearly mature or mature y5 thymocytes and playing a major role in
their interaction and function (Mackay et al, 1989). T19 could also be responsible for
the homing pattern of y8 T cells. In vitro activated y5 T cells, such as those from the
gut epithelium, express less T19 than resting y5 T cells (Mackay et al, 1991). The
distribution of T19 cells in peripheral lymphoid organs is exclusively restricted to the
small lymphocyte population, exhibiting the characteristics of normal recirculating
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lymphocytes and being responsive to T cell mitogens but not to B cell mitogens
(Mackay et al, 1986).
y8 T cells do not recognise antigens presented by MHC Class I or Class II
encoded proteins, and the ligand for y8 TCR has not yet been identified (Haas et al,
1990), although it is known that they use an adhesion molecule distinct from CD2.
The functional properties of y5 T cells are not yet clear, but their location
predominantly in epithelial surfaces suggest they could be a first line defence for the
elimination of infected or transformed epithelial cells, and are apparently recruited to
sites of active inflammation. In vitro experiments have also suggested some cytotoxic
activity. (Hein and Mackay, 1991). Other possible roles that have been suggested for
y8 T cells are involvement in normal pregnancy and thymocyte development (Janeway
et al, 1988).
Several MAbs specific for the T19 molecule on sheep and cattle have been
produced, namely 86D (Mackay et al, 1989), SBU-T19, 197, IL-A29, CC-15 and CC-
39 (Hein et al, 1991).
The reactivity of MAb 86D, one of the markers used in our studies, is very
similar or identical to that of anti-y8 MAbs described in other species (Mackay et al,
1989). However, whether or not MAb 86D recognises all y8 T cells is questionable. A
y8 lymphocyte subset in bovine PB has been shown to be T19+ 86D~ (Mackay and
Hein, 1989).
Results obtained from the first workshop on ruminant leukocyte differentiation
molecules placed all the anti-T19 MAbs into workshop cluster WC1, and MAbs to the
y8 TCR into workshop cluster WC2 (Hein et al, 1991; Howard et al, 1991). MAb
CC15 recognises all WC1 in the sheep (Davis et al, 1990), while 86D is the MAb that
characterises the WC2 (Mackay et al, 1989).
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1.5.10 MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) ANTIGENS
(OVINE LEUCOCYTE ANTIGENS, OLA)
The MHC is a region of highly polymorphic genes whose products are
expressed on the surface of a variety of cells (Hammerling et al, 1975; David et al,
1976). This locus was discovered in the 1940's during the transplantation of tissue
from one individual to another. The MHC-encoded proteins are commonly referred to
as 'MHC molecules' or 'MHC antigens'. They are involved in the regulation of T and B
lymphocyte differentiation, in the ability of the host to mount humoral and cell
mediated immune responses and in the basic cell-cell interactions that maintain the
integrity of the immune system (Puri et al, 1987). There are two types of MHC gene
products namely Class I and Class II. MHC antigens in the sheep are designated ovine
leukocyte antigens (OLA) (Puri et al, 1985).
MHC Class I antigens in man and many other species are a series of membrane
glycoproteins described as the classical 'transplantation antigens' (Gogolin-Ewens et
al, 1985). They are found on the surface of peripheral blood leukocytes (Brown et al,
1979) and of many other cells (Fleming et al, 1981; Muller et al, 1983; Daar et al,
1984). Their main function is the recognition of foreign antigens by cytotoxic T-
lymphocytes and the direction of cytotoxic effector cells against virus-infected targets
(Zinkernagel and Doherty, 1974).
MHC Class II antigens are heterodimeric cell surface glycoproteins consisting
of an a-chain and a (3-chain (Schwartz and Cullen, 1978). These antigens are
constitutively expressed by B lymphocytes (Sachs and Cone, 1973), monocytes
(Winchester et al, 1976), certain haematopoietic precursor cells (Winchester et al,
1977), and Langerhans and dendritic cells (Rowden et al, 1977). Expression of MHC
Class II antigens can also be induced on a variety of cell populations including T
lymphocytes (Frelinger et al, 1974), macrophages (Steinman et al, 1980; Steeg et al,
1982), endothelial cells (Pober et al, 1983) and epithelia (Barclay and Mason, 1982).
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Sheep Class II molecules have a tissue distribution very similar to that ofman (Daar et
al, 1984) and mice (Natali et al, 1981). Class II molecules are involved in humoral
immune responses to soluble and cellular antigens (Kappes and Strominger, 1988),
and have a major role presenting processed antigen to T cells.
Sheep Class EI molecules were first described by Millot (1978), and later by
Puri and others (1985) and Hopkins and others (1986), using a panel of MAbs. In man
they are encoded by three distinct loci DP, DQ and DR and molecular analysis and
sequencing data have identified a further two subregions, DN (Trowsdale and Kelly,
1985; Bodmer et al, 1988) and DO (Tonnelle et al, 1985). In the sheep they appear to
be controlled only by two linked polymorphic loci, DR and DQ (Scott et al, 1987;
Puri and Brandon, 1987; Dutia et al, 1990a; 1990b).
1.6 PLAN OF THESIS
This work has combined the use of sheep leukocyte MAbs with flow
cytometry and BAL for the study of MVV-induced lymphoid interstitial pneumonia.
The primary pulmonary pathology induced by MVV is characterised by a
mononuclear cell infiltration of interalveolar septae (Watt et al, 1992). As the types
and functions of cells in BALF reflect their counterparts in the pulmonary interstitium
(Haslam et al, 1980), the technique of BAL can be used to monitor in vivo lung
pathology during MVV-infection and to provide insight into cellular immune events
in the normal and diseased ovine lung. The use of MAbs to sheep leukocytes and flow
cytometry will facilitate characterisation of the phenotypes of both BALF and PB
leukocytes. Furthermore, it will allow qualitative and quantitative comparisons of
leukocyte subsets in BALF with those in PB, both in health and during the course of
MVV-infection.
All the MAbs used for this work had been previously characterised. When this
work started, no MAbs specific for macrophages had been characterised and hence,
most of the MAbs employed were lymphocyte markers. Only markers of activation
were employed on BALF macrophages.
MAb VPM18 (Hopkins and Dutia, 1990), the ovine homologue of the human
CD45 molecule was used in this study as a positive control for leukocyte staining, as it
is absent from non-leukocytic cells.
Staining with VPM8, the anti-ovine light chain specific MAb (Jones, 1988),
was used to characterise B cells, as B cells are classically defined by the expression of
surface immunoglobulin.
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17D.13 (Mackay et al, 1988b) and SBU-T8 (Maddox et al, 1985b) were MAbs
against the two main T lymphocyte subsets, CD4 and CD8 respectively. They were
included to characterise, respectively, T helper and T cytotoxic/suppressor cells, and
later to calculate the CD4+/CD8+ ratio. The CD4+/CD8+ ratio can be considered as
an important measure of the immunoregulatory status (Hoffman et al, 1980).
Two MAbs which characterise y5 T cells, namely 86D (Mackay et al, 1989)
and CC-15 (Mackay et al, 1991) were included in this work because previous studies
in man had suggested a role of these cells in the pulmonary immune response
(Agostini and Semenzato, 1990).
To elucidate the possible role of immune cells in the pathogenesis of maedi,
assessment of the activation status of those cells was essential. Therefore, several
markers of activation were employed. F10/91/43, an anti-CD5 MAb, was used as a
parameter of lymphocyte activation, as loss of CD54" has been reported to occur
during lymphocyte activation in the sheep (Hopkins and Dutia, 1990). MAbs against
MHC Class II antigens with -DR and -DQ specificity were used in single colour flow
cytometric analyses as markers of activation both on BALF and PB lymphocytes and
on BALF macrophages. They were also employed in double colour flow cytometric
analyses, combined with MAbs for the different T cell subsets. This allowed the
characterisation of the differential pulmonary expression of DQ and DR by the
different T cell subsets. Two pan MHC Class II MAbs, namely SW73.2 (Hopkins et
al, 1986) and VPM36+VPM38, a combination of a -ocDR (VPM36) and a -aDQ
(VPM38) anti-MHC Class II MAbs were employed. VPM37P and VPM54a were the
anti-MHC Class II MAbs with DR specificity used, and VPM41P and VPM36a those
with DQ specificity (Dutia et al, 1990a; 1990b). Also as activation markers, two
MAbs, F10/150/39 (Mackay et al, 1990) and L180/1 (Hunig et al, 1986), which
characterise the adhesion molecules LFA-1 and LFA-3 respectively, were applied both
to BALF and PB lymphocytes and to BALF macrophages. Finally, IL-A111, an and
EL-2Ra MAb (Naessens et al, 1992), was included in this study with a double
purpose: firstly, to measure the activation state of BALF and PB lymphocytes and,






4 CHAPTER 2: GENERAL MATERIAL AND METHODS
I
i
I 2.1. EXPERIMENTAL ANIMALS
) The MVV-infected animals were Texel sheep, purchased from a Scottish
commercial sheep flock as previously described (Watt et al, 1990; 1992a). The
original flock had been established between 1972 and 1979 from 30 pedigree Texels
imported from France. All animals purchased were seropositive to MVV, as
determined by an agar gel immunodiffusion test (AGIDT) (Winward et al, 1979).
Although the flock was maintained at grass, prior to the experimental period, animals
were housed in individual pens for variable lengths of time.
Uninfected breed, age, and sex-matched control sheep were obtained from the
Marshall Building, University of Edinburgh. They were housed in a single pen.
To eliminate gastrointestinal worms and lungworms, both groups of animals
were treated every two months with oral ivermectin (Oramec Drench; Merck Sharp &
Dohme, Hoddesdon, UK) at the recommended dose (2.5 ml/10 kg body weight).
Housed animals were fed ad libitum on hay and water with a regulated supply of
concentrates.
2.2. CLINICAL EXAMINATION OF THE ANIMALS
Animals were examined thoroughly using standard clinical techniques, faecal
examination for lungworm larvae, routine haematology and clinical biochemistry
procedures.
The respiratory system was studied with particular emphasis; sheep were
examined for coughing, nasal discharge and dyspnoea and lung fields were




Serum from all sheep was examined for specific precipitating antibodies to
MVV by the AGIDT (Winward et al, 1979). The viral antigen for the AGIDT was
prepared from ovine lung cultures persistently infected with virus strain WLC-1, from
the Central Veterinary Laboratory (Weybridge, UK). The immunodiffusions were
examined at 24 and 48 h. The test was repeated in inconclusive cases.
2.4. COLLECTION OF BRONCHOALVEOLAR LAVAGE FLUID (BALF)
Transendoscopic bronchoalveolar lavage (BAL) was performed under general
anaesthesia using an Olympus XQ10 fibreoptic endoscope (Olympus Corp., New
Hyde Park, NY). Anaesthesia was induced with intravenous 20 mg/kg thiopentone
sodium (Intraval Sodium, May & Baker, Rhone Merieux, Harlow, UK), the animals
intubated with 9.5-10 mm cuffed endotracheal tubes and placed in sternal
recumbency. When required, an additional intravenous steroid anaesthetic was
employed (Saffan; Pitman-Moore Ltd, Cheshire, UK). Topical anaesthesia of the
trachea and major bronchi (5 ml of 2% Xylocaine, Astra, King's Langley, UK) was
used to minimise coughing during bronchoscopy (Fig. 2.1).
The 7 mm diameter endoscope was introduced through the endotracheal tube
until it wedged in a selected lobar bronchus of the diaphragmatic lobe. 200 ml of
sterile physiological saline solution (Aqupharm, Animal Care Ltd, Dunnington, UK)
were instilled in 50 ml aliquots via the biopsy channel of the endoscope into the
occluded bronchus. BALF was then aspirated gently after each infusion, either using a
manual pump (Mityvac pump-3, Arnolds Veterinary Products, Shrewsbury, UK) or 50
ml syringes. The recovered BALF (Fig. 2.2) was pooled in precooled plastic
containers and maintained on ice until processed, always within 20 min of collection.
Instillation and recovery of the lavage fluid took less than 90 s. The fibreoptic
endoscope was always disinfected after use by soaking in a glutaraldehyde solution
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Figure 2.1. Performance of bronchoalveolar lavage (BAL) technique in the
anaesthetized sheep.




(Cidex, Surgikos, Johnson & Johnson Medical Inc., Arlington, Texas, USA) for at
least 30 min.
2.5. PROCESSING OF BALF
BALF was filtered through a loose cotton gauze to remove mucus and the
volume recorded. BALF was then centrifuged at 800 g for 10 min at 4°C in a GS-6R
centrifuge (Beckman, Palo Alto, California, USA) to sediment cellular material, and
the supernatant removed and stored at -2CPC. The cell pellet was resuspended in 5 ml
of sterile PBS and a total BALF count was performed using a System 9000 automated
cell counter (Serono, Baker Diagnostics, Allentown, Pennsylvania, USA). Viability of
the BALF cells, as determined by 0.4% trypan blue dye exclusion (Appendix 111.6),
was always greater than 90%.
2.6. PREPARATION OF CYTOCENTRIFUGE PREPARATIONS
Cytocentrifuge or cytospin preparations were made using a cytocentrifuge
(Shandon Southern Instruments Ltd, Cheshire, UK). 50 pi of the BALF cell
suspension in PBS at 106 cells/ml were centrifuged at 800 g for 7 min. Preparations
were then air dried and stained in Leishman's solution (Appendix III.5), or were fixed
using a water soluble aerosol fixative (Smear fix, Vale Laboratories, London) and
stained with toluidine blue (Appendix III.4).
2.7. DIFFERENTIAL LEUKOCYTE COUNT
Differential counts of 300 BALF cells were performed on Leishman's stained
preparations. Absolute BALF cell counts were determined for each cell type by
multiplying the cell ratio (%) by the total BALF cell count/100.
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2.8. PERIPHERAL BLOOD (PB) COLLECTION
PB samples were collected by jugular venepuncture into evacuated tubes
containing potassium ethylene diamine tetra acetic acid (EDTA) (Becton Dickinson,
Rutherford, USA).
2.9. SEPARATION OF PERIPHERAL BLOOD LEUKOCYTES
For flow cytometry, peripheral blood leukocytes were harvested from PB
following removal of erythrocytes by tris-ammonium chloride lysis (Tris-NF^ CI)
(Mishell and Shiigi, 1980) (Appendix M.2). A total leukocyte count was performed
using a System 9000 automated cell counter (Serono, Baker Diagnostics, Allentown,
Pennsylvania, USA).
2.10. IMMUNOFLUORESCENT LABELLING TECHNIQUE
2.10.1 Single colour flow cytometry
Minor modifications of the methods of Mackay and others (1988b) were
adopted in this study. BALF and PB cell suspensions were labelled using an indirect
immunofluorescence method. Aliquots of 1.5 x 105 BALF or peripheral blood
leukocyte cells were transferred into round-bottomed mini-test tubes (Sterilin,
Hounslow, UK), centrifuged at 800 g for 3 min, the cell pellet resuspended in 50 (il of
primary MAb or control reagent and incubated at 4°C for 45 min.
The cells were then washed three times in 750 |il of PBA buffer (Appendix
II. 1) and incubated in 50 p.1 of fluorescein isothiocyanate conjugated (FITC) F(ab')2
fragment of rabbit immunoglobulins to mouse IgG (Dako, Copenhagen, Denmark),
diluted 1:100 in PBA for 30 min at 4°C in the dark. Prior to use, the diluted FITC-
conjugate was centrifuged at 11500 g for 10 min to remove particulate debris.
Following three further washes in PBA buffer, the cells were resuspended in
100 (il PBS containing 1% w/v paraformaldehyde (BDH, Poole, UK) (Appendix II.2)
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and maintained in the dark at 4°C to minimise the capping or shedding of surface
proteins (Lanier and Warner, 1981) pending analysis, which was always within 24 h
of labelling. The control samples were treated similarly except that either the primary
MAb was omitted or they were incubated with an irrelevant MAb, namely VPM53,
which labels an epitope on Ileobacter (McOrist, 1987). The irrelevant MAb was used
to establish background fluorescence level.
MAbs and conjugates were titrated to determine their optimal working
dilutions (Fig. 2.3). Sheep efferent lymph lymphocytes were stained for single-colour
flow cytometric analysis with MAbs VPM37 (Dutia et al, 1990a; 1990b), VPM41
(Dutia et al, 1990a; 1990b), a pan MHC Class II reagent (VPM36+VPM38) (Dutia et
al, 1990a; 1990b), VPM8 (Jones, 1988), LFA-1 (Mackay et al, 1990) and LFA-3
(Hunig et al, 1986), in the dilutions: undiluted, 1/10, 1/20, 1/50 and 1/100. The
optimal working dilution of each of the MAbs employed was that which gave the most
intense fluorescence (according either to the percentage of positively staining cells or
to the mean channel number of the fluorescence intensity) and also the clearest
separation between the positive and negative populations. This experiment
demonstrated that optimal staining was obtained using all the MAbs as undiluted
tissue culture supernatants.
To establish the optimal working dilution of the FITC conjugate, different
dilutions of FITC were tested against the undiluted MAbs. The working dilution 1:100
was selected as it gave the strongest specific fluorescence with the lowest background
staining of the negative control.
2.10.2 Dual colour flow cytometry
A modification of the sandwich staining procedure described by Pechhold and
Kabelitz (1992) was employed. It is a rapid staining procedure that only requires two
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Figure 2.3. Titration of MAb. Fluorescence histograms of PBL stained with MAb
VPM37, VPM41, anti-Pan Class II (VPM36 + VPM38), LFA-1, LFA-3 and VPM8,
used as neat supernatant, and in the following dilutions: 1/10, 1/20,1/50 and 1/100 are
shown. As negative controls, unstained cells were employed (PBA-PBA). Logarithmic
fluorescence intensity is plotted on the abscissa in arbitrary units and linear cell
frequency is given on the ordinate.
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Figure 2.3. Titration ofMAb (Continued)
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incubation steps; firstly, a simultaneous addition of unconjugated and biotinylated
MAbs and secondly, the addition of fluorochrome-labelled avidin/streptavidin
followed by fluorochrome-labelled Ig.
Essentially, 50 pi of the BALF or PB cell suspension containing 1.5-2 x 105
cells/ml were incubated for 30 min at room temperature with combinations of
biotinylated (25 pi) and unconjugated (25 pi) MAbs. The biotinylated and
unconjugated MAbs employed were of different isotypes. Cells were then washed
twice in 750 pi of PBA and 12.5 fil of 1:200 streptavidin-phycoerythrin (Amersham
International, Amersham, UK) was added (for analysis on the FL2 channel which
measures red fluorescence). After 5 min, 12.5 pi of 1:250 isotype specific FITC-
conjugated rabbit antimouse IgGj (The Binding Site, Birmingham, UK) or 1:500
FITC-conjugated rabbit anti-rat IgG2b (Serotec, Kidlington, UK), depending on the
species of origin of the primary MAb, were added (for analysis on the FL1 channel
which measures green fluorescence) and incubated for 30 min at 4°C. The cells were
again washed with PBA, resuspended in 250 pi of PBA and kept at 4°C in the dark
pending analysis. As analysis was always performed within 4 h, fixation of the cells in
a paraformaldehyde solution was not considered necessary. As negative controls,
combinations of the biotinylated MAbs plus normal mouse serum (1:1000) (Sigma,
Poole, UK) and normal rat serum (1:500) (Sigma, Poole, UK) were included to
determine respectively the extent of fluorescent antimouse Ig and anti-rat Ig antibodies
binding once avidin has reacted with the biotinylated MAb.
2.11. FLOW CYTOMETRIC ANALYSES
Flow cytometric analyses were carried out on a fluorescence-activated cell
analyser, (FACSCAN; Becton-Dickinson, Mountain View, CA, USA) with a 488 nm
argon laser. FITC (520nm) emission was detected with the photomultiplier tube
voltage set at 555 mV. The Consort 30 Version F programme was used in the
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acquisition and storage of the flow cytometric data, while analyses were performed
using either Consort 30 or Lysis.
Separate live gates for lymphocytes and for macrophages were set for each
BALF and peripheral blood leukocyte sample, based on correlated forward light
scatter (FSC) and side light scatter (SSC) parameters. Dead cells were excluded on the
basis of their size, indicated by their FSC. A minimum of 5000, and in most cases
10000, gated cells was analysed.
2.12. LYMPHOCYTE CULTURE
2.12.1 Preparation of peripheral blood leukocytes for culture
Hypotonic lysis with tris-ammonium chloride was performed. 10 ml of jugular
blood were collected into heparinised vacutainers (Becton-Dickinson, Rutherford,
USA), mixed with 35 ml of prewarmed (37°C) tris-ammonium chloride and allowed
to stand at room temperature for 3 min for complete lysis of the red blood cells to
occur. Then, blood was centrifuged at 800 g in a Megafuge 1.0 (Heraeus, Sepatech,
Essex, UK) for 15 min at 4°C and the supernatant discarded. The cell pellet was
resuspended in RPMI 1640 'complete culture medium' (Appendix II.5) and washed
three times in RPMI 1640 'wash culture medium' (Appendix II.6). Finally, leukocytes
from the cell pellet were manually counted using a haemocytometer (Improved
Neubauer, Hawksley and Sons, London, UK) and adjusted to the working
concentration of 2 x 105 cells/ml in RPMI 1640 'complete culture medium'.
2.12.2 Preparation of BALF lymphocytes for culture
BALF was centrifuged at 800 g for 10 min in a Megafuge 1.0 (Heraeus,
Sepatech, Essex, UK) at room temperature and the cell pellet resuspended in 10 ml of
RPMI 1640 'complete culture medium' (Appendix II.5). For removal of alveolar
macrophages by adherence, BALF was incubated for 90 min at 37°C in a humidified
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atmosphere of 5% CO2 in air using a T-162 (162 cm2) tissue culture flask (Costar,
Cambridge, UK) which was kept in a horizontal position, with the cap loosely fitting.
After the 90 min incubation, the flask walls were gently flushed with RPMI 1640
'complete culture medium' using a pipette; non-adherent cells were removed and
centrifuged at 800 g for 7 min. Leukocytes from the cell pellet were manually counted
using a haemocytometer (Improved Neubauer, Hawksley and Sons, London, UK) and
adjusted to the working concentration of 2 x 10^ cells/ml in RPMI 1640 'complete
culture medium'.
2.12.3 Mitogen
A stock solution of concanavalin A (Con A) (Sigma, Poole, UK) at a
concentration of 1 mg/ml was prepared in RPMI 1640 'supplemented culture medium'
(Appendix II.4), aliquoted and stored at -70°C. The same batch of the mitogen was
used throughout the study.
2.12.4 Optimisation of culture system conditions
2.12.4.1 Comparison ofperipheral blood lymphocytes (PBL) separation techniques
To determine which lymphocyte separation technique was better for this study,
separations by density gradient centrifugation over Lymphoprep (Appendix III. 1) and
tris-ammonium chloride hypotonic lysis (Appendix III.2) were compared. Leukocytes
isolated by each method were stained for CD4, CD8, y5 T cells, CD5, VPM8 and IL-
2R using the appropriate MAbs and then analysed by flow cytometry.
Analyses revealed that when using Lymphoprep a considerable proportion of
T-lymphocytes in all the subsets and also lymphocytes expressing IL-2R were lost in
comparison to those separated by hypotonic red blood cell lysis with tris-ammonium
chloride. However, more B cells were obtained with the density gradient
centrifugation over Lymphoprep (Figs. 2.4 and 2.5). In view of these results, and since
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Figure 2.4. Light scatter profiles of a PB sample from a control animal subjected to
two different lymphocyte separation techniques, namely density gradient
centrifugation over Lymphoprep (A) and tris-ammonium chloride buffer lysis (B).











Figure 2.5. Comparison of cell separation techniques in control sheep 96. PBL were
separated by either hypotonic lysis of RBC using Tris-ammonium chloride (Tris-
NH4CI), or by density gradient centrifugation over Lymphoprep, and stained for flow
cytometry using 17D.13, SBU-T8, 86D, ST-1, VPM8 and IL-111A, in order to assess
the proportion of CD4+, CD8+, y5, CD5+ , B cells and EL-2R stained by each MAb
within the lymphocytic gate. Results are expressed as percentages of positively stained
cells by reference to a negative control.
a( } = cells separated by Tris-NH^Cl
b(....) = cells separated by Lymphoprep
c( ) = negative control
1. CD4+ T cells
(a) Tris-NH4C1 = 31.43%
(b) Lymphoprep = 14.16%
400
I. ) 18X29231 I
2. > rs42Q2aaa
2. ) IBX29232B
2. CD8+ T cells
(a) Tris-NH4C1 = 24.34%











3. yd+ T cells
(a) Tris-NH4C1 = 6.74%
(b) Lymphoprep = 5.46%
4. CD5+ T cells
(a) Tris-NI^Cl = 30.4%
(b) Lymphoprep = 14.51%
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5. B cells
(a) Tris-NI^Cl = 21.92%
(b) Lymphoprep = 36.67%
FL 1
6. IL-2R+ cells
(a) Tris-NH4C1 = 17.98%
(b) Lymphoprep = 11.75%
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the main purpose of this study was the culture of T-lymphocytes, tris-ammonium
chloride hypotonic lysis was the method adopted and employed for subsequent cell
separation.
2.12.4.2 Effect ofmitogen concentration
A range of concentrations of Con A was titrated against a fixed peripheral
blood leukocyte concentration of 2 x 105 cells/ml, obtained by tris-ammonium
chloride hypotonic lysis, over a 72 h culture period. Duplicate controls were set up for
each Con A concentration and also a duplicate control of the cell suspension without
mitogen was prepared. The Con A concentrations tested were: 0.5, 1, 2.5, 5, 10 and 20
|ig/ml. The highest percentage of IL-2R expression was obtained with 1-5 }ig/ml of
Con A, thus 5 |!g/ml was the mitogen concentration adopted throughout the
experiment. Results are shown in Fig. 2.6.
Figure 2.6. Con A titration. 2 x 105 peripheral blood leukocytes/ml were cultured in
the absence of Con A and with different Con A concentrations: 0.5, 1, 2.5, 5, 10 and




2.12.5 Culture and stimulation of BALF and PB cells
BALF and PB cell suspensions were cultured with 5 (ig/ml Con A (Sigma,
Poole, UK) in sterile 24-flat bottomed well plates (Costar, Cambridge, UK). Cultures
to which no mitogen was added were employed as controls. All cultures were set in
duplicates and incubated in a humidified atmosphere of 5% CQ in air at 37°C for 3
days. Microplates were then centrifuged at 800 g for 7 min, supernatants stored at
-20°C for further immunological assays and cell pellets were recovered by flushing
the wells with RPMI 1640 'complete culture medium'.
2.12.6 Flow cytometric analyses in cultured lymphocytes
Dual-colour flow cytometric analyses were performed on cultured
lymphocytes. The modified sandwich staining procedure described in section 2.10.2
was employed (Pechhold and Kabelitz, 1992). Flow cytometric analyses were carried
out as previously described.
2.13. STATISTICAL ANALYSES
Cell counts, cell ratios, BALF volumes and flow cytometric data were non-
normally distributed (Merchant et al, 1992; Schwartz et al, 1993). Hence, all the
paired and unpaired sample comparisons were made using the non-parametric
Wilcoxon Rank Test or the Mann-Whitney Test respectively, with a significance level
of 95%. Statistical analyses were performed using Minitab (Minitab Inc.,
Pennsylvania, USA).
2.14. VIRUS INOCULUM FOR EXPERIMENTAL MVV INFECTION
The virus isolate employed for the experimental MVV infection is a British
isolate ofMVV, designated EV1 (Sargan et al, 1991). This vims was first isolated by
cocultivation of PBMCs from a sheep with an acute maedi-like disease (displaying
symptoms of arthritis and pneumonia) with an ovine skin cell line (derived by explant
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and cultivation of a skin biopsy from an uninfected sheep) until syncitia appeared
(approximately 12 days). Extracellular virus was passaged twice more through these
cells (m.o.ix 0.1 TdD50/cell) and harvested at 12 days post-infection. Cultured fluid
was finally harvested, divided into 5 ml aliquots and stored at -70° C.
2.15. TGF-|3 GROWTH INHIBITION ASSAY
TGF-p was quantified by its ability to inhibit epithelial cell proliferation.
Plasma and BALF supernatant samples were assayed for TGF-[3 activity using a mink
lung epithelial cell line, MV. 1 .Lu (ECACC, Porton Down, Salisbury, Wiltshire, UK).
This method is based on the procedures of Tucker and others (1984) and Ikeda and
others (1987).
2.15.1 Preparation ofmink lung epithelial cells
MV.l.Lu mink lung epithelial cells were maintained in the high glucose
formulation of DMEM medium (Gibco Ltd., Paisley, Scotland) supplemented with
10% heat-inactivated foetal calf serum (Ato Tek, Ltd., Glasbury, Hereford, UK)
(Appendix II.7). Cells were kept at 37°C in 10% CO? and passaged at a seed density
of 5 x 105 cells/T-75 (75 cm2) tissue culture flask (Costar, Cambridge, UK) at 3-day
intervals. Subconfluent cells were used to initiate the growth inhibition assay.
To detach cells from the flask surface, 5 ml of versene (BDH, Poole, UK)
(Appendix II.8) were added, incubated for approximately 2 min and discarded. A
combination of trypsin (DIFCO, Detroit, Michigan, USA) and versene (BDH, Poole,
UK) (1:4) (Appendix II.9), sufficient to cover the cells, was then added and incubated
for 5 min. Recovered cells were resuspended in 4 ml of 'supplemented DMEM
medium' (Appendix II.7) and centrifuged for 10 min at 800 g. Supernatant was
discarded, and the cell pellet resuspended in 3 ml of 'supplemented DMEM medium'.
A cell count was performed using a haemocytometer and the cell concentration was
adjusted to 3-5 x 104 cells/well.
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2.15.2 Acidifying procedure
Since TGF-j3 is normally secreted in a latent form, BALF supernatants and
plasma samples had to be transiently acid-activated. Acidification was accomplished
by addition of 3 pi of 5 M HC1 to 200 (il of the samples to reach a pH of 1.5 to 3, and
left at room temperature for 30 min. Samples were then neutralised with 10.6 pi of a
1.4 M NaOFl dilution in 0.7 M Hepes to a pH of 7.4. Finally, 600 pi of 'supplemented
»
DMEM medium were added.
2.15.3 Assay for TGF-p
Cells were seeded at 3-5 x 104 cells/well in a volume of 100 pi 'supplemented
DMEM medium' in 96-well flat bottomed microtitre plates. After 1 h, 100 pi of
twofold dilutions of acidified plasma and BALF supernatant samples or 100 pi of
serial dilutions of a TGF-P], and occasionally a TGF-P2, standard preparation
(NIBSC, Hertfordshire, UK) were added. 22 h later the medium was removed and
cells were pulsed for 2 h with 3[H]-TdR (American International, Amersham, UK)
(specific activity of lpCi/well) at 37°C. At the end of the pulsing period, cells were
washed twice, first with 200 pi of trypsin/versene, and then with 100 pi of trypsin, and
left at 37°C in 10% CO2 for 30 min, to induce cell detachment. Cells were then
harvested onto Wallac glass fiber filter mats (Wallac Oy, Turku, Finland) using a
Harvester 96 (Tomtec, Orange, Conn, USA), and finally radioactivity was determined
in a LKB Wallac 1218 Rackbeta liquid scintillation counter (Wallac Oy, Turku,
Finland).
Each sample was assayed in triplicate. Concentrations of TGF-P were
expressed in ng/ml based on a standard curve that was generated with each set of
assays by using either human recombinant TGF-p] or TGF-P2 (NIBSC,
Hertfordshire, UK) (Fig. 2.7).
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Fig. 2.7. TGF-p dose response curve. MV.l.Lu mink lung epithelial cells were plated
at a density of 3-5 x 104 cells/well and treated with 100 pi of serial dilutions of a
TGF-pj or TGF-P2 for 22 h. Conditioned media were then collected and cells were
pulsed for 2 h with 3[H]-TdR at 37°C. TGF-P activity was expressed as percent
inhibition of cell proliferation by the indicated dilutions of TGF-p^ or TGF-P2. The



















































To block TGF-p activity, BALF supernatant and plasma were incubated with
chicken monospecific polyclonal antibodies to TGF-fi. Samples were incubated at
37°C in 10% C02 for 1 h with 1:100 dilution of anti-TGF-(3[ (NIBSC, Hertfordshire,
UK), anti-TGF-f^ (NIBSC, Hertfordshire, UK) or nonimmune chicken IgGj
(Sigma, Poole, UK). The samples were then tested in the mink lung epithelial cell
inhibition assay as described above.
2.16. PLASMA AND BALF UREA DETERMINATIONS
BALF supernatant urea concentrations were determined using a commercial
enzymatic assay kit (Bun Endpoint, Sigma, Poole), employing a modification of the
technique of Rennard and others (1986). To minimise bacterial degradation of urea,
samples were processed and assayed immediately after thawing to room temperature.
Prior to assay, BALF supernatants were centrifuged at 12000 g for 5 min (Maxifuge,
Whiteleafe Scientific, Dulverton) to remove precipitated matter which could affect
optical density measurements. Reaction mixtures of 1.04 ml freshly prepared reagent
and 0.21 ml BALF supernatant or urea standard were gently mixed within the cuvettes
(Semimicro, BDH, Poole) and incubated at room temperature for 5 min. The
absorbance was determined spectrophotometrically (CE 292, Cecil Instruments,
Cambridge) at 340 nm using a 0.5 cm light path. The mean absorbances of duplicate
samples were subtracted from the sum of the absorbance of a reagent blank (1.04 ml
reagent and 0.21 ml distilled water) and that of a BALF supernatant blank (1.04 ml
distilled water and 0.21 ml BALF supernatant) to yield the change in absorbance.
The urea concentration was determined from a standard curve prepared using a
glucose/urea nitrogen standard solution (Sigma, Poole, UK).
Plasma urea concentrations were kindly determined by the Clinical Diagnostic
Laboratory, R(D) SVS using a Technicon RAXT (Technicon, Dublin).
BpK
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2.16.1 Determination of PELF TGF-p concentrations
f
Assuming that urea, being a small freely diffusible molecule, is present in
f
equal concentrations in plasma and in PELF, the concentration of PELF in BALF
samples can be determined by the urea dilution technique (Rennard et al, 1986).
The plasma: BALF urea ratios were determined for each sample. The products
of these ratios and the BALF TGF-(3 concentration yielded the urea adjusted BALF
TGF-P concentration, which was considered to be the PELF TGF-J3 concentration.
[PELF TGF-P]= [BALF TGF-p] x [PLASMA UREA]/[BALF UREA]
immm
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CHAPTER 3: PHENOTYPIC ANALYSIS
BRONCHOALVEOLAR LAVAGE FLUID (BALF)






A phenotypic analysis of the cells present in PB and BALF of maedi-visna
virus (MVV) seropositive (n=i2) and control sheep (n=13) was performed. Cells were
labelled by indirect immunofluorescence using MAbs for leukocyte common antigen
(LCA), CD4, CD8, y5-TCR, CD5, IgG light chain, three different MHC Class II
reagents and the lymphocyte function-associated antigens 1 (LFA-1) and 3 (LFA-3),
and analysed by flow cytometry. BALF from MVV-infected sheep had significantly
increased percentages of lymphocytes, neutrophils and CD8+ lymphocytes and
decreased percentages of CD4+ and CD5+ lymphocytes (p< 0.05). The CD4+/CD8+
ratio was significantly inverted in MVV-infected sheep (p< 0.001). The percentages of
y8 T lymphocytes and B lymphocytes did not differ significantly from those of the
controls. MVV-infected animals showed increased MHC Class II expression on
BALF macrophages and upregulated expression of LFA-1 and LFA-3 on BALF
lymphocytes (p<0.05). There were no significant differences in lymphocyte
phenotype distributions in PB between MVV-infected sheep and controls. The
lymphocyte phenotype distributions of BALF and PB were not significantly
correlated. These data show the phenotypic changes occurring in the cellular
components of BALF during the course of natural MVV infection in live sheep, and
their possible relationship with the pathogenesis of lentiviruses. Other findings that
could contribute to a better understanding of the pulmonary immune response during
MVV infection are also reported and discussed.
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3.2. INTRODUCTION
The mucosal lining of the mammalian respiratory tract contains many
components of the immune system, including phagocytes, lymphocytes and
immunoglobulins, all of which become involved in immune and inflammatory
reactions. By analysing representative samples of pulmonary secretions, therefore, a
great deal of information about the nature of respiratory diseases can be obtained
(Mair, 1987).
Bronchoalveolar lavage (BAL), performed using a fibreoptic endoscope, has
enabled sampling of the cell populations resident within the airways. The cell
population harvested by this procedure correlates fairly well with cell populations
obtained from fractionated lung preparations (Curtis and Kaltreider, 1989) and
transbronchial lung biopsies (Tomichi et al, 1989). This, together with the safety and
repeatability of the procedure, has made BAL one of the main techniques for the
collection of samples from the lower respiratory tract.
The study and characterisation of MAbs to sheep lymphocyte antigens has
allowed detailed studies of lymphocyte subpopulations from different ovine tissues
such as jejunal Peyer's patches (Hein et al, 1989), large intestinal lymphoid follicles
(Aleksandersen et al, 1990) and mammary gland (Lee et al, 1991), facilitating the
investigation of cellular aspects of the sheep immune system (Mackay et al, 1985;
Maddox et al, 1985b; Beya and Miyasaka, 1986; Beya et al, 1986; Hopkins et al,
1986). Some MAbs against ovine macrophages have also been recently developed
(Pepin, 1992).
Immunofluorescence labelling with MAbs and flow cytometry are techniques
with great relevance as research tools having numerous applications in biology and
medicine. They have enabled studies of the density and distribution of cell surface
determinants and the identification of functional subpopulations of cells. This
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methodology has been applied to the investigation of pulmonary immune responses
and has proved to have many advantages over other available immunological
techniques. Hence, phenotypic study of the cellular components of BALF has been
widely reported in man (Yamada et al, 1986), mice (Curtis and Kaltreider, 1989),
rabbits (Shellito et al, 1981), rats (Thrall and Barton, 1984), pig (Gehrke and Pabst,
1990, Asai et al, 1993) and horses (McGorum, 1992; McGorum et al, 1993).
Phenotypic analyses of ovine lymphocytes and macrophages recovered by BAL have
also been reported (Cordier et al, 1990; Nash et al, 1992; Burrells and Sutherland,
1994).
Phenotypic analyses of BALF cells have proven extremely useful in the
investigation of several pulmonary inflammatory conditions including human AIDS
(Randall Young et al, 1985), asthma (Smith and Deshazo, 1993), pulmonary
sarcoidosis (Hunninghake and Crystal, 1981), hypersensitivity pneumonitis (Keller et
al, 1984), idiopathic pulmonary fibrosis (Ginns et al, 1982) and equine chronic
obstructive pulmonary disease (McGorum et al, 1993).
Although phenotypic analyses of BALF lymphocytes and macrophages in
MVV-infection (Cordier et al, 1990) had already been performed, the present work
can be justified as it differs in several important respects with that of Cordier and
others. Simultaneous comparison of PB and BALF parameters were not seen in the
previous studies. Furthermore, Cordier and others employed excised lungs obtained
from the abattoir for the collection of BALF, while the present study was performed
on BALF collected from live animals. Cordier and others (1990) did not determine the
serological status of the animals employed, while in the work described here all the
infected animals were seropositive to MVV. Besides, both the control and the MVV-
infected sheep used in this study were breed-, sex- and age-matched. Finally, except
for one common MAb, SBU-T8, all the other MAbs used by Cordier and others
106
differed from those used in this work. In spite of these differences, Cordier and others'
data are useful parameters with which to compare and discuss the present results.
The aims of this study were to characterise the immunoregulatory cells present
in PB and BALF from control and naturally MVV-infected animals in a flock of
British Texel ewes; to determine whether alterations of these cells occur, and if so, to
provide some insight into the possible contribution of these immune cell populations
to the pathogenesis of maedi.
3.3. MATERIALS AND METHODS
3.3.1 ANIMALS
Twelve adult Texel ewes (body weight range 40-75 kg), seropositive for MVV
by the agar gel immunodiffusion test (AGIDT) and thirteen breed, sex and age
matched seronegative controls (body weight range 53-87 kg) were used. Both groups
of animals were kept under similar management conditions as described in Chapter 2.
3.3.2 SAMPLE COLLECTION AND PROCESSING
PB and BALF samples were collected and processed as previously described
(Chapter 2).
3.3.3 MONOCLONAL ANTIBODIES
The murine MAbs used as primary stage reagents are listed in Table 3.1. As a
second stage reagent a fluorescein isothiocyanate (FTTC)-conjugated F(ab')2 fragment
of rabbit immunoglobulins to mouse Ig (Dako, High Wycombe) was employed at a
previously determined optimal dilution of 1:100.
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Table3.1.Listofmonoclonalantibodies(MAb )employedf rsingle-colourfl wcytometrica lyses. MAbsISOTYPEANTIGENIDENTIFIED
REFERENCE
LYMPHOCYTEMARKERS VPM18 17D.13 SBU-T8 86D F10/91/43 VPM8
IgG,IgG,IgG2aIgGiIgG, IgG,
OvineCD45R OvineCD4 OvineCD8 OvineWC2(y8Tcells)OvineCD5 OvinelightchainI
Hopkins&Dutia,1990 Mackayetl,1988 Maddoxetl,1985b Mackayetl,1989 Beyatal,1986 Jones,1988
LYMPHOCYTEANDMACR PHAGEMARKERS VPM36+38 VPM37 VPM41 F10/150/39 LI80/1IgG, IgG,IgG,IgG, IgG,
TotalvineMHCClass11 OvineMHCClass11(3(DR)OvineMI1CClass1[3(DQ)OvineLFA-1 OvineLFA-3




3.3.4 COMPARISON OF ERYTHROCYTE LYSIS TECHNIQUES
When performing flow cytometry on PB lymphocyte subpopulations which
have been selected using forward (FSC) and side (SSC) light scatter parameters, it
may prove difficult to exclude erythrocytes from the 'analysis gate', particularly if
large immature erythrocytes are present. To eliminate this problem, contaminant
erythrocytes must be lysed prior to flow cytometric analysis. The success of
erythrocyte lysis can then be assessed by determining the percentage of leukocytes
present in the gated leukocyte population using flow cytometry following labelling
with an antibody against the leukocyte common antigen (LCA).
Two techniques of erythrocyte lysis, namely osmotic shock lysis (Appendix
III.3) and tris-ammonium chloride buffer hypotonic lysis (Appendix III.2) were
compared. Aliquots of PB from seven control animals were subjected to both
erythrocyte lysis techniques and their lymphocyte phenotype distributions determined
by flow cytometry following staining for CD4, CD8, yd T cells, CD5 and B cells.
3.3.5 IMMUNOFLUORESCENT LABELLING TECHNIQUE
BALF and PB cell suspensions were labelled using the single colour labelling
technique described in Chapter 2.
3.3.6 FLOW CYTOMETRIC ANALYSES
Samples were analysed as described in section 2.11. A minimum of 5000, and
in most cases, 10000 individual cells from each sample were collected and the
analyses were performed by setting separate live gates around the lymphocyte or
macrophage populations respectively based on correlated FSC and SSC parameters.
FSC and SSC amplifications were linear, while FITC amplification was logarithmic
(all 256 channels). FSC and SSC scatter profiles of PB enabled the identification of
four different cell populations considered to represent dead cells/erythrocytes,
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lymphocytes, monocytes and granulocytes (Fig. 3.1). The scatter profiles of BALF
showed three different cell populations: erythrocytes/dead cells, lymphocytes and
macrophages/granulocytes.
Data were presented as fluorescence profiles with the cell frequency on the
ordinate and the log fluorescence intensity on the abscissa. Consort 30 and Lysis
software packages (Becton Dickinson Ltd., Los Angeles, California, USA) were used
to analyse these data. The results were expressed either as the percentage of cells
positively stained or as the relative fluorescence intensity (the 'mode' or 'mean channel
number'). The mean channel number of a particular fluorescence profile provides an
indication of the intensity of fluorescence either on, or within the cells under
examination.
To confirm whether or not the differences found in the expression of some of
the markers were due to differences in the size or complexity of the cells, the FSC and
SSC measurements on the different cell populations of the MVV-infected animals
were compared with those of controls.
3.3.7 STATISTICAL ANALYSES
As data were not normally distributed, paired and unpaired sample
comparisons were made using the non-parametric Wilcoxon Rank Test and the Mann-
Whitney Test respectively, assuming a significance level of 95%.
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Figure 3.1. Light scatter profiles of ovine PB and BALF. Distinct populations of cells
have characteristic scatter profiles which can be defined by electronic gates on the
flow cytometer. The four identifiable cell populations on the PB profile are labelled as
(1) dead cells/erythrocytes, (2) lymphocytes, (3) monocytes and (4) granulocytes. The
three identifiable cell populations on the BALF profile are labelled (1)












3.4.1 CLINICAL STATUS OF THE ANIMALS
MVV-infected sheep had lower body condition than controls, but showed no
other clinical signs of respiratory disease. MVV-infected animals had varying degrees
of subclinical pulmonary dysfunction as assessed by pulmonary function testing
(Collie et al, 1993). Clinical and haematological examination did not indicate the
presence of any other significant respiratory disease unrelated to MVV infection in
either group.
3.4.2 COMPARISON OF ERYTHROCYTE LYSIS TECHNIQUES
Scatter profiles from those PB samples which had been subjected to tris-
ammonium chloride hypotonic lysis had larger numbers of cells which had FSC and
SCC profiles consistent with those of lymphocytes and granulocytes (Fig. 3.2). There
was no statistical difference in the lymphocyte phenotype distribution of PB samples
subjected to the two different lysis techniques (Fig. 3.3, Table 3.2). Tris-ammonium
chloride was used for subsequent studies.
Figure 3.2. Light scatter profiles of a PB sample from a control animal subjected to
two different erythrocyte lysis techniques, namely osmotic shock lysis (A) and tris-
ammonium chloride buffer lysis (B). More lymphocytes (LYM) and granulocytes











Figure 3.3. Comparison of erythrocyte lysis techniques in control animal 96.
Erythrocytes were lysed either by osmotic shock lysis or by Tris-ammonium chloride
buffer (NH4CI), and PBL were stained for flow cytometry using 17D.13, SBU-T8,
86D, ST-1 and VPM8, in order to assess the proportion of CD4 , CD8+, y8, CD5*
and B cells within the lymphocytic gate. Results are expressed as percentages of
positively stained cells by reference to a negative control.
a( 1 = cells separated by osmotic shock lysis.
b(..») = cells separated by Tris-NE^Cl
c( ) = negative control
1. CD4+T cells
(a) osmotic shock lvsis = 36.59%
(b) Tris-NH^Cl = 41.39%
2. CD8+ T cells
(a) osmotic shock lysis = 16.60%




3. y5+ T cells
(a) osmotic shock lysis = 14.00%
(b)Tris-NH4Cl= 11.11%
rL l
4. CD5+ T cells
(a) osmotic shock lvsis = 31.86%




(a) osmotic shock lvsis = 32.34%
(b) Tris-NH4C1 = 33.20%
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Table 3.2. Comparison of osmotic shock lysis and tris-NF^Cl hypotonic lysis in
peripheral blood leukocytes from control animals (n=7). Results are expressed as
median and ranges of percentages of positively stained cells with the corresponding
MAbs by reference to a negative control (unstained cells).
MAb OSMOTIC SHOCK TRIS NH4C1
CD4 22.3 (15.9-42.5) 33.4 (26.7-46.3)
CD8 4.1 (0.8-16.6) 3.1 (1.1-13.7)
y5 5.2 (2.9-18.5) 5.1 (2.8-15.1)
CD5 22.0 (12.8-43.2) 33.4 (27.2-45.3)
VPM8 64.2 (32.3-88.7) 46.2 (27.0-75.4)
Not significant p> 0.05
3.4.3 BALF CYTOLOGY
According to the histologic criteria the following cell types were identified on
t
cytocentrifuge preparations stained with Leishman s stain: alveolar macrophages,
lymphocytes, neutrophils, eosinophils, mast cells, epithelial cells and erythrocytes.
Alveolar macrophages (Figs. 3.4 and 3.5). The population of alveolar macrophages
was quite heterogeneous, including small, monocyte-like cells with a round to oval
shape and few vacuoles, and larger cells containing two or more nuclei and numerous
vacuoles.
Lymphocytes (Fig. 3.4) Small and large lymphocytes could be recognised. Small
lymphocytes were round cells with concentric circular nuclei. Their cytoplasm was
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scant, transparent or bluish in colouration and localised as a narrow strip around the
nucleus. Large lymphocytes had more abundant and intensely blue staining cytoplasm.
The variably shaped nucleus was usually eccentric and contained paler chromatin than
the small lymphocytes. Occasional small basophilic granules were observed in the
cytoplasm of both small and large lymphocytes.
Neutrophils (Fig. 3.4) were easy to recognise due to the typical lobulations of their
nuclei (from two to five depending on their maturity state). Their cytoplasm was
eosinophilic and usually contained numerous granules.
Eosinophils were characteristic cells with a bilobed nucleus (although occasionally
monolobed). Uniformly sized eosinophilic granules were present within the
cytoplasm, often obscuring the nuclear morphology. Disrupted eosinophils were
occasionally recognised as a free nucleus surrounded by the eosinophilic granules.
Mast cells (Fig. 3.5) were readily recognised due to their oval, centrally located
nucleus and numerous basophilic cytoplasmic granules, although they were
heterogeneous with respect to size and granularity. Occasionally, to confirm the
identity of these cells, a specific staining technique 'toluidine blue' (Appendix III.4)
was necessary as their granules stained metachromatically with this dye.
Epithelial cells recovered in the BALF seemed to be closely correlated to the degree
of trauma caused by the endoscope during BALF collection. Samples from animals
which coughed during BALF collection contained higher numbers of epithelial cells.
The first BALF aspirate contained more epithelial cells than subsequent aspirates.
Two types of epithelial cells were distinguished, namely ciliated columnar epithelial
cells and cuboical epithelial cells. The former had a prominent brush border and a
basal nucleus. These cells were recognised individually, although pairs and small
clusters were more common. The latter were variable in size with a round centrally
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Figure 3.4. Photomicrograph of BALF cells from a control sheep showing five
alveolar macrophages (M), a neutrophil (N) and a small lymphocyte (L), x 1000.
Figure 3.5. Photomicrograph of BALF cells from a control sheep showing seven
alveolar macrophages (M), one of them binucleated, and a mast cell (MA), x 1000.
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located hyperchromic nucleus and a shape varying from round to square. These cells,
when single, were considered difficult to differentiate from alveolar macrophages.
3.4.4 BALF RECOVERY VOLUME
There were no significant differences in the volumes of BALF recovered from
either group of animals (Table 3.3).


















Not significant (p> 0.05)
3.4.5 TOTAL AND DIFFERENTIAL BALF CELL COUNTS
Total BALF cell counts were similar in both MVV-infected animals and
controls (Table 3.4). MVV-infected animals had significantly higher percentages of
lymphocytes and neutrophils (p< 0.05) (Figs. 3.6 and 3.7) and significantly decreased
percentages of alveolar macrophages and eosinophils (p< 0.05) when compared with
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Figure 3.6. Photomicrograph of BALF cells from a MVV-infected animal.
Accumulation of lymphocytes (L), x 1000.
Figure 3.7. Photomicrograph of BALF cells from a MVV-infected animal.
Accumulation of neutrophils (N) and lymphocytes (L), x 1000.
controls (Table 3.5). MVV-infected animals had significantly higher absolute numbers
of lymphocytes (p< 0.001), neutrophils (p< 0.001) and alveolar macrophages (p<
0.05) (Table 3.6).
Table 3.4. Total BALF cell counts (cells/ml) for controls and MVV-infected animals
(median and ranges).
CONTROL 1.00 X 107 (0.64- 2.76) x 107
(n=13)
MVV 1.68 x 107 (0.08- 3.15) x 107
(n=12)
Not significant (p> 0.05)
Table 3.5. BALF differential cell counts for control and MVV-infected animals
(median percentages and ranges).
CONTROL (n=13) MVV (n=12)
NEUTROPHILS 1 (0-3) 5 (1-3)*
LYMPHOCYTES 5(3-20) 13 (6-57)*
MACROPHAGES 86 (79-91) 69 (37-91)*
EOSINOPHILS 4(0-11) 1 (0-9)*
MAST CELLS 1 (0-2) 0 (0-2)
Significantly different at p< 0.05.
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Table 3.6. Absolute cell counts (xlOVml) in BALF from control and MVV-infected
animals (median and ranges).
CONTROL fn=13) MVV fn=121
NEUTROPHILS 1.0 (0.0-3.0) 9.2 (1.6-15.0)*
LYMPHOCYTES 5.0 (3.0-20.0) 21.8 (10.0-95.7)*
MACROPHAGES 86.0 (79.0-91.0) 116.7 (62.1-152.8)+
EOSINOPHILS 4.0 (0.0-11.0) 1.7 (0.0-15.1)
MAST CELLS 1.0 (0.0-2.0) 0.8 (0.0-3.3)
+ Significantly different at p< 0.05
* Significantly different at p< 0.001
3.4.6 DIFFERENTIAL PB CELL COUNTS
No significant differences were observed between both groups of animals in
the percentages of PB neutrophils, lymphocytes, monocytes or basophils (Table 3.7).
Eosinophils were significantly increased in the control animals (p< 0.05).
Table 3.7. Differential cell counts in PB of control and MVV-infected animals
(median percentages and ranges).
CONTROL (n=13) MVV (n=12)
NEUTROPHILS 37 (6-50) 41 (21-78)
LYMPHOCYTES 58 (38-84) 55 (21-76)
MONOCYTES 4(1-9) 3 (0-9)
EOSINOPHILS 4(1-9)* 0 (0-2)
BASOPHILS 0 (0-4) 0 (0-1)
* Significantly different at p< 0.05
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3.4.7 BALF AND PB LYMPHOCYTE PHENOTYPE DISTRIBUTIONS
In BALF of MVV-infected animals, the most noticeable changes were a
significant decrease (p< 0.05) in CD4+ T lymphocytes and a significant increase
(p< 0.05) in CD8+ T lymphocytes. This resulted in a significant inversion (p< 0.001)
of the CD4+/CD8+ ratio in BALF of MVV-infected animals. A significant decrease
(p< 0.05) of CD5+ lymphocytes was also observed. The percentage of y5 T cells in
BALF did not show significant variations. The percentage of BALF B cells was
increased in MVV-infected animals, albeit non significantly (Table 3.8, Fig 3.8).
No significant differences were found in PB lymphocyte subsets between
control and MVV-infected sheep (Table 3.9). The CD4+/CD8+ ratio in PB was
similar in both groups.
The lymphocytic phenotypes from BALF were compared with those from PB,
with values for control and MVV-infected animals being analysed separately (Fig.
3.9). Significantly higher percentages of CD4+ and CD5+ cells (p< 0.05) were found
in BALF of control and MVV-infected animals when compared with PB. PB
contained higher percentages of B cells (marked with MAb VPM8) than BALF,
although this was statistically significant only for the control group (p< 0.05).
There were no significant differences in the FSC or in the SSC values for
BALF lymphocytes (Appendix 1.3.1).
3.4.8 BALF MACROPHAGE PHENOTYPING
Most BALF macrophages expressed LCA, but none expressed CD4, CD8, y8-
TCR, CD5 or IgG-light chain molecules. When analysing the quantitative
fluorescence of unlabelled BALF macrophages, their frequency histogram appeared
shifted to the right of unlabelled BALF lymphocytes. This was due to the inherent
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Table3.8.LymphocytesubsetsinBALFfr montrolandMVVinf ctedanimals. CD45CD4CD8ySTCRCD5BcellsMHCCla sIID4/CD8ratioCONTROL86.954.618.8353.921.162.43 0(n=13)(68.4-96.7)(42.3- 7.1)(8.5-30.4)(3 8-19.6)(40.6-66.9)(13.1-51.1)(1 1-9 .1)(1 8-5.3) MAEDL89.633.4*29.0*5.432.6*33.11.40.9#(n=12)(73.3-98.9)(10.6-67.1)( .-68.3)(1 -25.8)(10.7-57.6)( 1.9-92.6)(12.2-69.6)(0.3-4.0) Resultsareexpressedam dianofp rcentagesofpositivelylabelledcellsilymphocytegatwi hr ngesb ck ts* Significantlydifferefromcontro sp<0.05(Mann-Whitneyonparametricr kest) #Significantlydifferefromcontro sp<0.001(Man -Whitneyonparametricktest)
Table3.9.Lymphocytesubs tsineriph ralblo d(PB)fr mc ntrolaMVVinf ct dni als. CD45D48ySTCRCBcells4/ D8ratioMHCCl sII CONTROL96.219 324 76.8.1 50 93.7 (n=13)(92.2-98.7)( .4-45 5)7 5 1.6)3 -9 9(9 6-3 .1)(17.5-65.8)0.2 3 7(5 .4-87.7) MAEDI98.119 826.50.146 7077.0 (n=12)(91.1-99.1)(9.7-28 611.3-43.43 4 .28. 7 5)( .-65.3)0.2 1(48.3- 0.2) Resultsareexp essedmedianofpercentagesositivelylab llc linymphocytegawi hrangbra k Nosignificantdifferen esfromco trol(Mann-Whi neypara etr cr kt s )
Figure 3.8. Summary of the lymphocyte phenotypic changes observed in BALF
during MVV infection, with respect to a control animal. MVV-infected animals show
a decrease in the proportion of CD4+ and CD5+ T lymphocytes, an increase in the
proportion of CD8+ T lymphocytes, and no changes in the proportion of y5 T
lymphocytes.
(i) Lymphocyte subsets in BALF from a control animal.
(ii) Lymphocyte subsets in BALF from a MVV-infected animal.
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□ PBL m BALF




□ PBL ^ BALF
Figure 3.9. Comparison of lymphocyte phenotype distributions in BALF and PB from
control (n=13) and from MVV infected (n=12) animals. Results are expressed as
median of percentages of positively labelled cells. For results of statistical
comparisons see section 3.4.7.
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fluorescence of BALF macrophages, also referred to as 'autofluorescence'. This effect
was readily overcome by decreasing the excitation wavelength of the flow cytometer
prior to cytometric analysis (Parks et al, 1986).
The median FSC and SSC values for alveolar macrophages did not differ
significantly between controls and MVV-infected sheep (Appendix 1.3.2).
3.4.9 MHC CLASS H EXPRESSION BY BALF MACROPHAGES AND
LYMPHOCYTES
The results of the expression of the MHC Class II molecules on BALF
macrophages are shown in Table 3.10 and in Fig. 3.10. There was no significant
difference in the percentages of positively staining macrophages between the two
groups of animals (Appendix 1.3.3), consistent with the finding that these antigens are
constitutively expressed on most of the ovine alveolar macrophages (Nash et al,
1992). However, BALF macrophages from MVV-infected animals showed a
significantly greater increase in MHC Class II molecule expression, as determined by
the higher 'mode of fluorescence intensity' or 'mean channel number', following
staining with the three reagents (Table 3.10, Fig. 3.10 and Appendix 1.3.4).
Although BALF lymphocytes from both groups of animals expressed MHC
Class II molecules, there were no significant differences in their expression in the two
groups (Appendix 1.3.5).
3.4.10 LFA-1 AND LFA-3 EXPRESSION BY BALF LYMPHOCYTES AND
MACROPHAGES
As with the MHC Class II molecules, the 'mean channel number' was also used
for the study of LFA-1 and LFA-3 on both BALF lymphocytes and macrophages.
BALF lymphocytes from MYY-infected animals had significantly (p< 0.05) increased
LFA-1 and LFA-3 (Table 3.11). BALF macrophages from MVV-infected animals
showed increased expression of both molecules and this was significant for LFA-3 (p<
0.05) (Table 3.12, Fig. 3.11).
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Figure3.10.FluorescencehistogramsfMHCCl sIIxpressiononBALFmacrophagesfr mcontrolndMVV-infectedshe p.L garith icfluo esce cei te ityplott dnthabscissaarbitraryunitsandine rcellfr quencygivenotheordi ate.(...)N g tivecontrol.Flu rescencep fil sarshiftedtot ightiMVV-infectedanimalsbothases.
Table 3.11. LFA-1 and LFA-3 expression on BALF lymphocytes from control and




(47.7 - 312.0) (12.1 - 81.9)
MAEDI 255.8* *70.9
(76.3.- 360.4) (51.3 - 126.5)
Significantly different from controls at p< 0.05.
Table 3.12. LFA-1 and LFA-3 expression on BALF macrophages from control and








(15.0- 117.7) (37.0- 175.0)
Significantly different from controls at p< 0.05.
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LFA-1LFA-3
Figure3.11.FluorescencehistogramsfLFA-1ndLFA-3expressiononBALFmacrophagesfr mcontrolndMVV-infectedshe p.Logarithmicfluorescencei te ityplottedthabscissaarbitraryunitsandlin rcellfr quencygivenotheordinate.(...)Neg tivecontrol.Flu rescenceprofil sarshiftedtorightiMVV-infectedanimalsbothcases.
3.5. DISCUSSION
The sampling of the sheep lung by BAL reflects accurately the immune
response occurring in the affected organ. It also offers many advantages over previous
analyses of the immune response in man and animals which used peripheral blood
lymphocytes (PBL), spleen or lymph node cells (Meeusen et al, 1988; Prior and
Haslam, 1992).
Characterisation of the BALF cellular immune response during the course of
natural MVV infection has been previously described (Cordier et al, 1990; 1992).
The present study is an extension of the work of Cordier and others (1990).
Results in the present work show that BALF cells from MVV-naturally infected sheep
have different phenotype profiles and different levels of expression of some cell
surface molecules from uninfected controls. This is concordant with the results of
Cordier and others (1990). These alterations could play a key role in the pathogenesis
of MVV in the lung and their investigation may provide a better understanding of the
pulmonary pathogenic mechanisms of lentiviruses.
The combination of the BAL technique in vivo with single colour
immunofluorescent labelling with MAbs and flow cytometric analyses has enabled
this work to be performed without sacrifice of the animals. Future studies could be
performed using the same animals to further investigate this disease.
The total BALF cell counts of MVV-infected animals were not significantly
different from those of controls. This is in contrast to the increased BALF cellularity
noted in the study of Cordier and others (1990). This discrepancy could be a
consequence of differences in the two studies. Firstly, the present study used MVV
seropositive sheep, while Cordier and others used lungs collected from an abattoir
which had histological evidence of MVV infection, despite the histopathological
134
lesions of maedi not being pathognomonic (Cutlip et al, 1978; De Boer et al, 1978).
Secondly, it is possible that the sheep used in both studies were in different stages of
disease. Thirdly, as the age of the sheep used by Cordier and others was not stated, an
age difference in the populations studied could account for differences in the results of
the two studies.
Differential BALF cell counts (Table 3.5) of control animals were similar to
those previously reported for normal ovine lungs (Burrells, 1985b). MVV-infected
animals had significantly increased percentages of BALF lymphocytes and neutrophils
and reduced percentages of BALF macrophages. While Cordier and others (1990),
also described increased percentages of BALF neutrophils in MVV-infected sheep,
increased percentages of BALF lymphocytes and reduced percentages of BALF
macrophages were not observed.
The finding of significantly increased percentages of BALF lymphocytes and
neutrophils is concordant with interstitial lung diseases in man and animals and in
pulmonary AEDS (Weinberger et al, 1978; Martin et al, 1983).
Cordier and others (1990) found increased secretion of neutrophil chemotactic
activity (NCA) by BALF cells from MVV affected animals. This cytokine could
account for the amplified recruitment of neutrophils in the affected lungs. The
pathogenic role of these neutrophils in the lung, if any, remains to be determined.
While in sheep (Weiss et al 1983), monkeys (Kazmierowski et al 1977), dogs (Cohen
and Batra 1980; Damiano et al 1980), horses (McGorum et al, 1993) and man (Von
Essen et al 1991), repeated BAL may elicit a transient migration of neutrophils into
the lungs, this phenomenon cannot explain the increased number of neutrophils in
BALF from MVV-infected animals as only a single lavage was performed in this
study.
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Increased numbers of neutrophils in the alveoli is also a common finding in
pulmonary bacterial infection (Damiano et al, 1980). The BALF neutrophilia noted in
the present study was unlikely to have resulted from such a bacterial infection, as
clinical and haematological examinations of these animals did not indicate the
presence of any other significant concomitant pulmonary infection unrelated to MVV
infection. Routine bacteriological culture of BALF was not performed because the
frequent contamination of BALF by oropharyngeal organisms renders this technique
of limited value in diagnosing pulmonary bacterial infections (Bartlett et al, 1976).
BALF from MVV-infected sheep had a significant lymphocytosis (Table 3.5),
consistent with the finding that lymphocytes are the main mononuclear cell type
present in MVV pulmonary lesions (Georgsson and Palsson, 1971). The increased
BALF lymphocyte population could have resulted from recruitment of lymphocytes
from PB and from other lymphoid organs, or from a local proliferation of lymphocyte
populations within the lung. IL-2 could be involved in a proliferation of preexisting T
cells (Hunninghake et al, 1983; Pinkston et al, 1983).
The numbers of lymphocytes in BALF from normal sheep and the comparison
of lymphocyte phenotype distributions within BALF and PB has been recently
established (Burrells and Sutherland, 1994). T lymphocytes account for almost the
whole lymphocyte population in the lungs of healthy sheep, while B lymphocytes
generally represent less than 10%. The present findings were concordant with these
previous investigations.
Decreased percentages of BALF macrophages were the result of proportional
increases in other cell populations in BALF. When reported as absolute concentrations
rather than percentages, the numbers of BALF macrophages were significantly higher
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than those of controls. A macrophage alveolitis has been described in some patients
with AIDS (Agostini et al, 1991).
The increased percentages of neutrophils and lymphocytes and reduced
percentages of macrophages seen in BALF of the MVV-infected animals appeared to
be a local phenomenon within the lung, as these animals had no significant alterations
in the numbers of circulating neutrophils, monocytes or lymphocytes.
There were no significant differences in the proportion of BALF mast cells
between both groups of animals. The specific role of these cells in the ovine lung has
not yet been determined.
The percentages of BALF eosinophils in the control and MVV-infected
animals were within the normal range previously reported (Begin et al, 1981; Rola-
Pleszczynski et al, 1981; Burrells and Williams, 1986), however, MVV-infected
animals had an unexplained reduction in the proportion of eosinophils when compared
with controls.
Natural infection with MVV was accompanied by a significant decrease in the
BALF lymphocyte CD4+/CD8+ ratio, this decrease being due to both a significant
increase in CD8+ T lymphocytes and a significant reduction in CD4+ T lymphocytes.
Cordier and others (1990) had previously reported a decreased BALF lymphocyte
CD4+/CD8+ ratio in MVV infection. However, while they observed an increase of the
CD8+ population, no significant change of the CD4+ population was found. Cordier
and others used the anti-CD4 MAb, SBU-T4, while in the present study, a different
anti-CD4 MAb, 17D.13 was employed. Anti-CD8 MAb SBU-T8 was common for
both studies. CD4+/CD8+ ratio inversion has also been found in synovial fluid of
sheep with MVV-experimentally induced arthritis (Harkiss et al, 1991). The decreased
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BALF lymphocyte CD4+/CD8+ ratio in MVV-seropositive animals could indicate
either a state of increased immunoreactivity or a phenomenon related to a state of
immunotolerance. Changes in this ratio can also indicate imbalances in immune-
reactivity (Tizard, 1986) or pathology associated with a variety of virus infections
(Novotney et al, 1990).
Human AIDS related lymphoid interstitial pneumonia also show an analogous
reduced CD4+/CD8+ ratio and a preponderance of CD8+ T cells (Venet et al, 1984;
Kennedy-Stoskopf, 1989). Disease complications associated with AIDS are usually
attributed to a total depletion of CD4+ T cells, predisposing the patient to
opportunistic infections (Fauci et al, 1984). The depletion of CD4+ T cells in AIDS is
present both in PB and in BALF (Agostini et al, 1993). In contrast, MVV-infected
sheep had normal CD4+ T cells in PB, and significantly reduced, but not totally
depleted CD4+ T cells in BALF. Recent studies have, however, suggested that
immunocompromised lymphocytic function during MVV infection could predispose
animals to opportunistic infections (Brodie et al, 1992). The different CDT*~ T cell
patterns characterising MVV and AIDS suggests that although both causal lentiviruses
induce a lymphoid interstitial pneumonia, the pathogenesis of the two conditions show
important differences.
The cause of the decreased percentage of CD4+ T lymphocytes during the
course of MVV-infection remains unexplained. While HTV selectively destroys
human CD4+ T cells (Rankin et al, 1988), MVV is not lymphocytotropic, therefore
viral infection of ovine CD4+ does not occur (Gorrell et al, 1992). In MVV, CD4+ T
lymphocytes could be destroyed following an interaction with virus antigen presenting
cells, such as macrophages and dendritic cells via MHC Class II antigens. An
inhibition of proliferation of CD4+ T cells, due to cytokines produced during the
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interaction of infected macrophages and lymphocytes, could also account for the
reduced numbers of CD4+ T lymphocytes (Narayan et al, 1988a).
MVV-infected sheep had increased BALF CD8+ ratios, as occurs in human
AIDS (Venet et al, 1985; Semenzato, 1991) and in some types of hypersensitivity
pneumonitis (Berman et al, 1990). The effect of the increased numbers of CD84" T
lymphocytes in MVV-infection is still unclear, although it has been suggested that the
CD8+ T lymphocytic alveolitis in man could induce damage of the lung epithelium
and cause clinical respiratory distress (Meignan et al, 1990). CD8+ T lymphocytes
could induce lung damage by activating macrophages through the production of
mediators such as y-interferon (y-IFN) (Kaufmann, 1988). This y-EFN could cause
expression of MHC Class II antigen in infected and uninfected macrophages
potentiating the lymphoproliferative inflammatory disease in the lung (Kennedy-
Stoskopf et al, 1985b). Furthermore, cytotoxic T cells could act bimodally either
clearing virus or amplifying viral infections (Giorgi et al, 1987a; 1987b). In AIDS this
dual function has also been proposed and therefore, this lymphocyte subset could
either contribute to the tissue damage (Klatzmann and Gluckman, 1986) or serve as an
inhibitory mechanism of HIV replication by production of a soluble factor (Walker et
al, 1986).
The proportion of CD5+ cells in BALF from MVV-infected animals was also
significantly decreased. As an almost total loss of cell membrane CD5 follows ovine
lymphocyte activation (Hopkins and Dutia, 1990), this finding suggests that BALF T
lymphocytes were activated during MVV-infection. The presence of activated
lymphocytes in the BALF of infected animals indicates the presence of an ongoing
local immune process and suggests that these lymphocytes could contribute to the
genesis of lung tissue lesions through the interaction with other effector cells and the
production of mediators (Mornex et al, 1984; Klatzmann and Gluckman, 1986).
Activated T lymphocytes have a well established role in AIDS by promoting the
progression of HIV infection (Mahalingam et al, 1993), and in human pulmonary
sarcoidosis through the release of certain lymphokines such as monocyte chemotactic
factor and migration inhibitory factor (Mornex et al, 1985).
No significant differences were found between the BALF y8 T lymphocytes of
MVV-infected and control animals. Cordier and others (1992), obtained similar
findings using a different MAb, namely SBU-T19, which has the same specificity as
that used in the present study. While the biological function of y8 T cells is not yet
fully understood, protection of epithelial surfaces, participation in cytotoxicity and
participation in macrophage proliferation and granuloma formation have been
suggested (Augustin et al, 1989; Mackay and Hein, 1989; Modlin et al, 1989; Haas et
al, 1990; Spits, 1991). The recent finding of increased y5-TCR cells in some patients
with hypersensitivity pneumonitis (Semenzato, 1991) and in patients with HIV-1
infection (Agostini and Semenzato, 1990; Agostini et al, 1994) suggests they have a
role in the pulmonary immune response. Human BALF y8 T cells show different
phenotypic characteristics when compared with those of blood, as they coexpress CD8
and the NK-related CD56 marker (Agostini and Semenzato, 1990).
LFA-1 and LFA-3 molecules were upregulated on BALF lymphocytes from
MVV-infected animals. Both molecules are cell adhesion molecules with an active
role in leucocyte circulation, activation and proliferation (Arnaout, 1990; Pardi et al,
1992). Thus, the increased expression of both LFA-1 and LFA-3 in MVV-infection
could account for the pulmonary recruitment of circulating lymphocytes and their in
situ activation, and also for the interstitial lymphoid proliferation. Furthermore, as
LFA-1 expression by lymphocytes is increased on activation (Kurzinger et al, 1981;
Nishimura and Itoh, 1988), the increased expression of this molecule on BALF
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lymphocytes from MVV-infected animals suggests that these cells are activated in
maedi.
No significant differences were found between the BALF B lymphocytes of
MVV-infected and control animals, suggesting that pulmonary B cells do not have an
important role in the pathogenesis of maedi. There are no previous studies examining
BALF B cell percentages in MVV-infection. In AIDS, BALF B cells are increased
and also present functional abnormalities (Chess et al, 1984; Young et al, 1985;
Martinez-Maza et al, 1987).
To examine whether differences seen in the expression of some lymphocyte
surface antigens between control and MVV-infected sheep were due to differences in
the cell size or complexity, the FSC and SSC scatter measurements on BALF
lymphocytes of the controls were compared with those of MVV-infected sheep as
previously reported for PBL of patients with sarcoidosis (Shakoor and Hambkin,
1992). The fact that no significant differences in the mean FSC or SSC values were
detected between BALF lymphocytes of both groups of animals indicated that the
differences seen in the expression of some lymphocyte antigens were not due to
differences in the lymphocytes size or complexity.
Cell surface phenotypes of ovine BALF macrophages from control and MVV-
infected animals were similar. These cells expressed LCA, but not CD4, CD8, CD5
and yS-TCR molecules, consistent with the findings of Nash and others (1992). In
contrast, BALF macrophages from normal humans and rats (Crocker et al, 1987) and
some large macrophage-like cells from ovine afferent lymph (Mackay et al, 1988b)
express CD4. CD4 and CD8 molecules are also expressed on cultured ovine
macrophages derived from blood monocytes from both MVV-infected and control
animals (Wei Cheng Lee, personal communication). In man, CD4 molecules on BALF
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macrophages act as receptors for the HIV virus resulting in a low grade persistent
infection of these cells in vitro (Plata et al, 1990). As CD4 is absent from ovine BALF
macrophages, these molecules cannot act as receptor molecules for MVV; MHC Class
II antigens have been shown to act as a component of the cellular receptor for ovine
MVV (Dalziel etal, 1991).
BALF macrophages showed autofluorescence, similar to that of human BALF
macrophages (Edelson et al, 1984). While all the causes of autofluorescence are not
yet clear, this seems to be a function of cell size, cell type, excitation wavelength and
emission detection range and is usually attributable to normal cell constituents such as
flavin nucleotides and pyridine which tend to predominate in larger cells (Benson et
al, 1979; Parks et al, 1986). Accumulation of ageing pigments within cells such as
lipofucsin or ceroid which alter the cellular metabolism (Shapiro, 1983) and changes
in the fluorescence of pyridine nucleotides following alteration in the intracellular
redox state due to oxidant stress (Edelson et al, 1985) are also potential causes for the
autofluorescence. In the present study, the problem of autofluorescence was
minimised simply by performing flow cytometry using a reduced excitation
wavelength.
The significant increased expression of MHC Class II molecules in BALF
macrophages of MVV-infected animals seems to be an indicator of a state of
activation in this cell population. This finding is concordant with the work of Cordier
and others (1990), who also found increased spontaneous release of fibronectin and of
NCA (as previously reported) by BALF macrophages.
The interstitial lung disease observed in MVV infection is probably mediated
by activated macrophages expressing MHC Class II molecules. These cells are not
only the target cells for MVV but, by presenting MVV antigen in association with
MHC Class II antigens to th cells, could cause proliferation of CDS4" lymphocytes,
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resulting in inflammation and tissue damage. Furthermore, as MHC Class II antigens
are a component of the cellular receptor for MVV (Dalziel et al, 1991), increased
expression of these molecules could promote the spread of the virus to uninfected
macrophages, allowing persistence of the virus within the host.
Finally, MHC Class II molecule expression on macrophages is regulated by y-
IFN (Zink et al, 1987; Nash et al, 1992) which is produced during the interaction
between the lentivirus-infected macrophages and lymphocytes (Narayan et al, 1985).
The y-IFN produced in vivo, by increasing the expression of MHC Class II antigens on
BALF macrophages might contribute to the host lymphoproliferative response to
MVV (Kennedy-Stoskopf et al, 1985b).
The lack of significant differences in the mean FSC and SSC values between
both groups of animals confirmed that the greater expression of MHC Class II
molecules found on BALF macrophages from MVV-infected animals was not
attributable to variations in cell size or complexity (Shakoor and Hamblin, 1992).
LFA-1 molecule expression by BALF macrophages was not significantly
affected by MVV-infection. In AIDS, a decreased percentage of LFA-1+ BALF
macrophages has been observed (Bene et al, 1988).
When compared with PB, BALF from control sheep had significantly higher
percentages of CD4+, CD5+ and lower proportions of B cells, consistent with the
findings of Burrells and Sutherland (1994). Similar differences in PB and BALF
lymphocyte phenotype have been reported in man (Yamada et al, 1986) and horses
(McGorum et al, 1993). Nelson and others (1990) reported differences between
lymphocytic phenotypes in rat lung vascular beds and PB. Furthermore, functional
differences between lung and blood lymphocytes have been demonstrated (Nelson et
al, 1990). These findings indicate that lymphocyte phenotype compartmentalisation
may occur in normal individuals.
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Although correlated phenotypic changes in PB and synovial fluid lymphocytes
in MVV-infected animals have been described (Kennedy-Stoskopf et al, 1989), in this
study, alterations in the distribution of lymphocyte phenotypes in BALF from MVV-
infected animals were distinct from and not associated with lymphocyte phenotype
changes in PB. Furthermore, phenotypes of PBL from control and MVV-infected
sheep showed considerable individual variation, suggesting that the determination of
PBL phenotypes is not a valuable indicator of the pathological processes occurring in
the lung during the course of MVV infection. These findings indicate that local
pulmonary immune mechanisms may be operative without corresponding systemic
involvement (Salvaggio and Karr, 1979; Westermann and Pabst, 1990). Consequently,
phenotypic evaluation of BALF lymphocytes provides a more accurate assessment of
the pathological processes occuring during the course of MVV infection than
evaluation of PBL. Furthermore, many factors other than the presence of disease,
including age, sex, stress and treatment with drugs can influence PB lymphocyte
phenotype distributions (Westermann and Pabst, 1990). Despite these reservations,
functional and phenotypic evaluations of human PB T-lymphocytes have proved
useful in the assessment of immunological status in several diseases (Moretta et al,
1979; Brouet et al, 1980).
To summarise, the altered BALF T cell phenotypic profiles of MVV-naturally
infected sheep, together with the upregulation of MHC Class II molecules on BALF
macrophages and of LFA-1 and LFA-3 molecules on BALF T lymphocytes would
suggest that activation of BALF lymphocytes and macrophages occurs during natural
MVV-infection. Further studies into the state of activation of BALF T lymphocytes in
MVV-infection were performed and are described in Chapter 4.
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CHAPTER 4: FLOW CYTOMETRY STUDY ON THE ACTIVATION OF
BALF AND PB T LYMPHOCYTES DURING THE NATURAL COURSE OF
MVV INFECTION.
4.1. SUMMARY
A study on the stage of activation of lymphocytes recovered by BAL and from
PB in MVV-infected (n=7) and control (n=7) sheep was performed using dual-colour
flow cytometry. The lymphocyte population was defined by its light scattering
properties. Three parameters of lymphocyte activation were assesed, namely cell size
and complexity, cell surface interleukin-2 receptor (IL-2R) expression, and DR and
DQ MHC Class II molecule expression. MVV-infected animals showed upregulation
of DR and DQ MHC Class II molecules on BALF lymphocytes, without changes in
cell size and complexity or increased expression of EL-2R. No evidence of PB
lymphocyte activation was detected. These findings suggest that an impaired process
of lymphocyte activation occurs during natural MVV-infection.
4.2. INTRODUCTION
Although MVV seems not to be lymphotrophic (Gorrell, 1992), lymphocytes
are the main cell type which accumulate in the lung during infection (Narayan and
Clements, 1989). The putative role of T lymphocytes in human lung immune response
and immunologic lung diseases has given rise to many functional and phenotypic
studies of this particular cell type (Davidson et al, 1985). All the lymphocyte
categories, such as T, B and NK cells are present in the lung, but research work has
mainly concentrated on T lymphocytes as they form the predominant lymphocyte
population in epithelial lining fluid (Saltini et al, 1984). Pulmonary lymphocytes differ
from circulating lymphocytes in that, even when resting, some appear to be partially
activated, (Semenzato, 1991). Hence, experiments performed on unimmunised canine
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lungs have shown that while unstimulated lymphocytes comprise over 90% of the
bronchoalveolar lymphoid cells, the remainder of the lymphoid cells are activated
lymphocytes and very occasional plasma cells (Brownstein etal, 1980).
Previous studies of BALF cells from MVV-naturally infected sheep had shown
altered T lymphocyte phenotypic profiles. All these changes, together with an
upregulation of LFA-1 (Kurzinger et al, 1981) and LFA-3 (Mackay et al, 1988b)
molecules on BALF T lymphocytes suggest an active T lymphocyte involvement
during the respiratory form of the disease (Watt et al, 1992b; Lujan et al, 1993).
In HIV infection, T cell activation is a consistent and early feature
(Mahalingam et al, 1993). It is known that the accumulation of lymphocytes in the
lung not only plays a passive role in the alveolitis, but these lymphocytes by
undergoing activation might contribute to the development of lesions in the
pathogenesis of lymphocytic alveolitis through interactions with other effector cells
(Mornex et al, 1985). Activation of lung T cells is also considered a major factor in
the pathogenesis of human interstitial lung disease (ILD) (Crystal et al, 1981; Ginns et
al, 1982; Keogh and Crystal, 1982; Mornex et al, 1984; 1985). Infection with MVV
provides an animal model of diffuse fibrosing ELD in humans (Cordier et al, 1989).
The aim of this study was to determine the degree of activation of PB and BALF T
lymphocytes of MVV-infected sheep.
MAbs and phenotypic analysis of activation markers have been successfully
used in recent years to probe for cell surface molecules involved in T lymphocyte
activation (Yu et al, 1980; Hunig et al, 1986) and for the assessment of the
immunological status of some diseases such as idiopathic myositis (Miller et al,
1990). In the latter study, cell size and the presence of MHC Class II and IL-2R
antigens were the parameters of T cell activation. The presence of these markers has
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been reported to be good evidence of lymphocyte activation in man, both in vivo
(Yachie et al, 1983; Morris et al, 1993) and in vitro (Krown et al, 1983).
4.2.1 T LYMPHOCYTE ACTIVATION
Lymphocytes recognise and respond to foreign antigens by undergoing a series
of multiple transformations, all these changes being grouped together under the name
of 'activation'. The process of activation involves a series of cellular and lymphokine-
mediated events, depends upon the participation of effector cells such as mononuclear
phagocytes and other leukocytes and culminates in T cell proliferation and the
emergence of specific effector T lymphocytes (Goodman, 1982; Samelson, 1989).
Most of the current knowledge of the cascade of molecular events in T cell
activation is derived from in vitro experiments in which T cells can be stimulated in a
controlled manner, and their responses measured accurately. These cellular events,
although still incompletely understood, comprise the following interconnected steps;
1) Early signal transduction events, include membrane phospholipid
breakdown, elevated protein kinase C activity and increased cytoplasmic calcium.
After TCR antigen-binding, intracellular signalling is transduced to the cytoplasm
through the CD3 complex of surface molecules (June, 1991). The TCR/CD3 complex
functions, thus, as a signal transducing unit, being critical to T cell recognition by
conferring antigen-specificity and initiating the cascade of biochemical events for T
cell activation (Clevers et al, 1988). Apart from the TCR/CD3 complex, multiple
additional accessory molecules, such as CD4, CD8, CD45, CD28 and CD2 can fully
activate T cells in combination with a TCR/CD3 mediated signal (Geppert et al,
1990).
2) Transcriptional activation of a variety of genes; the transcription or
expression of the IL-2R gene enables the proliferation of T cells, thus controlling both
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the initiation and the maintenance of the immune response. After the transcription of
the EL-2 and IL-2R genes, there is activation of the genes coding for some other
lymphokines, such as y-IFN, TNF-a and IL-4.
3) Expression of new cell surface molecules (i.e. MHC Class II molecules or
transferrin receptor).
4) Secretion ofcytokines (i.e. y-IFN, TNF-a, IL-2, EL-3, IL-4, IL-5 and IL-6).
5) Induction ofmitotic activity; functional and mitotic responses of T cells to
antigenic stimulation last only for brief periods, and the responses decline as the
antigen is eliminated.
4.2.2 PARAMETERS OF LYMPHOCYTE ACTIVATION
For the estimation of T lymphocytes activation, several individual parameters
have been described (Mornex et al, 1985; Hancock et al, 1986);
1) Measurement of changes in RNA and DNA content of cells (as their
increase characterises proliferating cells), either by flow cytometry or through P H]
thymidine uptake.
2) Cell size, as large lymphocytes are regarded as an early indicator of
activation.
3) Cytological features, such as size, have also been used to separate
lymphoid cells into unstimulated lymphocytes, activated lymphocytes and plasma
cells (Browsntein et al, 1980).
4) Presence of activation antigens, such as MHC Class II antigens.
5) Spontaneous release of lymphokines, i.e. EL-2.
6) Increased response to mitogens.
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4.2.3 INTERLEUKIN-2 AND ITS RECEPTOR.
The production of IL-2 and expression of its receptor are main events in the T
cell response (Reem and Yeh, 1984; Waldmann, 1986).
IL-2 or T cell growth factor, first described in 1976 as a factor promoting
growth of T lymphocytes from normal human bone marrow (Morgan et al, 1976) is a
glycoprotein with apparent MW 15,500 which is synthesised and secreted by T cells
in the initial phase of their activation by antigens and mitogens or in mixed
lymphocyte culture (MLC) in the presence of macrophage-derived interleukin-1 (IL-1)
(Smith, 1980; Diamantstein et al, 1986; Kaczmarck, 1986). IL-2 binds to each cell
with two distinct affinities, one high and one low. IL-2, through binding to high
affinity EL-2R, exerts growth promoting and proliferation effects on activated T cells
(Smith et al, 1979; Robb et al, 1981), proliferation and activation ofNK cells (Henney
et al, 1981), proliferation of lymphokine activated killer cells (Grimm et al, 1983),
induction of cytotoxic T cell activity, promotion of B-cell proliferation and
differentiation in vitro (Tsudo et al, 1984; Waldmann et al, 1984) and control of
lymphokine production (Waldmann, 1986). The role of the low affinity receptor
remains unknown (Dukovich et al, 1987).
4.2.4 THE USE OF IL-2R AS AN ACTIVATION MARKER
T lymphocyte proliferation is characterised by the appearance of new cell
surface antigens termed 'T cell activation antigens'. These activation antigens are not
present on resting T cells and each has a characteristic and reproducible time of
appearance after T cell activation by mitogens. Based on their temporal appearance
they have been classified as early, intermediate or late antigens (Corner et al, 1983).
According to this classification EL-2R is an 'early antigen' and its expression is
considered to be a better and earlier indicator of lymphocyte activation than DNA
synthesis, as EL-2R is required for DNA synthesis (Miyawaki et al, 1982; Cotner et al,
1983). Hence, the measurement of IL-2R reactive cells has been considered as a valid
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parameter of early T cell activation (Prince and John, 1986; Famularo et al, 1990;
Santos et al, 1991; Morris et al, 1993), appearing shortly after the in vitro activation of
T cells (Larsson and Coutinho, 1979; Miller et al, 1990). The transition of T cells
from a resting to an activated state is thus marked by the expression of IL-2R (Greene
et al, 1984, 1986a; Kronke et al, 1984).
Although in vitro stimulated B cells and monocytes/macrophages and NK cells
also express IL-2R (Waldmann, 1986) as they do it to a much lesser extent than
activated T cells (Famularo et al, 1990) IL-2R can be regarded as T cell specific. EL-
2R is a more sensitive activation marker than other T cell activation-associated
antigens, such as the transferrin (Omary et al, 1980; Trowbridge and Omary, 1981) or
the insulin receptor (Helderman and Strom, 1979), which are widely distributed in
many proliferating cell types (Santos et al, 1991).
Most of the knowledge about the structure, function and expression of the
human EL-2R was obtained through the production of the anti IL-2R, anti-Tac or anti-
CD25 MAb by Uchiyama and others (1981). A MAb specific for bovine EL-2R a-
chain, which crossreacts with ovine CD25, has also been recently produced (Naessens
et al, 1992).
4.2.5 THE USE OF MHC CLASS H ANTIGENS AS ACTIVATION MARKERS
Human MHC Class II antigens, which are constitutively expressed on some
cell types such as B cells, monocytes and dendritic cells (Kaufman etal, 1984; Kappes
and Strominger, 1988), fall into the category of activation antigens on peripheral T
cells (Mittler et al, 1983).
In man, the appearance of MHC Class II antigens on T cells is a relatively late
event after mitogen-dependent activation of T cells (Ko et al, 1979), being expressed
in higher density in the G2 phase of activated T cells (Matsui et al, 1986). Therefore,
these antigens are regarded as 'late antigens' (Corner etal, 1983).
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However, there is considerable inter-species variation in the expression of
MHC Class II by T lymphocytes. Hence, while human T lymphocytes synthesise and
express MHC Class II antigens only after activation (Ko et al, 1979; Robbins et al,
1988), feline (Rideout et al, 1992), canine (Deeg et al, 1982) and equine (Crepaldi et
al, 1986; Monos et al, 1989) MHC Class II molecules are constitutively expressed by
T-lymphocytes. In mice, there is some controversy regarding whether the MHC Class
II antigens expressed on activated T cells are synthesised by T cells (Lorber et al,
1982) or adsorbed from the stimulating cell population (Singh et al, 1984). In sheep,
expression of MHC Class II molecules is dependent both on the age of the animal and
the physiological location of the T cells (Dutia et al, 1993). A proportion of ovine
resting peripheral (Dutia et al, 1993; Burrells and Sutherland, 1994) and efferent
lymph (Hopkins et al, 1993b) T cells express DR+ MHC Class II molecules.
Expression of MHC Class II DQ+, however, can be considered as an activation
marker in the sheep (Dutia et al, 1993; Hopkins et al, 1993b).
4.2.6 THE USE OF DUAL COLOUR FLOW CYTOMETRY TO STAGE BALF
T LYMPHOCYTE ACTIVATION
The study of BALF T lymphocyte activation by flow cytometry, unlike
estimation of mediator release, allows a direct quantification of the numbers of
activated cells. The combined qualitative and quantitative determination of the
diversity of activation markers expressed by BALF T lymphocytes might prove useful
for the assessment of the possible relationship between these markers and disease
progression. It could also provide criteria for staging the intensity of the lymphocytic
alveolitis, giving a better method for studying the ongoing local immune response in
the lung during the course ofMVV infection.
When trying to identify the specific function of a cell, the presence, absence or
degree of expression of multiple markers on the surface of that cell provides more
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information about its specific function than the study of the presence of a single
antigenic determinant (Carter and Meyer, 1990).
Two colour flow cytometry enables simultaneous measurement of the
fluorescence intensity of two antigens on each cell, allowing thus a correlated,
multiparametric evaluation of markers related to cell function.
The use of dual and multiple colour immunofluorescence, although available
for some time, did not play an important role in clinical investigation until recently
due to technical problems and the lack of suitable fluorochromes. Today, the
availability of new dyes, such as fluorescein-phycoerythrin, has made dual colour
immunofluorescence a valuable technique.
4.3. MATERIALS AND METHODS
4.3.1 ANIMALS
Seven adult Texel ewes (age range 3-7 years), seropositive to MVV by the
AGIDT, and seven breed, sex and age matched seronegative controls ewes were used
(Chapter 2). Different animals from those employed in Chapter 3 were selected for
this study.
4.3.2 SAMPLE COLLECTION
BALF and PB sample collection and processing were performed as previously
described in Chapter 2. A control and a MVV seropositive animal were sampled on
each occasion.
4.3.3 MONOCLONAL ANTIBODIES AND REAGENTS
MAbs and the immunoconjugates used in this study are listed in Table 4.1.
Biotinylated MAbs were conjugated to biotin according to the method of Hudson and
Hay (1989).
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R-phycoerythrin-streptavidin (PE-SA) complex (Amersham International,
Amersham, U.K.) was used as a second step reagent to complex with the biotinylated
MAbs. Rabbit anti-mouse IgGj FITC (The Binding Site, Birmingham, UK) was used
to label unconjugated primary MAbs, since they were all of the IgGj isotype. Rabbit
anti-rat IgG2b FITC (Serotec, Kidlington, UK) was employed to label the
unconjugated primary rat MAb SW73.2.
All the MAbs and immunoconjugates were used at previously determined
optimal working dilutions (Table 4.2).
4.3.4 DUAL COLOUR LABELLING TECHNIQUE
The staining procedure employed has been previously described (Chapter 2).
4.3.5 DUAL COLOUR FLOW CYTOMETRIC ANALYSIS
Quantification of antigen expression was as described by Hopkins and others
(1989), using a FACSCAN flow cytometer (Becton Dickinson Ltd, Los Angeles,
California) equipped with Consort 30 version F software. A 488-nm light (200 mW,
argon laser) was employed in order to excite fluorescein and phycoerythrin. The
electronic compensation of the machine for FL1-FL2 and FL2-FL1 was adjusted for
each combination of MAb to optimise the two-colour analyses. Linear amplification
was used for the physical parameters (FSC, SSC) and logarithmic amplification used
for the fluorescence parameters (FL1-green, FL2-red).
Between 5-10 x 103 cells were collected per sample and red and green
fluorescence analyses were performed on viable resting lymphocytes and blast cells,
discriminated from dead cells and alveolar macrophages on the basis of their FSC
versus SSC light scatter.
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IMMUNOCONJUGATES RabbitantimouseIgGj Rabbitnti-ratIgG2b Phycoerythrinlab lledst ptavidin
Table 4.2. Optimal working dilutions for monoclonal antibodies and conjugates for












Rabbit anti-mouse IgGj 1:250
Rabbit anti-rat IgG2b 1:1000
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4.3.6 STATISTICAL ANALYSES
Results obtained from the double staining were analysed in two different ways:
firstly, by setting quadrants by reference to a relevant negative control (as explained in
Chapter 2) and then calculating the percentage of double positively labelled cells and
secondly, by performing curve subtraction analyses. As data were non normally
distributed, BALF and PB sample comparisons between MVY-infected and control
sheep were made using the Mann-Whitney non parametric test, with a significance
level of 95%.
4.4. RESULTS
4.4.1 LYMPHOCYTIC PHENOTYPES IN BALF AND PB
As reported in previous studies (Lujan et al, 1993), the most consistent
findings in the BALF lymphocyte subsets from MVV-infected animals were a
decrease in the percentage of CD4+ T cells [control= 39.1 (32.5-50.8); MVV= 23.4
(11.4-40.8)], an increase in the percentage of CD8+ T cells [control= 17.3 (9.8-35.6);
MVV= 29.6 (12.1-74.9)] and a significant inversion (p< 0.05) of the CD4+/CD8+
ratio [control= 2.9 (0.9-3.9); MVV= 1.0 (0.2-1.3)] (results expressed as median and
range of percentages of positively labelled cells). No changes were observed in the
percentage of y8 T cell population. No significant differences in PB lymphocyte
subsets were observed between the two groups of animals.
4.4.2 BLAST TRANSFORMATION IN LYMPHOCYTES FROM BALF AND
PB
In both BALF and PB, lymphocytes from control and MVV-infected animals
showed similar distribution on the FSC/SSC dot plot (Fig. 4.1).
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Figure 4.1. Light scatter profiles of BALF and PB from a control (A) and a MW-
infected (B) animal. The gate shows the lymphocyte population that is present in the
same location for both groups of animals. No blast transformation is observed.
BALF
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4.4.3 MHC CLASS H EXPRESSION IN BALF
4.4.3.1 CD4+ T LYMPHOCYTES
The coexpression of CD4 and MHC Class II molecules on BALF lymphocytes
is shown in Table 4.3 and Figure 4.2, respectively.
MVV-infected animals demonstrated a significant (p< 0.05) increase in the
percentage of CD4+ T cells expressing all the MHC Class II MAbs employed, namely
SW73.2, VPM54 (DR) and VPM36 (DQ), both by quadrant and by curve subtraction
analyses.
4.4.3.2 CD8+ T LYMPHOCYTES
Table 4.4 and Fig. 4.3. show the coexpression of CD8 and MHC Class II
molecules on T cells. In the CD8+ T cell subpopulation of MVV-infected animals
there was a significant increase (p< 0.05) in the percentage of cells expressing SW73.2
and VPM54 (DR). The percentage of CD8+ T cells positive for VPM36 (DQ) was
increased in the MVV-infected animals, although this increase was not significant.
Results obtained by quadrant statistics were consistent with those obtained by curve
subtraction analyses.
4.4.3.3 yS T LYMPHOCYTES
The coexpression of y5 and MHC Class II molecules on T cells is presented in
Table 4.5 and Fig. 4.4, respectively. There were very few yS-TCR lymphocytes in the
BALF of both control and MVV-infected animals [control= 5.3 (2.8-11.1); MVV= 3.0
(1.5-9.9)] (results expressed as median and range of percentages of positively labelled
cells in lymphocyte gate). However, most of the y8-TCR lymphocytes in both groups
of animals expressed the whole range of the MHC Class II molecules. y8-TCR BALF
lymphocytes from the MVV-infected group expressed a higher density of MHC Class
II molecules as compared with controls, although this difference was not significant.
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Table4.3.CoexpressionofMHCla sIImoleculesrL-2RndD4nlympho ytibronchoalve laravagflui fromcontrola dMVV-infectedsh ep CD4/SW73.2/VPM544/ 36D4/IL-2R (a)CONTROL n=7 (b)42.9 (10.7-57.2) 32.1 (10.8-60.0)19.2 (8.1-59.3) 12.7 (10.1-23.9)12.8 (3.1-30.4) 14.0 (3.4-23.5)












































































Figure4.2.Contourmapsfd alstainedCD4+lymphocytesf mBALFfr ontrola dMVV-infectedanimal.FL-1(gr nfluorescence)othabcissaa dFL-2(rfluor nce)othor inat .FL-2distinguishesCD4f,ndFL-1distinguishesMHCClaIIndIL-2Rexpression.Anincr aseiMHCCl sImoleculesiobservedf rSW73.2(pa -ClassI),VPM54(DR)andVPM36(DQ),whilet ereinoincr aseIL-2Rexpr ssion.
Table4.4.CoexpressionofMHCla sIImoleculesrL-2RndD8nlym hocytibronch alv olarl v gf ui fromcontrola dMVV-infectedsh ep CD8/SW73.2/VPM548/ 36CD8/IL-2R (a) (b)CONTROL n=755.2 (23.4-75.6) 20.6 (5.5-52.5)26.7 (15.9-66.8) 27.3 (6.3-41.1)15.5 (7.5-61.1) 17.2 (4.6-31.4)




















































Figure4.3.Contourmapsofd ls inedCD8+ly phocytesfr mBALFf controla dMVV-infecteda imal.FL-1(gr nfluorescence)onthab issadFL-2(refluor scence)othordinate.FL-2disti guishesCD84",a dFL-1d t guishesMHCClaIIndIL-2Rexpression.AnincreaseMHCCla sIImoleculesiob ervedfSW73.2(p n-ClassII)anVPM54(DR),whileth roncreaseinVPM36(DQ)orIL-2Rexpression.



























Figure4.4.Contourmapsfdu lstainedy8T-lymphocytefr mBALFac tr ldMVV-infectedanim l.FL-1(g e fluorescence)nthabcissandFL-2(redfluor s ence)thordi ate.FL-2distingui h sy8Tc ll ,an-1distinguisheMHCClII andIL-2Rexpression.Anonsignificantincr aseMHCClasIImol culeiob rv dfSW73.2(pan-Cl sI ),VPM54DR)d VPM36(DQ),whiletherisnoncreaseIL-2Rexpr ssion.
4.4.3.4 EL-2R EXPRESSION
Tables 4.3, 4.4 and 4.5 and Figs. 4.2, 4.3 and 4.4 show the expression of IL-2R
molecules by BALF lymphocyte subsets. There were no significant differences in the
expression of IL-2R by any of the three T cell subsets between control and MVV-
infected animals as confirmed both by quadrant statistic and by curve subtraction
analyses.
The mean channel number of EL-2R expression on BALF T lymphocytes was
also studied, and it did not revealed any significant differences between the control
and the MVV-infected group (Appendix 1.4.1)
4.4.4 PB LYMPHOCYTE PHENOTYPING
No significant differences between the two groups of animals were observed
for the expression of MHC Class II or IL-2R by any of the three T cell subsets in PB.
Results are shown in Tables 4.6, 4.7 and 4.8 and in Figs. 4.5, 4.6 and 4.7.
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Figure4.5.Contourmapsfdu lst inedCD4+PBly phocytesfromc t olMVV- cteda imal.FL-1(gr nfl o es e ce) theabcissandFL-2(refluor scence)onthrdi ate.FL-2distingui h sCD4+,a dL-1disti guish sMHCClaIIdR expression.Nodiff rencesinthexpre sionofMIICClaIm leculesrL-2Rreob e v db tw nthcontrolaMVV-i fected animal.





















































Figure4.6.Contourmapsofd alst inedCD8+PBlymphocytesf omcontrola dMVV-infecteda imal.FL-1(gr nfluorescence)theabcissaandFL-2(rfluor scence)onthor i ate.FL-2distinguishesCD8+,ndFL-1disti gui hesMHCClasIIndIL-2Rexpression.Nodiffe ncesnthxpressionfMHCCla sIImoleculesr1L-2Rarob ervedb tw nhontrolathMVV-infectedanimal.
Table4.8.CoexpressionofMHCCla sIIrL-2Rmol culesndy8Tlymphocytesi p iph ralloodfr mc nt ola d MVV-infectedsheep Y8/VPM54y8/VPM36y8/IL-2R CONTROL17.111.318.1 n=5(5.1-46.2)(5.6-27.1)(11.5-26.7) MAEDI35.515.422.9 n=8(21.4-57.5)(8.4-57.5)(13.6-35.3) Resultsareexp essedmedianofpercent gesdoubl -positivelyl ll dllilymph cyteg twi hrangesi pare heses.
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Figure4.7.Contourmapsofd lst inedy8PBly phocytesfr mcontrola dMVV-infecteda imal.FL-1(gr nfluor scence)habcissaandFL-2(refluore cence)onthordinat .FL-2distinguishesy5Tcell ,ndFL-1di ti guishesMHCClaIIndIL-2Rexpression.Nodiffe ncesnthexpressionfMHCCla sIIm leculesrobservedf a yfthMAbu :VPM54(DR),VPM36(DQ)andIL-2Rbetweenhcontrola dtMVV-infectedanimal.
4.5. DISCUSSION
In this study lymphocyte subsets in BALF and PB for control and MVV-
infected animals were of similar phenotype to those previously described in Chapter 3.
The measurement of three parameters generally considered as markers of activation,
i.e. blast transformation, expression of MHC Class II molecules and expression of IL-
2R, permitted investigation of the stage of activation of the BALF and PB T
lymphocytes of naturally MVV-infected sheep.
The availability of the MAbs VPM54 and VPM36 (Dutia et al, 1990a; 1990b),
homologous to the human DR and DQ respectively, permitted the study of the
differential expression of DR and DQ locus products on BALF T cell subpopulations.
Marked differences in expression of MHC Class II antigens with respect to
lymphocytes in other body compartments from sheep were found (Table 4.9). While
in adult peripheral blood and efferent lymph MHC Class II molecules are mainly DR,
with very little DQ expression (Dutia et al, 1993), in BALF from both adult control
and MVV-infected animals a considerable proportion of CD4+, CD8+ and y5 T
lymphocytes also express DQ molecules. In adult sheep afferent lymph, the majority
of all T cells express both DQ and DR molecules, with a predominance of DR
molecules, and in the lymph node over 50% of the cells express DR and 30% are DQ+
(Dutia et al, 1993). No previous quantification of the different locus products on T
cells from the ovine lung has been reported.
In man, specific functions for the different isotypes ofMHC Class II have been
proposed. Hence, while DR may present antigen specifically to % cells, regulating
the immune response, DQ molecules may be responsible for the presentation of
antigen to T5 cells (Nieda et al, 1988) and are involved in the control of immune
suppression (Hirayama et al, 1987; Oliveira and Mitchison, 1989). In this induction of
suppression, DQ molecules might contribute directly to activation of CD8f T cells, or
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indirectly through the activation of CD4+ suppressor-inducer T cells (Yachie et al,
1982; Dorf and Benacerraf, 1985). It has also been suggested that DQ molecules
might play a major role in predisposition to autoimmune diseases such as type I
(insulin-dependent) diabetes mellitus (Todd et al, 1987), thyrotoxicosis (Foulis, 1986)
and primary biliary cirrhosis (Ballardini et al, 1984). MHC Class II-DR antigens on T
cells may mediate signal transduction (Odum et al, 1991). Enhanced expression of
DR+ lymphocytes has been found on peripheral blood CD8+ T cells from patients
with AIDS and with the pre-AEDS syndrome (Engleman et a\, 1980) and in patients
with idiopathic myositis (Davidson et al, 1985).
Similarly to man, the differential expression of DR and DQ locus products of
ovine BALF T lymphocytes might also be related to the existence of functional
differences between them. Experiments to investigate their possible different roles are
currently in progress (Hopkins et al, 1993b).
Increased cell size and complexity, produced as a consequence of antigenic
stimulation, are regarded as early parameters of activation (Goodman, 1983;
Samelson, 1989). These changes, however, were not found in MVV-infected sheep.
This lack of blast transformation in BALF and PB lymphocytes of MVV-infected
animals could be the first indicator of an impaired lymphocyte activation.
In contrast, MHC Class II molecules, which are also regarded as activation
markers for T lymphocytes (Corner et al, 1983), were increased in BALF T
lymphocytes of MVV infected animals. Only CD4+ and CD8+ T lymphocytes
showed upregulation of MHC Class II molecules, while no significant changes were
observed in the yd T population. CD4+ and CD8+ T lymphocytes were also the main
T cell subsets that had shown phenotypic changes in previous studies (Cordier et al,
1992; Lujan et al, 1993).
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The existence of a proportion of ovine resting T-lymphocytes bearing MHC
Class II antigens has been described (Dutia et al, 1993; Hopkins et al, 1993b; Burrells
and Sutherland, 1994). Our results in control animals were consistent with these
reports. The constitutive expression of MHC Class II antigens by ovine T cells
suggests an important role for these molecules in normal T cell function.
In MVV-infected animals, the upregulated expression of MHC Class II
antigens by BALF T lymphocytes is concordant with human interstitial lung diseases,
including pulmonary sarcoidosis (Hunninghake and Crystal, 1981; Mornex et al,
1985) and hypersensitivity pneumonitis (Mornex et al, 1984).
Hopkins and others (1993b) showed that the expression of MHC Class II-DQ
molecules by sheep efferent lymph T cells was the result of recent activation.
Presumably, ovine T cells from other body compartments will also require a previous
process of activation prior to expression of DQ locus products. If this assumption is
true, then upregulated expression of DQ locus products by BALF T lymphocytes from
MVV-infected animals indicates an ongoing process of activation within the lung.
Accumulation of activated lymphocytes in the lung would contribute to the interstitial
lung disease through the production of a network of inflammatory cytokines. These
cytokines may increase the expression of MHC Class II antigens by T cells (Steinman
et al, 1980) and by alveolar macrophages. Increased expression of MHC Class II
molecules on BALF macrophages of naturally MVV-infected sheep had been
observed (Chapter 3). It is known that ovine MHC Class II antigens act as a
component of a cellular receptor for MVV (Dalziel et al, 1991). Hence, enhanced
MHC Class II molecules expression by alveolar macrophages would amplify the
number of potential MVV-infected alveolar macrophages and could facilitate spread
and persistence of the virus.
The major function of MHC Class II molecules is to present processed antigen
to T cells, thus playing a central role in the induction of the immune response. The
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functional role of these antigens on 'activated' T cells remains largely unknown,
although the magnitude of T cell responses seems to be related to the level of
expression of MHC Class II antigen (Maris et al, 1983). Hence, quantitative variation
in MHC Class II expression is associated with immunodeficiency, and could explain
human immunological diseases such as the lymphomatous form of Hodgkin's
disesase, lepromatous leprosy or sarcoidosis (Janeway et al, 1984). Also, as MHC
Class II antigen is the natural ligand for CD4, its induction on activated T cells may
play a role on regulating certain CD4 functions (Odum et al, 1991), such as cell
adhesion (Doyle and Strominger, 1987).
In sheep, as in man and mice, expression of MHC Class II on T cells is
involved in the presentation of soluble antigen in vivo. However, apart from this
presentational function, a regulatory role is also suggested (Hopkins et al, 1993b).
Impaired lymphocyte activation is also suggested by the finding that levels of
IL-2R expression on BALF T lymphocytes from infected sheep were not elevated,
despite using a highly sensitive assay for detection of IL-2R (Zola et al, 1990; Santos
et al, 1991). IL-2R is expressed at low levels on normal human BALF T lymphocytes
(Pinkston et al, 1983; Becker et al, 1990) and the increase of this receptor is
considered as a parameter of lymphocyte activation (Zola et al, 1991). However,
disorders of IL-2R expression have been reported in primary and acquired
immunodeficiency and rheumatic diseases (Prince et al, 1984; Waldmann et al, 1985;
Greene et al, 1986b; Campen et al, 1988; Mahalingam et al, 1993) and in blood of
patients with insulin-dependent diabetes mellitus (Kontiainen et al, 1991). In lymph
nodes of lentiviral-infected sheep, both decreased IL-2 production (Ellis and
DeMartini, 1985a) and lack of IL-2R expression by the CD8+ T subpopulation (Bird
et al, 1993) have been observed.
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The fact that elevated MHC Class II expression on BALF T lymphocytes from
MVV-infected sheep was not coincident with a similar elevation in IL-2R expression
suggests that different forms of activation are possible, each cell being characterised
by particular phenotypes. Alternatively, the upregulation of MHC Class II molecules
on T cells of MVV-infected animals may not be simply a consequence of a viral-
induced T cell activation. Discrepancy between Class II and IL-2R expression has also
been found in some inflammatory lesions in synovial tissues (Burmester et al, 1984),
in feline immunodeficiency virus infection (FIV) (Rideout et al, 1992) and in
Sjogrens's syndrome (Jonhson et al, 1987), an autoimmune disease of man which has
pulmonary histopathologic similarities to MVV infection.
The increased MHC Class II antigen expression in BALF T lymphocytes from
MVV-infected animals has two possible explanations. Firstly, an upregulation induced
by cytokines from activated T cells, such as y-EFN (Nash et al, 1992; Hopkins et al,
1993b) and, in the case of MVV-infected animals, to the specific lentivirus-induced
interferon (LV-IFN) (Kennedy et al, 1985). Hence, the higher levels of MHC Class II
molecules on BALF T lymphocytes from MVV-infected animals might reflect a
cytokine-mediated immune dysfunction. Secondly, the persistent viral infection of
alveolar macrophages could cause chronic stimulation of BALF T lymphocytes,
which would then maintain enhanced expression of MHC Class II antigens on their
surface.
Several possible explanations can be proposed for the absence of a
concomitantly increased expression of IL-2R in BALF T lymphocytes from MVV-
infected animal;
Firstly, lymphocytes could be going through an impaired process of activation.
Secondly, this absence could be due to decreased levels of IL-2 in BALF, as
IL-2 is a preliminary requisite for EL-2R expression (Williams et al, 1985). Decreased
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levels in IL-2 activity have been found in mononuclear leukocytes culture
supernatants derived from the posterior mediastinal lymph nodes of MVV-infected
sheep (Ellis and DeMartini, 1985a). The levels of IL-2 present in BALF were not
investigated in this study.
Thirdly, a decline of IL-2R expression could also be possible, as in vitro
studies have shown that the expression of this receptor on activated cells is transient
after antigenic stimulation (Depper et al, 1984), this expression being restored by
reexposure to initial stimuli (Cantrell and Smith, 1983).
Fourthly, other lymphokines present in the PELF, such as an IL-2 inhibitory
factor or a suppressor factor could interfere with the production of IL-2 (Neng Lai et
al, 1989) and the expression of EL-2R.
Finally, viral infection and/or subsequent activation of macrophages could lead
to decreased IL-2R expression, as occurs in FIV infection (Lawrence et al, 1992).
To explain the increased expression of MHC Class II molecules by BALF T
lymphocytes and the lack of a similar elevation in EL-2R expression we favour the
hypothesis that BALF T lymphocytes from MVV-infected sheep are undergoing an
impaired process of lymphocyte activation. Some aspects of the pathogenesis of MVV
infection, especially those regarding viral persistence, would lead to disruption of the
immune system. As a consequence, some cellular immune responses may be
amplified (i.e. upregulated expression of MHC Class II antigens), while others (i.e. IL-
2R expression) may be suppressed. The increased proportion of BALF CD8+ T
lymphocytes could also contribute to a defect in IL-2R expression, as CDS"1" T cells
are thought to contain suppressor as well as cytotoxic lymphocytes (Takata et al,
1990). In addition, viral infection of alveolar macrophages could give rise to a
cytokine-mediated dysregulation which could contribute to recruitment of increased
numbers of lymphocytes to the alveoli, leading to inflammation and lung pathology.
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Further studies are required to investigate if this anomalous pattern of
lymphocyte activation observed during the course of the natural disease is maintained
under in vitro conditions.
Finally, the fact that no significant changes in MHC Class II molecules
expression in PBL between control and MVV-infected animals were found in this
study, further suggests a compartmentalisation of the immune response to the lung
during the course ofMVV infection, as was discussed in Chapter 3.
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CHAPTER 5: IN VITRO BALF AND PB LYMPHOCYTE RESPONSE TO
MITOGEN-STIMULATION DURING NATURAL MVV INFECTION
5.1. SUMMARY
To investigate the effects of MVV infection on cell-mediated immunity, the in
vitro response of BALF and PB lymphocytes to exogenous mitogen was investigated.
BALF and PB lymphocytes from control (n=9) and MVV-infected (n=7) animals were
cultured for 3 days in the presence and absence of concanavalin A (Con A).
Lymphocyte expression of an early activation marker, the IL-2R antigen, a parameter
of lymphocyte activation, was quantified by dual-colour flow cytometry using the
bovine anti-IL-2R MAb EL-A111. IL-2R expression by lymphocytes in BALF and PB
from control and MVV-infected animals, with and without Con A stimulation, were
compared.
In the absence of Con A stimulation, IL-2R expression on cultured BALF
CD8+ and y8 T cells was significantly (p< 0.05) lower for MVV-infected animals than
for controls. After Con A stimulation, expression of IL-2R on BALF CD4+
lymphocytes from MVV-infected animals remained significantly (p< 0.05) lower than
that of cells from controls. Comparisons within group showed that the control group,
after Con A-stimulation, had significantly increased IL-2R expression by all the T cell
subsets, namely CD4+ (p<0.001), CD8+ (p< 0.001) and y8 T cells (p< 0.05). In the
MVV-infected group, this increase was significant (p< 0.05) for CD4+ and CD8+ T
cells, but not for y5 T cells.
In vitro mitogen stimulation of PB T lymphocytes from both control and
MVV-infected animals induced a significant elevation in EL-2R expression for all T
cell subsets when compared to cultured unstimulated control cells. However, there
was considerable heterogeneity in the response to Con A of PB T cells from both
groups of animals. The expression of IL-2R followed a different pattern to that of
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BALF lymphocytes, unstimulated y8 T cells from MVV-infected animals having
significantly (p< 0.05) higher IL-2R expression than those of controls. Cultured
unstimulated CD8+ T cells from MW-infected animals had significantly (p< 0.05)
lower LL-2R expression than cultured unstimulated CD8+ cells from controls.
From these studies it can be concluded that the BALF T lymphocyte immune
dysfunction observed during natural MVV infection, characterised by impaired IL-2R
expression, is maintained under in vitro conditions.
5.2. INTRODUCTION
The previous investigation of the state of activation of BALF and PB T
lymphocytes from naturally MVV-infected animals showed an anomalous pattern of
BALF T lymphocyte activation. Hence, while BALF T lymphocytes from MVV-
infected animals expressed MHC Class II molecules strongly on their surface, one of
the parameters suggesting a process of activation, increased surface IL-2R expression,
another main index for lymphocyte activation, was lacking.
This study was developed to assess whether the defective lymphocyte
activation observed in the natural disease was maintained under in vitro conditions.
5.2.1 THE STUDY OF LYMPHOCYTE TRANSFORMATION BY FLOW
CYTOMETRY
Both mitogen- and antigen-induced lymphocyte transformations have become
widely used tools in experimental studies and for practical clinical tests. The discovery
(Nowell, 1960) that phytohemagglutinin (PHA), a lectin extracted from kidney beans,
transformed small lymphocytes into proliferating lymphoblasts in tissue culture
formed the basis of this technique. Today, T-cell mitogens commonly used together
with PHA are the lectins concanavalin A (Con A) (obtained from the jack bean), and
pokeweed mitogen (obtained from the pokeweed plant, and which also stimulates B
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cells) (Oppenheim and Schecter, 1980; Tizard, 1986). The adequacy of all these
mitogens for stimulation of ovine lymphocytes has been previously described
(Burrells and Wells, 1977). Con A was the mitogen employed in this study.
Assays of lymphocyte transformation provide a simple, rapid and quantitative
indication of cell-mediated immunity (Oppenheim et al, 1970; Catalona et al, 1975).
The conventional assay for T-lymphocyte proliferation is based on incorporation of
radioactive thymidine into the DNA of activated lymphocytes (Maluish and Strong,
1986). An alternative reliable method to assess T lymphocyte proliferation is the
analysis of early activation markers, such as IL-2R, by flow cytometry (Prince and
John, 1986). IL-2R expression is a prerequisite for DNA synthesis by activated
lymphocytes and hence, the study of surface IL-2R expression on these cells will be a
reliable indicator of proliferative responsiveness (Miyakawi et al, 1982).
5.3. EXPERIMENTAL DESIGN
Seven adult Texel ewes (age range 3-7 years), seropositive to MVV by the
AGIDT (Winward et al, 1979), and 9 breed, sex and age-matched seronegative
controls ewes were used (Chapter 2). Different animals from those employed in
Chapters 3 and 4 were selected for this study. BALF and PB lymphocytes obtained
from these animals were cultured for 3 days both in the presence and absence of Con
A (experimental culture conditions are described in sections 2.12.4 and 2.12.5). The
level of IL-2R expression by the cultured lymphocytes was then compared, both
within groups (i.e. comparison of EL-2R expression in unstimulated and Con A-
stimulated BALF and PB lymphocytes) and between groups (i.e. comparison of EL-2R
expression by cells from MVV-infected and control animals).
5.4. MONOCLONAL ANTIBODIES AND REAGENTS
The same biotinylated mouse MAbs described in Chapter 4 were used in this
study, namely SBU-T4 (and CD4), SBU-T8 (and CD8) [Maddox et al, 1985b] and
CC-15 (anti-y8 T cells) [Mackay et al, 1991].
The activation marker used on cultured lymphocytes was the bovine MAb IL-
A111 (Naessens et al, 1992) against IL-2R-cc.
Combinations of phycoerythrin labelled streptavidin (Amersham International,
Amersham, U.K.) and rabbit antimouse IgGj FITC (The Binding Site, Birmingham,
U.K.) were employed as secondary step reagents.
All the MAbs and reagents were used at previously determined optimal
working dilutions (Table 4.2).
5.5. STATISTICAL ANALYSIS
As data were non normally distributed, BALF and PB sample comparisons
were made using the Mann-Whitney non-parametric Test, with a significance level of
95%.
5.6. RESULTS
5.6.1 EFFECT OF Con A-STIMULATION ON CELL SIZE
BALF and PB lymphocytes from both groups of animals, following 3 days
culture in the presence of Con A were of intermediate to large size and blastoid in
morphology (Fig. 5.1). They showed an increase in size and complexity when
compared with those unstimulated cells as measured by FSC and SSC (Fig. 5.2,
Appendices 1.5.1 and 1.5.2).
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Figure 5.1. Blastoid morphology of BALF lymphocytes from a control animal
cultured in vitro for three days in the presence of Con A (5|ig/ml). Most lymphoblasts
were intermediate to large in size.
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Figure 5.2. Effect of Con A-stimulation on cell size. Flow cytometry scatter profile of
ovine BALF lymphocytes (top) and PB lymphocytes (bottom) after three days culture
in the absence (A) and in the presence of Con A (5|ig/ml)(B). Small lymphocytes are
distinguished by their characteristic low forward scatter (FSC) and side scatter (SSC),
lower boxes. Lymphoblasts are distinguished by their characteristic high FSC/SSC,
upper boxes. BAJLF and PB lymphocytes cultured for three days in the presence of
Con A (B) increased their size when compared with unstimulated lymphocytes (A),










Con A-stimulated BALF lymphocytes from MVV-infected animals had
significantly increased FSC and SSC. BALF lymphocytes from control animals also
had increased FSC and SSC parameters after Con A stimulation, but this increase was
not significant (Table 5.1).
Table 5.1. Median of forward (FSC) and side (SSC) light scatter parameters of the
gates established for unstimulated (No Con A) and Con A-stimulated BALF
lymphocytes in control (n=9) and MVV-infected (n=7) animals. FSC values refer to
cell size, while SSC values relate to cell complexity and internal structure. All cells
were cultured in vitro for 3 days prior to analysis. Mann-Whitney non parametric rank
test.
CONTROLS MVV-INFECTED
FSC: 39,149 FSC: 43,156
No Con A
SSC: 6,57 SSC: 8,57
FSC: 42,160 FSC: 43,208*
Con A
SSC: 7,71 SSC: 8,78
* Significantly different from unstimulated cells at p< 0.05.
Con A-stimulated PBL from both control and MVV-infected animals had
significantly increased FSC and SSC parameters (Table 5.2).
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Table 5.2. Median of forward (FSC) and side (SSC) light scatter parameters of the
gates established for unstimulated (No Con A) and Con A-stimulated PBL in control
(n=9) and MVV-infected (n=7) animals. FSC values refer to cell size, while SSC
values relate to cell complexity and internal structure. All cells were cultured in vitro
for 3 days prior to analysis. Mann-Whitney non parametric rank test.
CONTROLS MVV-INFECTED
FSC: 47,173 FSC: 40,184
No Con A
SSC: 6,52 SSC: 6,63
FSC: 50,226* FSC: 45,223*
Con A
SSC: 8*,95* SSC: 11*,123*
* Significantly different from unstimulated cells at p< 0.05.
5.6.2 COMPARISON OF WHOLE BALF CELLS vs MACROPHAGE-
DEPLETED BALF CELLS
Macrophages, amid their multiple function can control both positively and
negatively lymphocyte growth and differentiation (Unanue, 1981) and lymphocyte
responses to antigens and mitogens (Lipscomb et al, 1982). Previous studies have
shown that the proliferative response is a complex function depending on several
factors such as numbers ofmacrophages and duration of culture (Liu et al, 1984).
To standardise our technique, EL-2R expression on cultured lymphocytes
obtained from whole BALF was compared with that from lymphocytes recovered
from BALF partially depleted of macrophages (as described in section 2.12.2). BALF
lymphocytes from two controls and one MVV-infected sheep were employed for this
study. After depletion of macrophages, mitogen stimulated BALF lymphocytes
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expressed higher levels of IL-2R (Table 5.3). These results suggest that BALF
macrophages interfere with the expression of IL-2R by BALF lymphocytes. Depletion
of BALF macrophages was, therefore, routinely carried out.
Table 5.3. Comparison of IL-2R expression on BALF lymphocytes from whole
BALF and from partially macrophage-depleted BALF in two control and one MVV-
infected animal. Cells were cultured in vitro for 3 days prior to analysis. Results are
expressed as percentages of positively stained cells within the total lymphocyte
population.
SHEEP NUMBER
C 92 C 98 MVV 28
MACROPHAGE CON A %IL-2R
DEPLETION STIMULATION
- - 4.30 5.32 1.50
- + 9.63 6.47 10.71
+ - 3.39 6.16 12.76
+ + 13.30 16.76 28.32
5.6.3 IN VITRO STIMULATION OF BALF LYMPHOCYTES
5.6.3.1 Within group effects of Con A stimulation
Controls: The expression of EL-2R was significantly increased on Con A-stimulated
CD4+ (p<0.001), CD8+ (p< 0.001) and y5 T cells (p< 0.05) when compared with
unstimulated cells (Table 5.4). The percentage of IL-2R expressing cells within the
total lymphocyte population was not significantly increased after Con A stimulation
(Table 5.4, Figs. 5.3 and 5.4).
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MW-infected animals: The expression of IL-2R was significantly increased on Con
A-stimulated CD4+ and CD8+ T lymphocytes (p< 0.05) when compared with
unstimulated cells (Table 5.5). The percentage of y5 T cells expressing EL-2R was also
increased after Con A stimulation, but this increase was not statistically significant.
The percentage of IL-2R expression within the total lymphocyte population was
significantly (p< 0.05) elevated after Con A stimulation (Table 5.5, Figs. 5.3 and 5.4).
5.6.3.2 Between group (MVV vs controls) effects of Con A stimulation
5.6.3.2.1 Total IL-2R expression
No significant differences were found in the overall percentage of BALF
lymphocytes expressing IL-2R between control and MVV-infected animals, either in
the absence of Con A or after Con A stimulation (Tables 5.6 and 5.7).
5.6.3.2.2 Expression ofIL-2R by CD4+ T lymphocytes
The percentage of CD4+ T lymphocytes expressing IL-2R after Con-A
stimulation was significantly (p< 0.05) lower in BALF from MVV-infected animals
when compared to that of the controls (Table 5.7, Fig. 5.6).
5.6.3.2.3 Expression ofIL-2R by CD8+ T lymphocytes
Prior to Con A stimulation, the percentage of CD8+ cells expressing IL-2R in
BALF from MVV-infected animals was significantly lower (p< 0.05) than that from
control animals (Table 5.6). After Con A stimulation, expression of IL-2R by CD8"1"
BALF T lymphocytes from MVV-infected animals was not significantly different
from that of the controls (Table 5.7, Fig. 5.7).
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5.6.3.2.4 Expression ofIL-2R by y5 T lymphocytes
As with CD8+ T lymphocytes, the percentage of unstimulated BALF y8 T
cells expressing IL-2R in MVV-infected animals was significantly lower (p< 0.05)
than that of the controls (Table 5.6). Following Con A stimulation, expression of EL-
2R by BALF y5 T lymphocytes was not significantly different from that of control
animals (Table 5.7).
5.6.3.2.5 Coexpression ofCD4+ and CD8+ by Con A-stimulated BALF lymphocytes
Two-colour immunofluorescence labelling with the biotinylated anti-CD8
MAb, SBU-T8 and the unconjugated anti-CD4 MAb 17D.13 and flow cytometry
revealed that while a very small proportion of resting T lymphocytes from BALF
expressed CD4 and CD8 simultaneously, after 3 days culture with Con A, the
proportion of double positive T cells increased significantly (Table 5.8).
Table 5.8. Coexpression of CD4+/CD8+ by unstimulated (No Con A) and Con A-
stimulated BALF lymphocytes from control (n=9) and MVV-infected (n=7) animals.
All cells were cultured in vitro for 3 days. Results expressed as median of percentages
of double-positively labelled cells in lymphocyte gate with ranges in parentheses.
CONTROL MVV-INFECTED
UNSTIMULATED 4.3 (1.2-16.1) 1.3 (0.3-3.3)
Con A-STIMULATED 16.9 (7.8-25.6)* 27.3 (4.7-33.4)*
*
Significantly different from unstimulated cells at p<0.05 (Mann-Whitney non
parametric rank test).
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5.6.4 IN VITRO STIMULATION OF PBL
5.6.4.1 Within group effects of Con A stimulation
Controls: The expression of IL-2R was significantly increased (p< 0.05) on Con A-
stimulated CD4+, CD8+ and y5 T lymphocytes when compared with unstimulated
PBL. The percentage expression of IL-2R by all lymphocytes was also significantly
increased (p< 0.05) after Con A stimulation (Table 5.9, Figs. 5.3, 5.5- 5.7).
MW-infected animals: The expression of IL-2R was significantly increased on Con
A-stimulated CD4+ (p< 0.05), CD8+ (p<0.001) and y8 T lymphocytes (p< 0.05) when
compared with unstimulated cells. The percentage of all lymphocytes expressing EL-
2R was also significantly (p< 0.05) elevated after Con A stimulation (Table 5.10, Figs.
5.3, 5.5- 5.7).
5.6.4.2 Between group (MVV vs controls) effects of Con A stimulation
5.6.4.2.1 Total IL-2R expression
The percent expression of IL-2R by PB lymphocytes from control sheep was
not significantly different from that of MVV-infected sheep after culture in the
absence, or presence, of Con A stimulation (Tables 5.11 and 5.12).
5.6.4.2.2 Expression of IL-2R by CD4+T lymphocytes
No significant difference in the percentage of CD4+ lymphocytes expressing
EL-2R was observed between cultured PBL from control and MVV-infected animals,
after culture in the absence, or presence, of Con A stimulation (Tables 5.11 and 5.12,
Fig. 5.6).
5.6.4.2.3 Expression ofIL-2R by CD8+T lymphocytes
A lower proportion (p< 0.05) of unstimulated cultured CD8+ lymphocytes
from MVV-infected animals expressed IL-2R than from controls. After Con A
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stimulation the percentage of CD8+ lymphocytes bearing IL-2R was not significantly
different from that of the controls (Tables 5.11 and 5.12, Fig. 5.7).
5.6.4.2.4 Expression ofIL-2R by yd T lymphocytes
The percentage of cultured yd T cells bearing IL-2R antigen was significantly
increased (p< 0.05) in unstimulated PBL from MVV-infected animals when compared
with controls. After Con A stimulation EL-2R expression by y5 T lymphocytes was
similar in both control and MVV-infected animals (Tables 5.11 and 5.12).
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Figure 5.3. IL-2R expression of PB and BALF lymphocytes from control (n=9) and
MVV-infected sheep (n=7) after TCR stimulation in vitro with Con A. Data are shown
as median of percentages of IL-2R+ lymphocytes after 72h in culture with or without
Con A stimulation. Mann-Whitney non parametric rank test.
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Figure 5.4. Fluorescence histograms of surface expression of EL-2R on unstimulated
(2) and Con A-stimulated (5|ig/ml) (3) BALF lymphocytes from a control (riP BT 70)
and a MVV-infected (n° 68) sheep. Logarithmic fluorescence intensity is plotted on
the abscissa in arbitrary units and linear cell frequency is given on the ordinate.
Normal mouse serum (NMS) was used as the negative control (1).
After culture for three days, a higher increase in the percentage of IL-2R was
observed in those BALF lymphocytes stimulated with Con A
U14:181211016\FL1\
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Figure 5.5. Fluorescence histograms of surface expression of EL-2R on unstimulated
(2) and Con A-stimulated (5pg/ml) (3) PBL from a control (n° MS 28) and a MVV-
infected (n° 36) sheep. Logarithmic fluorescence intensity is plotted on the abscissa in
arbitrary units and linear cell frequency is given on the ordinate. Normal mouse serum
(NMS) was used as the negative control (1).
After culture for three days, a higher increase in the percentage of EL-2R was
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Figure 5.6. Con A induced expression of EL-2R on CD4+ BALF and PB lymphocytes
from control (n=9) and MVV-infected (n=7) animals. Data are presented as median of
the percentages of IL-2R4" CD4+ T cells after 72 h of culture unstimulated (No Con
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Figure 5.7. Con A induced expression of IL-2R on CD8+ BALF and PB lymphocytes
from control (n=9) and MVV-infected (n=7) animals. Data are presented as median of
the percentages of EL-2R+ CD8+ T cells after 72 h of culture unstimulated (No Con
A) or stimulated with 5(ig/ml of Con A. Mann-Whitney non parametric rank test.
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5.7. DISCUSSION
Our previous studies (Chapter 4) on the stage of activation of BALF and PB T
lymphocytes from MVV-infected animals suggested an impaired BALF T lymphocyte
activation during the course of MVV infection. The aim of this experiment was to
determine whether the anomalous pattern of lymphocyte activation observed during
the course of the natural disease was maintained under in vitro conditions. The
expression of IL-2R (an early marker of lymphocyte activation) by in vitro cultured
BALF and PB lymphocytes in response to exogenous mitogen stimulation was
studied.
In this work, and for both groups of animals, the percentage of all unstimulated
BALF and PB T cells which expressed IL-2R differed from values reported in Chapter
4 (Tables 4.4-4.8). In Chapter 4, however, IL-2R expression by BALF and PB
lymphocytes was studied immediately after isolation of the cells, while in the present
work lymphocytes were cultured for 72 h in vitro prior to analysis. The in vitro culture
procedure could explain this difference.
Cell proliferation in response to various mitogens is commonly employed to
investigate the functional integrity of lymphocytes (Rola-Pleszcynski et al, 1981).
Characterisation of the blastogenic responses of ovine lymphocyte suspensions to
certain mitogens has already been performed (Burrells and Wells, 1977).
Responses of pulmonary lymphocytes from humans (Daniele et al, 1975),
monkeys (Kazmierowski et al, 1976) and sheep (Rola-Pleszcynski et al, 1981) to
mitogens have been reported. IL-2R expression by activated lymphocytes after
mitogen stimulation has also been described (Kaczmarek, 1986).
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The poor response of BALF lymphocytes to mitogens previously described by
some authors (Burrells, 1985b) was not observed in this study, as BALF cultured
lymphocytes from both control and MVV-infected animals responded to Con A
stimulation with proliferation and increase in size. After partial depletion of BALF
macrophages, the expression of IL-2R by Con A-stimulated BALF lymphocytes from
control and MVV-infected animals was increased, suggesting that BALF macrophages
have an inhibitory effect on BALF lymphocyte function (Liu et al, 1984). The poor
response of ovine BALF lymphocytes in Burrells' study (1985b) cannot be explained
by the inhibitory effect of BALF macrophages, as BALF phagocytic cells were
removed by carbonyl iron treatment prior to BALF cell culture.
Considerable heterogeneity was found in the stimulus-response relationship
exhibited by individual BALF and PB T cells from both control and MVV-infected
animals. This individual variation to mitogens was greater in the case of PB T cells as
was previously described (Burrells, 1985b). Although the biochemical basis of this
heterogeneity is currently unknown, it has been suggested that it could be due to the
individual differences of T cells in their requirements for activation (Geppert et al,
1990).
Following in vitro Con A stimulation, ovine BALF and PB T lymphocytes
from both control and MVV-infected animals increased their expression of IL-2R,
demonstrating that ovine T cells are immunocompetent, responding to activation
signals and expressing IL-2R in a manner similar to T lymphocytes from other species
(Rideout et al, 1992) and arguing against an acquired or constitutive dysfunction of
the T cell population. The fact that those cells, which in vivo showed very low
detectable levels of EL-2R, increased these levels after mitogen stimulation with Con
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A, indicates their normal response to the stimulation of the TCR/T3 complex by the
mitogen. This supports the interpretation that they had already undergone a prior
activation step, and were prepared to undergo blast transformation. These preactivated
T cells could have expressed EL-2R levels below the threshold necessary for detecting
immunofluorescence staining by flow cytometry (Burmester et al, 1984).
However, IL-2R expression by cultured unstimulated BALF T lymphocytes
from controls differed from that of cells from MVV-infected animals. Cultured
unstimulated BALF T lymphocytes from control animals expressed higher levels of
EL-2R than cultured unstimulated BALF T lymphocytes from MVV-infected animals,
those differences being significant in the case of the CD8+ and y5 T cell subsets.
Differences in EL-2R expression on BALF T lymphocytes from both groups of
animals might have occurred prior to any process of stimulation.
In both control and MVV-infected animals, cultured Con A-stimulated BALF
lymphocytes in all T cell subsets had increased IL-2R expression when compared with
their unstimulated controls. However, EL-2R expression by Con A-stimulated CD4+ T
cells from MVV-infected animals remained significantly lower than that of Con A-
stimulated CD4+ T cells from controls.
BALF CD4+ T lymphocytes from MVV-infected animals, despite undergoing
mitogen stimulation did not attain the same level of IL-2R expression as control
BALF CD4+ T lymphocytes. The capacity of BALF CD4+ T lymphocytes from
MVV-infected animals to respond could be diminished by multiple mechanisms, such
as by soluble factors present in the PELF. Although it has been reported that
suppression of immunity and severe lymphoid depletion are not prominent features of
ovine lentiviral infection of sheep (Pearson et al, 1989), this experiment shows that
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impaired cellular immunity may be affecting some BALF T lymphocyte subsets from
MVV-infected animals. Not only did BALF T lymphocytes from MVV-infected
animals fail to respond normally to activation (as suggested in Chapter 4), but IL-2R
expression was also reduced in unstimulated BALF CD8+ and y5 T lymphocytes in
vitro.
These results in BALF lymphocytes are concordant with those from Ellis and
DeMartini (1985b), who found decreased responses to Con A stimulation in PB and
pulmonary lymph node lymphocytes from adult sheep with naturally occurring ovine
lentiviral infection.
BALF T cells from MVV-infected animals may follow a similar pattern to
AIDS infected human T cells which, during the course of in vivo infection, do not
express the Tac antigen, although it is possible to detect this receptor after in vitro
mitogen stimulation (Lane and Fauci, 1985). Decreased lymphoproliferative responses
to mitogens and soluble antigens in patients with AIDS and related disorders have
been described (Schroff et al, 1983; Lane and Fauci, 1985; Prince and John, 1986).
Cats infected with FIV also manifest an inability to respond to mitogens characterised
by a defect in IL-2 production in secondary lymphoid organs (Lawrence et al, 1992).
The decreased response to activation observed in BALF lymphocytes from
MVV-infected animals could play an important role in the pathogenesis of MVV
infection. Hence, the poor response to mitogens could be related to defective IL-2
production as reported in AIDS studies (Munn et al, 1984; Prince et al, 1984; Ebert et
al, 1985; Gupta, 1986). This would cause an impaired lung immune defence during
MVV infection.
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Regarding the coexpression of CD4 and CD8 by Con A-stimulated BALF
lymphocytes, our findings are concordant with previous studies in normal humans
where small percentages of BALF cells were positive for both CD4 and CD8
(Davidson et al, 1985; Becker et al, 1990). Concurrent expression of CD4 and CD8 is
the rule in stage II maturing thymocytes, which further differentiate in the thymus,
segregating into reciprocal CD4+ and CD8+ subsets (Davidson et al, 1985). The
functional role of these subsets is unclear, although it seems to be complex and
heterogeneous, with cytotoxic cells present in both subsets and the CD4+ subset
containing both suppressor/inducer and helper functions (Romain and Schlossman,
1984).
It has been reported that, after in vitro culture, cells tend to acquire unusual
properties, such as the expression of both CD8 and CD4 (Tite and Janeway, 1984;
Oliveira and Mitchison, 1989). Some of these cells might represent T helper cells that
have lost their helper function and are now acting as cytotoxic cells.
Individual PBL from both control and MVV-infected animals, as previously
mentioned, showed a greater heterogeneity in the response to Con A than BALF
lymphocytes from the same animals. In concordance with what happened in BALF,
Con A stimulation increased the expression of EL-2R on all the T cell subsets in both
groups of animals. However, when comparing IL-2R expression between PBL from
control and MVV-infected animals, results were distinct from those obtained for
BALF. Hence, while lower percentages of unstimulated CD4+ and yS^ T cells from
control animals expressed IL-2R, higher percentages of unstimulated CD8+ T cells
from these animals expressed IL-2R. Following Con A-stimulation, all PB T cell
subsets from MVV-infected animals expressed higher IL-2R than those of controls.
Results obtained for PBL were hence, erratic and difficult to interpret. These results
differed from previous findings in which no differences between the level of response
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of PBL to mitogens between control and lentivirus infected sheep were observed
(Griffin etal, 1978; Sihvonen, 1981; Larsen etal, 1982b; Narayan etal, 1988).
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CHAPTER 6: EXPERIMENTAL MVV INFECTION: EARLY CELLULAR
IMMUNE RESPONSE
6.1. SUMMARY
A model of experimental infection with a lytic British isolate of MVV,
designated EV1, was developed. Twelve Texel sheep were allocated to three groups
and inoculated by the respiratory route with different inocula. Six of the animals
received 107-2 TCID50 of MVV EV1 strain. Two sheep were challenged with heat
inactivated MVV EV1 strain. An additional group of four sheep was sham-inoculated
with identically prepared virus-free buffer solution, animals in this group serving as
controls. Experimental infection was followed for 16 weeks post-inoculation (PI).
Prior to inoculation, routine haematology, BAL and flow cytometric analyses of
BALF lymphocytes were performed in all the animals to provide baseline parameters.
Dual and single colour flow cytometric analyses of BALF lymphocytes and
differential BALF cell counts were performed. Transforming growth factor-(5 (TGF-(3)
levels, in both BALF supernatant and plasma samples, were measured. Concentrations
of pulmonary epithelial lining fluid (PELF) TGF-p were calculated.
Precipitating antibodies to MVV developed in the MVV-inoculated animals
during the first 4 weeks PI. Changes in the cellular composition of BALF were
observed in the three groups of animals during the first 2 weeks PI and persisted
throughout all the sampling period. All groups showed increased percentages of
BALF lymphocytes and decreased percentages of BALF macrophages, these changes
being significant (p< 0.05) in the MVV-inoculated group when compared with the
other two groups of animals 4 weeks PI. Phenotypic changes in BALF T lymphocytes
from MVV-inoculated animals, compared with the other two groups, were
characterised by significantly decreased (p< 0.05) percentages of CD4+, CD5+ and y5
T lymphocytes, significantly increased (p< 0.05) percentages of CDS* lymphocytes
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and significant inversion (p< 0.05) of the CD4+/CD8+ ratio. All phenotypic changes
in BALF T cell subsets occurred between 2 and 6 weeks PI, and a trend to return to
baseline levels was evident at the end of the sampling period. Upregulated expression
of MHC Class II and IL-2R molecules was observed on BALF T lymphocytes from
the three groups of animals following inoculation.
TGF-(3 concentrations in PELF were approximately 165-fold higher than in
plasma. No significant differences in the concentrations of plasma or PELF TGF-(3,
either within or among groups, were observed.
These findings indicate that an early, short term cellular immune response
occurs during experimental MVV-infection.
6.2. INTRODUCTION
In spite of extensive work on the virology, serology and pathology of MVV
(Gudnadottir, 1974; Georgsson et al, 1976; Thormar, 1976) many aspects of the early
immune responses during MVV infection remain unexplained. The study of the acute
events associated with experimental MVV infection of the lungs, is of considerable
importance for understanding the subsequent course of the disease.
In this work, the development of an experimental pulmonary MVV infection in
a group of sheep, and the repeated monitoring of the local responses by BAL, allowed
the study of the early pulmonary immune response during ovine lentiviral infection.
The first successful experimental transmission of MVV was achieved by
Gudnadottir and Palsson (1967). Lambs were inoculated with a suspension of MVV
directly into the lungs, reproducing the pathology and clinical signs of visna. Since
then, experimental infection of sheep with MVV has become a normal practice for the
investigation of different aspects of the disease (Dawson et al, 1985; Geballe et al,
1985; Kennedy et al, 1985).
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Some work on the early (Sihvonen, 1981; Larsen et al, 1982a; Cordier et al,
1992) and late (Sihvonen, 1981; Larsen et al, 1982b) cellular immune responses in
sheep experimentally inoculated with MVV has already been performed. The present
work, however, used different inoculation, sampling and investigation techniques
from those from Sihvonen (1981) and from Larsen and others (1982a), and also
different inoculation and sampling techniques from those of Cordier and others
(1992).
Main differences between the present MVV-experimental infection and previous
ones.
a) Inoculation and sampling techniques
With respect to the inoculation and sampling techniques, Sihvonen (1981)
inoculated sheep with MVV, either intracerebrally or by respiratory route (either by
direct injection of the viral suspension into the lungs or intranasally), while Larsen and
others (1982a/b) used intraperitoneal, intramuscular, subcutaneous or intratracheal
inoculations, and Cordier and others (1992) employed transtracheal inoculation.
In this study, fibreoptic endoscopy and BAL were used to inoculate the
animals and to collect BALF samples. This technique enabled repetitive BAL
sampling from the lung lobe into which the inoculum was delivered.
b) Investigation techniques and objectives pursued
Sihvonen (1981) and Larsen and others (1982a) employed a lymphocyte
stimulation test and different serological assays for the study of the early humoral
immune response. Larsen and others (1992a) also studied the responses of BCG-
sensitised lymphocytes and lymphocyte responses to mitogens. Cordier and others
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(1992) used flow cytometry and indirect immunohistochemistry to identify the
lymphocyte subpopulations in BALF and lung tissue, respectively.
The present study used flow cytometry to monitor changes in phenotypes and
in the state of activation of BALF T cell subsets. The main advantage of this study
with respect to that of Cordier and others was the possibility of regular sampling,
while Cordier and others collected BALF samples only once at slaughter. Another
difference was the age of the animals, with adults being used in the present experiment
and lambs in Cordier's study.
Additionally, the present study employed a bioassay for transforming growth
factor (3 (TGF-p) to quantify pulmonary epithelial lining fluid (PELF) and plasma
levels of TGF-P. The reason for analysing this particular cytokine was that due to the
multifunctional role of TGF-P (both as an immunosuppressive and as a potent
proinflammatory molecule) it could account for many of the pathological features
observed during MVV-infection. Its chemotactic activity for both neutrophils
(Brandes et al, 1991; Reibman et al, 1991) and T lymphocytes (Adams et al, 1991),
could explain the accumulation of both types of cells in BALF (Chapter 3) and in the
pulmonary interstitium (Watt et al, 1992b). The enhanced expression of LFA-1, on
BALF lymphocytes (Chapter 3), could be mediated by the participation of TGF-P in
cell-cell and cell-matrix interactions (Ignotz et al, 1989). The lack of EL-2R expression
by activated BALF T lymphocytes (Chapter 4), could be a consequence of the ability
of TGF-P to block EL-2 mediated induction of 3L-2 receptors (Kehrl et al, 1986a;
Ahuja et al, 1993). The role of TGF-P as an inhibitor of lymphocyte function
(Wakefield et al, 1988) could explain the diminished activation of BALF lymphocytes
from MVV-infected animals in response to mitogen stimulation (Chapter 5). Finally,
TGF-P could account for the increased spontaneous release of fibronectin by alveolar
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macrophages (Ignotz and Massague, 1986) described in MVV-infected sheep by
Cordier and others (1990).
In summary, the present work is a dynamic study of the changes the ovine
lower respiratory tract undergoes during experimental MVV-infection. Not only the
appearance of changes, but also their timing are investigated. Neither the study of the
progressive phenotypic changes in BALF T cell subsets, nor the quantification of
TGF-P in ovine PELF had been described before.
6.2.1 CYTOKINES OF THE LUNG: TRANSFORMING GROWTH FACTOR
(TGF-p)
Cytokines are secretory molecules released by cells that signal the replication
and phenotypic changes of nearby cells. They are intimately involved in normal lung
homoeostasis (Kelley, 1990). Any anatomic or physiologic perturbation of the
normally stable lung will lead immediately to a cascade of cell-to-cell signaling events
mediated by the release of cytokines within the lung.
Those cytokines receiving the most attention to date in relation to pulmonary
diseases include platelet derived growth factor, IL-1, TFG-(3, tumor necrosis factor a
(TNF-a), insulin-like growth factor I and IL-6.
TGF-(3s are a family of multifunctional growth-modulating protein cytokines
with capacity to modulate a wide range of cellular behaviours (Kelley, 1993). TGF-p
is a dimeric protein of approximately 25 kDa. The two 12.5 kDa subunits are either
identical or closely related polypeptides, depending on the cell source. TGF-P exists
as three distinct homodimers, TGF-P] , TGF-P2 and TGF-P3 (Pelton et al, 1990).
Mature TGF-P3 has approximately 80% sequence homology with TGF-P] and TGF-
P2, while TGF-P] shares approximately 71% homology with TGF-P2 (Danielpour,
1989).
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TGF-P can be extracted from most tissues, platelets being the most
concentrated source of this molecule (Assoian et al, 1983). T lymphocytes,
macrophages, monocytes, neutrophils and fibroblasts also express TGF-p
constitutively. Normal and neoplastic tissues (Roberts et al, 1983) and most cells in
culture can also synthesise varying amounts of TGF-(3. Receptors for this cytokine
have also been found in almost all known cell lines (Wakefield et al, 1987). TGF-p is
normally secreted in a latent form that must be activated either by proteolytic cleavage
(Wakefield et al, 1988) or by treatment with acid (Wadhwa et al, 1991).
TGF-P exhibits a diverse range of properties, directed towards most cell types,
and is an important mediator of numerous cellular and physiological processes
(Danielpour et al, 1989; Roberts and Sporn, 1990). Its biological effects depend on
several factors (Wahl, 1992), namely tissue bed, target-cell type, state of cell
differentiation, influence of other growth factors and latent or active TGF-p. TGF-p
also inhibits the growth of many cell types in culture, including epithelial cells and
hepatocytes (Muller et al, 1987; Takehara et al, 1987; Coffey et al, 1988), and
stimulates the growth of others (Moses et al, 1985). It causes chemotaxis of
monocytes and neutrophils (Wahl et al, 1987; Reibman et al, 1991). TGF-P causes
synthesis of extracellular matrix proteins, such as collagen (Ignotz and Massague,
1986; Roberts et al, 1986) and fibronectin (Ignotz and Massague, 1986), and of
cellular receptors for matrix proteins. As a cytokine, TGF-P is potentially important
because it may induce immunosuppression (Wahl, 1992) antagonising many B and T
lymphocyte responses (Kehrl et al, 1986a; 1986b). Hence, it inhibits T cell
proliferation to polyclonal mitogens or in mixed leukocyte reactions and inhibits
maturation of CTLs. On non-immune effector cells, such as PMNs and endothelial
cells, TGF-P acts as an 'anti-cytokine', counteracting the effects of pro-inflammatory
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cytokines. It can also inhibit macrophage activation. In summary, TGF-p is largely a
negative regulator of immunity, although it has some positive effects.
Although some differences have been reported in the in vitro biological
activities of TGF-pj and TGF-f^ (i.e. TGF-f^ lacks the capacity of TGF-P] to inhibit
haematopoiesis) (Cheifetz et al, 1987; Ruscetti ex al, 1991), in general TGF-(3s 1, 2
and 3 have qualitatively similar activities when added to cells in culture (Graycar et al,
1989). Moreover, competition studies with TGF-P1; -(^ and -P3 also indicate that all
three proteins interact with the same cell-surface binding molecules (Graycar et al,
1989). Whether the three isoforms have distinct biological functions in vivo is still
unknown (Pelton et al, 1990).
6.2.2 TGF-p IN THE LUNG
TGF-p is one of the constitutively expressed cytokines of the normal
mammalian lung (Tovey, 1988). The presence of this cytokine on epithelial surfaces
of the distal lung stabilises the structural cell populations of the normal lung (Kelley,
1990). In normal human airways, TGF-|3 acts as a primary differentiation-inducing
factor for bronchial epithelial cells (Masui et al, 1986). It also modulates antioxidant
defense systems and the release of surfactant by epidermal growth factor (Kelley,
1990).
In contrast to its contribution to pulmonary homoeostasis, TGF-(3 is also
involved in the biology of pulmonary disease. Hence, the constitutive levels of TGF-P
in the lung can suppress intrapulmonary populations of T and B lymphocytes and NK
cells (Robinson et al, 1984; Holt, 1986). Furthermore, high local levels of TGF-P may
critically suppress repair processes after tissue injury, through the inhibition of
proliferation of endothelial cells (Heimark et al, 1986). Some pathogenic role for
TGF-P! in pulmonary fibrosis has also been suggested (Broekelmamm et al, 1991).
6.3. MATERIALS AND METHODS
6.3.1 EXPERIMENTAL SHEEP
Twelve male sheep (median body weight 46 kg, range= 35-52 kg) were
purchased from an accredited MVV-ffee Texel flock at the age of 8 months. Animals
were determined to be free of serum antibody to MVV by AGIDT (Winward et al,
1979) at the time of purchase.
To prevent horizontal transmission of MVV, each group of animals was
housed separately and direct contact between the different groups was prevented.
Animals were fed ad libitum hay and water with a regulated supply of concentrates.
Prior to BAL, animals were housed in individual pens, being moved to their
communal pens shortly after recovery from the anaesthesia. The sheep were
inoculated at 13 months old.
6.3.2 PREPARATION OF THE VIRAL ANTIGEN
Monolayers of ovine skin cells, derived from a skin biopsy from the groin of
Finn-cross adult sheep (Bird et al, 1993), were grown into T-75 (75 cm?) tissue
culture flasks (Costar, Cambridge, UK) in Dulbecco's modified Eagle medium
(DMEM) (Gibco Ltd., Paisley, Scotland) (Appendix 0.7) supplemented with 2mM L-
glutamine, 100 U/ml of benzyl-penicillin, 100 U/ml of streptomycin and 8% heat-
inactivated foetal calf serum (Ato Tek, Ltd., Glasbury, Hereford, UK) until 90%
confluent. Skin cell monolayers were then infected with 0.1 TCrD50/cell of EV1 strain
ofMVV (Sargan et al, 1991) in DMEM supplemented with 2% foetal calf serum (2%
DMEM). When extensive cytopathic effects were seen (usually 5-7 days post¬
infection), the virus-containing cell supernatant was harvested, clarified by
centrifugation at 800 g for 20 min, and stored at -70°C. The titre of the virus stock was
determined on skin cell monolayers, and the infectivity titre was calculated by using
the quantal method of Reed and Muench (Mohanty and Dutta, 1981).
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6.3.3 HEAT INACTIVATED VIRUS
The EV1 strain of MVV, prepared as described above (6.3.2), was inactivated
by incubation in a water bath at 56°C for lh. No residual infectivity remained as
determined by lack of cytopathic effect when cultured in monolayers of ovine skin
cells.
6.3.4 MOCK-INFECTED ANTIGEN
Monolayers of ovine skin cells were cultured, as described for the viral
antigen, for 5 days. Supernatant was then harvested and clarified by centrifugation at
800 g for 20 min. This supernatant was employed as mock-infection antigen.
6.3.5 DESIGN OF EXPERIMENT
The twelve sheep were allocated to three groups. A first group (CON) of four
animals was inoculated with mock-infected culture supernatant. A second group (HIC)
of two animals was inoculated with heat inactivated EV1 MVV. The third group
(MVV) consisting of six sheep was inoculated with 107-2 TCID50 of the strain EV1 of
MVV.
6.3.6 INOCULATION OF THE ANIMALS
All the animals were inoculated via the respiratory tract. Basically, the
procedure for the experimental inoculation of the animals was similar to the technique
already described for collection of BALF (Chapter 2). The fibreoptic endoscope was
wedged into the lobar bronchus of the left diaphragmatic lobe. 200 ml of the
appropriate inoculum were then infused through the lateral channel of the endoscope.
To ensure delivery of the inoculum, 25 ml of air were injected through the lateral
channel of the endoscope.
220
6.3.7 BALF COLLECTION
BAL was performed as previously described (Chapter 2). The lobar bronchus
of the left diaphragmatic lobe was always sampled. The timing of BAL procedure
during the experiment is shown in Table 6.1.
Table 6.1. Timing of sampling. The first samples were collected from all animals one
month prior the experimental inoculation (at the age of 12 months) to get baseline
parameters.










6.3.8 PERIPHERAL BLOOD (PB), PLASMA AND SERA COLLECTION
PB samples from all animals were collected simultaneously with BALF
samples (Table 6.1) as previously described (Chapter 2). For routine haematology
(leukocyte and erythrocyte counts, hematocrit, and leukocyte differential counts), PB
was collected into evacuated tubes containing EDTA (Becton Dickinson, Rutherford,
USA). For serology, blood was collected into preservative-free tubes (Becton
Dickinson, Rutherford, USA) and serum was stored at -20°C. For plasma collection,
221
iy. HW.,m^.A ,.UA,n
PB was collected into heparinised evacuated tubes (Becton Dickinson, Rutherford,
USA).
6.3.9 ANTIBODY ASSAY
Sheep serum was examined for specific precipitating antibodies to MVV by
the AGIDT (as described in Chapter 2). The first AGIDT was performed at the time of
the purchase of the animals. Then, AGEDT was performed at each sampling period,
and at 20 and 24 weeks PI.
6.3.10 CLINICAL EVALUATION
The inoculated sheep were monitored weekly for clinical signs of respiratory
disease. Haematological examination was performed at each sampling period.
6.3.11 FLOW CYTOMETRIC ANALYSES
Single and dual colour flow cytometric analyses were performed on BALF
lymphocytes as described in Chapters 3 and 4.
6.3.12 MAbs EMPLOYED
For single colour staining on BALF CD5+ lymphocytes, the murine MAb ST1
(Beya et al, 1986), with CD5 reactivity, was the only primary stage reagent used.
As second stage reagent a FITC-conjugated F(ab')2 fragment of rabbit
immunoglobulins to mouse Ig (Dako, High Wycombe) was employed at a previously
determined optimal dilution of 1:100.
The MAbs and immunoconjugates employed for dual colour flow cytometric
analyses of BALF lymphocytes, and their working dilutions were the same as reported
in Chapter 4 (Table 4.1), except for MAb SW73.2, which was not used.
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6.3.13 TGF-(3 GROWTH INHIBITION ASSAY
Quantification of plasma and PELF TGF-(3 was performed as described in
Chapter 2 (section 2.15).
6.3.14 PLASMA AND BALF UREA DETERMINATIONS
Plasma and BALF urea determinations were as described in Chapter 2 (section
2.16).
6.3.15 STATISTICAL ANALYSES
Cell counts, flow cytometry data and TGF-|3 levels were not normally
distributed.
Among group comparisons: Comparisons among the three groups were made
using the non-parametric Kruskal-Wallis test, with a significance level of 95%.
Within group comparisons: For comparisons within the control and the
MVV-inoculated group the paired-t test was employed with a significance level of
95%. No statistics were performed in the HIC group due to the small number of
animals.
6.4. RESULTS
6.4.1 CLINICAL STATUS OF THE ANIMALS
During an observation period of 4 months, clinical and haematological
examination of the three groups of animals, did not indicate the presence of disease.
During the experiment, five of the animals died after BALF samples were




Results of the AGIDT are shown in Table 6.2. Precipitating antibodies to
MVV developed within the first two weeks PI in three of the MVV-inoculated
animals, and between the second and the fourth week PI in the other three MVV-
inoculated animals. No seroconversion was observed either in the control sheep or in
the HIC group. This confirmed that all animals inoculated with MVV were
successfully infected with MVV, and that segregation of control and MVV-infected
sheep was effective.
Table 6.2. Development of serum precipitating antibodies to MVV as determined by
the AGIDT.
WEEKS PI
Sheep n° P 0 2 4 6 8 12 16 20 24
CON 70 _ _ _ D
CON 107 - - - - - - - -
CON 125 - - - - D
CON 129 - - - - D
HIC 35 _ _ D
HIC 141 - - - - D
MVV 14 _ + + + + + + +
MVV 56 - + + + + + + +
MVV 95 + + + + + + + +
MVV 102 - + + + + + + + +
MVV 105 - - + + + + + + +
MVV 120 - + + + + + + + +
P = Time of purchase
D = Death
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6.4.3. BALF CELL PHENOTYPIC ANALYSES
6.4.3.1 Comparison of data for MVV-inoculated animals and other groups
Compared with the other two groups, BALF from MVV-inoculated animals
had significantly (p<0.05) higher percentages of lymphocytes and significantly lower
percentages of BALF macrophages at 4 weeks PI (Fig 6.1. appendices 1.6.1 and 1.6.2).
Within the BALF lymphocyte population of the MVV-inoculated group there
was a significant (p<0.05) increase over control and HIC values in the percentage of
(a) CD8+ T cells at 2, 4, 6 and 8 weeks PI (Fig. 6.2, appendix 1.6.4), and (b)
CD4+/VPM36+ T cells (MHC Class II-DQ) at 2 weeks PI (Fig. 6.4, appendix 1.6.9).
When compared with the other two groups MVV-inoculated sheep showed
significantly (p<0.05) decreased percentages of BALF (a) CD4+ T cells at 6, 8 and 12
weeks PI (appendix 1.6.3), (b) decreased percentages of CDS4" T cells at 6 and 8
weeks PI, (c) decreased CD4+/CD8+ ratio at 4, 6, 8 and 12 weeks PI, (d) y5 T cells at
2, 6 and 8 weeks PI, and (e) y5+/ VPM54+ T cells (MHC Class fi-DR) at 4 weeks PI
(Figs. 6.2 and 6.3, appendices 1.6.5-1.6.8).
6.4.3.2 Within group time related changes - control animals
When compared to baseline values, control animals showed significandy
(p<0.05) increased percentages of BALF lymphocytes at 2, 8 and 12 weeks PI, and
significantly (p<0.05) decreased percentages of BALF macrophages at 2 weeks PI
(Fig. 6.1).
In control animals, there were no significant changes with time in the
percentages of BALF CD4+, CD5+, CD8+ and y8 T lymphocytes or in the
CD4+/CD8+ ratio (Figs. 6.2 and 6.3).
Compared with baseline data, within the BALF lymphocyte population control
animals had significandy (p<0.05) increased percentages of (a) CD4T/VPM544" T
cells (MHC Class H-DR) at 4, 6, 8 and 12 weeks PI, (b) CD4+/VPM36+ T cells
(MHC Class II-DQ) at 6, 8, 12 and 16 weeks PI, (c) CD4+/IL-2R+ T cells at 6, 8
(p<0.001) and 12 weeks PI, (d) CD8+/VPM54+ T cells at 6, 8 and 12 weeks PI, (e)
CD8+/VPM36+ T cells at 6, 8 and 12 weeks PI, (f) CDS*/EL-2R+ T cells at 6, 8, 12
and 16 weeks PI, (g) y5+/VPM54+ T cells at 2, 4 (pcO.OOl), 6, 8 and 12 weeks PI, (h)
y5+/ VPM36+ T cells at 6, 8 and 12 weeks PI, and (i) y5+/IL-2R+ T cells at 6, 8 and
12 weeks PI (Figs. 6.3-6.6).
6.4.3.3 Within group time related changes - MVV-inoculated animals
Compared with baseline values, the MVV-inoculated group showed
significantly (p<0.05) increased percentages of BALF lymphocytes throughout the
sampling period and significantly (p<0.05) decreased percentages of BALF
neutrophils at 2 and 4 weeks PI, and percentages of BALF macrophages at 2, 4 and 6
weeks PI (Fig. 6.1).
Compared with baseline values in the lymphocyte gate, BALF from the MVV-
inoculated group showed significantly (p<0.05) decreased percentages of (a) CD4* T
cells at 4, 6, 8, and 12 weeks PI, (b) decreased CD4+/CDS* ratio at 4, 6 and 8 weeks
PI, (c) CD5+ T lymphocytes at 4, 6 and 8 weeks PI, and (d) y5 T lymphocytes at 6
weeks PI (Figs. 6.2 and 6.3). There were, in contrast, significantly (p<0.05) increased
percentages of (a) CD8+ T cells at 2, 4 (pcO.OOl), 6 and 8 weeks PI, (b)
CD4+/VPM54+ T cells (MHC Class II-DR) throughout the sampling period, (c)
CD4+/VPM36+ T cells (MHC Class EI-DQ) throughout the sampling period, (d)
CD4+/IL-2R+ T cells at 2 and 12 weeks PI, (e) CD8+/VPM54+ T cells at 6, 8, 12
and 16 weeks PI, (f) CD8+/EL-2R+ T cells at 8 weeks PI, (g) y5+/ VPM54+ T cells
throughout the study, (h) y5+/ VPM36+ T cells at 4, 8, 12 and 16 weeks PI, and (i)
y5+/IL-2R+ T cells at 4, 6, 8 and 12 weeks PI (Figs. 6.2-6.6).
226
Fig. 6.1. Time related changes in the percentages of BALF lymphocytes, macrophagesand neutrophils during experimental MW-infection. Control sheep (CON) (n=4),
MVV-inoculated sheep (MVV) (n=6). Results expressed as medians.
* Significantly different between groups at p< 0.05

































Fig. 6.2. Time related changes in the percentages of BALF lymphocytes expressing
CD4 , CD8 and CD5 during experimental MW-infection. Control sheep (CON)
(n=4), MW-inoculated sheep (MVV) (n=6). Results expressed as medians.
* Significantly different between groups at p< 0.05
+ Significandy different from baseline at p< 0.05
Time (week)
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Fig. 63. Time related changes in the BALF CDA+ICD^~ ratio and in the percentages
of BALF lymphocytes expressing yd4" and CD4+/VPM54+ during experimental
MVV-infection. Control sheep (CON) (n=4), MW-inoculated sheep (MVV) (n=6).
Results expressed as medians.
* Significantly different between groups at p< 0.05








































Fig. 6.4. Time related changes in the percentages of BALF lymphocytes expressing
CD4+/VPM36+, CD4+/IL-2R+ and CD8+/VPM54+ during experimental MW-
infection. Control sheep (CON) (n=4), MVV-inoculated sheep (MVV) (n=6). Results
expressed as medians.
* Significantly different between groups at p< 0.05
+ Significantly different from baseline at p< 0.05
Time (week)
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Fig. 6.5. Time related changes in the percentages of BALF lymphocytes expressing
CD8+/VPM36+, CD8+/IL-2R+ and y8+/VPM54+ during experimental MVV-
infection. Control sheep (CON) (n=4), MVV-inoculated sheep (MVY) (n=6). Results
expressed as medians.
* Significantly different between groups at p< 0.05




Fig. 6.6. Time related changes in the percentages of BALF lymphocytes expressing
y5/VPM36+ and y5+/IL-2R+ during experimental MVV-infection. Control sheep
(CON) (n=4), and MW-inoculated sheep (MW) (n=6). Results expressed as
medians.
* Significantly different between groups at p< 0.05
+ Significantly different from baseline at p< 0.05
Time (week!
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6.4.4 PLASMA AND BALF UREA
Plasma urea (Appendix 1.6.17) concentrations for all animals (median 34.93
mg/dl, range 13.25-54.21) were within the working range of the assay (0-100 mg/dl).
All BALF samples had urea concentrations (median 0.59 mg/dl, range 0.07-1.28)
within the linear range of the assay (0.01-1.30 mg/dl) (Appendix 1.6.17).
Intraassay coefficient of variation for urea determination of BALF samples
with low (median 0.24 mg/dl) and high (median 1.16 mg/dl) urea concentrations,
based on 5 repeated duplicate assays were 0.43% and 0.54% respectively.
6.4.5 TGF-p BIOASSAY
In this assay, the inhibitory concentration (IC50X or concentration of either
TGF-P! or TGF-fL required for half maximal inhibition of proliferation of MV.l.Lu
mink lung epithelial cells was approximately 0.06 ng/ml (Fig. 2.7). Lack of reagents
for TGF-P3 precluded investigation of this homodimer.
Both TGF-pj and TGF-(32 neutralising antibodies partially blocked BALF
supernatant and plasma induced inhibition of MV.l.Lu mink lung epithelial cells
proliferation (Table 6.3). Acid activated BALF supernatant and plasma that had been
incubated with anti-TGF-(3 antibodies did not inhibit DNA synthesis by MV.l.Lu
mink lung epithelial cells to the same extent as acid-activated BALF supernatant and
plasma alone. Nonimmune chicken IgGj did not alter the inhibition. This indicates
that most of the inhibition in BALF and plasma was due to TGF-f^ and TGF-f^.
These results demonstrate the usefulness of the assay in estimating TGF-P levels in
unfractionated conditioned media that may contain an undefined mixture of growth
factors.
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Table 6.3. Blocking of TGF-Pi and TGF-f^-induced inhibition of MV.l.Lu mink lung
epithelial cells proliferation by preimmune antibody or chicken antibodies against
TGF-Pi and TFG-p^ Data are expressed as percent of proliferation inhibited by TGF-
Pi or TGF-p2. The concentration of TGF-Pi and TGF-P2 employed was 1 ng/ml. Anti-
TGF-P} and anti-TGF-P2 MAbs were used in a 1:100 dilution of the stock. As control,
3-5 x 104 cells MV.l.Lu mink lung epithelial cells in a volume of 100 jlxI run without




















No significant differences among groups were observed in the levels of plasma
TGF-p. No significant time-related changes were observed within groups (Fig. 6.7 and
Appendices 1.6.18 and 1.6.21).
6.4.5.2 PELF TGF-p
Concentrations of TGF-P in PELF, as derived from BALF TGF-P
concentrations by the 'urea dilution technique' (Chapter 2) are shown in Appendices
1.6.20 and 1.6.22. The BALF concentrations, which were used to calculate the PELF
TGF-P are given in Appendix 1.6.19.
No significant differences in the levels of PELF TGF-P either among or within
groups were observed (Fig. 6.7, appendix 1.6.22). PELF contained approximately 165-
fold more TGF-Pj than did plasma from the same animals (Table 6.5).
Table 6.5. Concentrations of TGF-p (ng/ml) in plasma and in PELF for: ALL=
combined data for three groups of animals; CON=control group; HIC= group
inoculated with heat inactivated MVV; MVV= group inoculated with MVV (median
of concentrations of TGF-P at different sampling times and range).
TGF-p (ng/ml)
PLASMA PELF
ALL 9.1 (0.4-29.6) 1167.0 (255.0-5736.0)
CON 10.1 (0.4-29.6) 1038.0 (255.0-5736.0)
HIC 9.3 (6.6-14.3) 776.2(582.4-1131.7)
MVV 8.2 (0.4-19.9) 2027.0 (369.0-5650.0)
235
Fig. 6.7. Time related changes in plasma and PELF TGF-p during experimental
MVV-infection. Control sheep (CON) (n=4), MW-inoculated sheep (MVV) (n=6).




Natural and experimental MVV infection show the typical pattern of a slow
virus infection regarding appearance of clinical signs and development of pathological
lesions (Sigurdsson, 1954). Virus persists for a very long time in the animal despite
the presence of active cellular and humoral immune responses (Larsen et al, 1982a).
This study of the early cellular immune response in the sheep lung following
inoculation with MVV, shows that an acute cellular immune response occurs in the
lung within 4 weeks PI.
A model was developed in which a large inoculum ofMVV was delivered by
bronchoscopy to a defined segment of one lobe of a sheep's lung with the expectation
that most of the changes of interest would take place in a small and defined area.
BALF was then collected at periodic intervals for 4 months. This model allowed ready
access to the target tissue and subsequent sequential studies in individual animals. It
was also expected that the large experimental inoculum would reproduce the
pulmonary disease soon after the initial infection. The main disadvantage of the
present work was that, in order to collect BALF, sheep had to undergo general
anaesthesia every two weeks. Anaesthesia, induced with intravenous thiopentone
sodium, was not always well tolerated, and four of the animals died either during
anaesthesia or during the anaesthetic recovery process.
The success of the experimental MVV infection in this work was confirmed by
the appearance of precipitating antibodies to MVV in the six sheep inoculated with the
virus between 2 and 4 weeks PI. No seroconversion was observed in the other two
groups of animals. This is concordant with previous results in MVV experimentally
inoculated sheep, where precipitating antibodies were found within a few weeks to a
few months after inoculation of large doses of virus (Terpstra and De Boer, 1973;
Oliver et al, 1981b; Larsen et al, 1982a; Tuboly et al, 1991). These antibodies are
237
thought to remain detectable in the blood for years (De Boer, 1975), and probably
throughout the life of the sheep. The sampling period in this work was not long
enough to assess for how long precipitating antibodies persist in blood.
During the 4 month sampling period no clinical signs were detected in the
MVV-infected animals. The absence of clinical signs was expected considering that
the incubation period to clinical disease is highly irregular, ranging from 2 months to
over 10 years in experimentally infected sheep (Nathanson et al, 1976).
When compared with control and HIC animals, MVV-inoculated sheep
presented significantly increased percentage of BALF lymphocytes and significantly
decreased percentage of BALF macrophages 4 weeks PI. However, both control and
MVV-inoculated animals presented increased percentages of BALF lymphocytes and
decreased percentages of BALF macrophages, when compared with baseline values,
as soon as 2 weeks PI. Increased numbers and percentages of BALF lymphocytes
(Lairmore et al, 1986; 1988a; Cordier et al, 1992) and neutrophils (Cordier et al,
1992) in experimentally MVV-infected animals have been described. However, all
previous studies were performed on excised lungs from lambs inoculated
transtracheally with MVV. No previous data on the BALF cellular composition of
MVV-experimentally infected adult sheep are available. Furthermore, in previous
studies the sacrifice of the animals did not permit repeated sampling during the
experiment.
The finding of increased percentages of BALF lymphocytes in the three
groups of animals suggests that this increase is not directly induced by MVV. An
inflammatory response induced by repeated BAL would also be unlikely, since it was
shown in a previous study that BAL can be repeated every two weeks without
influence on cellular or humoral contents of ovine BALF (Begin et al, 1981). It is
possible that recruitment of lymphocytes from PB or from lymphoid organs is a
response to the inflammatory effect caused by the inoculum itself, which contained
10% foetal calf serum. The existence of an inflammatory response in the lung as result
of its inoculation with MVV has been described and grossly characterised (Staskus et
al, 1991). In this work, each animal was inoculated with a 200 ml suspension of tissue
culture supernatant. Any constituent of the tissue culture medium employed to prepare
these suspensions could have acted as an antigen, causing inflammation at the
inoculation site and, therefore, accounting for the increased percentage of
lymphocytes in the three groups of animals.
As the experimental infection progressed, in BALF from MVV-inoculated
animals there was a significant decrease in the percentages of CD4+, CD54" and 76 T
cells, an increase in the percentage of CD8+ T cells and inversion of the CD4+ /CD8"^
ratio. These findings are analogous to those from a previous study in MVV-infected
sheep (Lairmore et al, 1988a), where the CD8+ subset was the predominant T cell
subset in BALF. These results, however, contradict those of Cordier and others
(1992), who reported an equal increase in the proportion of BALF CD4+ and CD8+ T
cells with no inversion of the CD4+/CD8+ ratio. However, while Lairmore and others
(1988a) inoculated their control sheep with virus-free culture medium alone as was
done in the present study, the study of Cordier and others (1992) was not properly
controlled as control sheep were inoculated with saline. Whether the changes in the
proportions of the different lymphocyte subsets are due to a migration of those
lymphocyte subpopulations to blood or other lymphoid organs, or to a continuous
destruction and regeneration can not be elucidated from this study.
The decreased percentage of BALF y5 T cells in the MVV-inoculated animals
could indicate participation of these cells in the pulmonary cellular immune response
as suggested by Agostini and Semenzato (1990). Interestingly, in the present study, 78
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T cells were the first T cell subset to return to baseline values in the MVV-infected
group. Although no changes in the pulmonary y5 T cells were observed in natural
MVV-infection (Lujan et al, 1993), the present data suggest participation of these
cells in the early pulmonary immune response.
In the present study, a very acute cellular immune response, detected by
phenotypic changes in BALF T cell subsets, was mounted against the MVV inoculum.
Early and short duration (2-6 weeks) cellular immune responses were also
demonstrated in. experimentally induced MVV infection using the lymphocyte
transformation test (Griffin et al, 1978; Larsen et al, 1982a). However, despite using a
high titre viral inoculum, lymphocyte phenotype changes returned to normal within 2
or 3 weeks. Several explanations can be proposed to account for the short duration of
the cellular immune response in the MVV-inoculated animals. Firstly, it is possible
that the infectivity of the MVV used, although sufficient to induce cytopathic effect in
vitro, was too low to induce lymphoproliferative disease and widespread virus
distribution in vivo. The cytopathic effect of high passage, laboratory adapted strains
of lentiviruses do not accurately predict in vivo pathogenicity (Lairmore et al, 1987).
Secondly, the inoculated MVV could have remained in a period of latency (Narayan,
1990). Thirdly, subsequent development of virus-induced immunosuppression, as
occurs in infections with other retrovirus including murine leukemia virus (Friedman,
1975) and equine infectious anemia virus (Kono et al, 1978), could account for the
observed short lived cellular immune response.
Following experimental inoculation of the sheep, the expression of MHC Class
II antigens and EL-2R by BALF CD4+, CD8+ and y8 T cells increased progressively
in control and MVV-inoculated animals. Significant differences in the expression of
MHC Class II and IL-2R antigens by T cell subsets between control and MVV-
inoculated animals were short-lived (Figs. 6.4 and 6.5). Previous studies (Lairmore et
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al, 1988a; Cordier et al, 1992) found no changes in the proportions of BALF T cells
expressing MHC Class II antigens in either control or MVV-infected lambs. The
differences in these studies could be due to differences in sampling times. The
increased expression of activation markers on BALF T cells from the three groups of
animals was probably induced by antigens in the culture media used to prepare all the
inocula (as suggested for the increased percentage of BAL lymphocytes). These
antigens could initiate the cytokine cascade and upregulate MHC Class II molecules
and IL-2R expression.
As the bioassay used for TGF-(3 is highly sensitive (Cheifetz et al, 1987; Ikeda
et al, 1987), samples could be assayed without prior concentration, avoiding
substantial losses of active TGF-p that may occur during concentration (Danielpour et
al, 1989). This bioassay, however, could not distinguish between TGF-Pj and TGF-
P2, as there were no differences in (a) the inhibitory effects of TGF-^ and TGF-(^ on
the epithelial cell proliferation assay, and (b) in the ability of antibodies against TGF-
Pi and TGF-P2 to neutralise the inhibitory effect of BALF and plasma on epithelial
cell proliferation. Furthermore, no reagents for the determination of TGF-P5 were
available. Distinction among homodimers was not considered important for this study
as all them have almost identical biological actions (Cheifetz et al, 1987; Graycar et
This is the first study to demonstrate that TGF-P is a normal constituent of
ovine PELF and plasma. Previously, high concentrations of latent TGF-p were found
in lymph draining from normal ovine lungs (Perkett et al, 1991). PELF from all three
groups of animals contained approximately 165-fold higher concentrations of TGF-P
than plasma, consistent with previous studies on healthy men (Yaumachi et al, 1988).
These findings suggest significant local production of TGF-p (Tovey, 1988;
Yaumachi et al, 1988).
al, 1989).
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Unfortunately, baseline values for plasma and PELF TGF-P were not
determined (Fig. 6.7). After 2 weeks PI, there were no significant differences in the
levels of plasma or PELF TGF-P among the three groups of animals. These results
indicate that dysregulation of this cytokine in PELF and plasma is not a feature of the
early immune response following experimental MVV infection. However,
concentrations of TGF-P in other pulmonary compartments, such as the pulmonary
interstitium and vascular walls, may have been altered. Indeed, altered levels of TGF-
(3 could account for many of the pulmonary pathological features associated with
MVV. As the three isoforms of TGF-P were not distinguished, alterations in the
relative concentrations of each isoform may have occurred without affecting the
overall TGF-P concentration. In situ hybridisation and immunohistochemistry could
be used to investigate the expression of TGF-Pj, -P2 and -P3 mRNA in alveolar
macrophages, as was done for TGF-p! mRNA in human pulmonary fibrosis
(Broekelmann et al, 1991).
TGF-P! is present in brain tissues of humans with AIDS and increased
concentrations of TGF-p are found in supernatants of PBMCs from AIDS patients. In
AIDS patients, TGF-P may cause impaired immune function, depletion of CD4+ T
lymphocytes, CD4+/CD8+ ratio inversion by promoting naive T cell growth and
suppressing mature CD4+ T cell proliferation, and enhanced cerebral recruitment of
HIV-1 infected monocytes, facilitating viral spread to and within the central nervous
system (Kekow et al, 1990; Wahl et al, 1991; Wahl, 1992).
In this study, it was necessary to express TGF-P values relative to a component
that would reflect the degree of dilution of the BALF. The proportion of PELF
harvested by BAL is affected by several factors including the 'dwell time' (the time the
lavage fluid is in contact with the pulmonary epithelium), the composition and volume
of the lavage fluid, the site of BAL and the presence of pulmonary disease (Davis et
al, 1982; Pingleton et al, 1983; Dohn and Baughman, 1985).
To overcome the problem of variable PELF recovery which occurs during
BAL, Rennard and others (1986) proposed using endogenous urea as a tracer
molecule. Urea is a small molecule which diffuses readily throughout body fluids.
Assuming that the concentration of urea in PELF is the same as that of plasma,
simultaneous determinations of plasma and BALF urea permit standardisation of the
variable concentrations of PELF in BALF samples and, hence, determination of the
concentration of cells and molecules in PELF. This 'urea dilution technique' was used
to determine PELF TGF-fi concentrations in this study. However, potential problems
limit the accuracy of the urea dilution technique. Urea rapidly enters BALF during the
lavage procedure (Peterson et al, 1993), leading to an overestimation of the volume of
PELF recovered. As the magnitude of this error is proportional to the 'dwell time', in
this study, BALF was aspirated immediately after instillation. Furthermore, reduced
BALF recovery volumes with increased BALF urea concentrations have been
described in patients with interstitial lung disease, leading also to an overestimation of
PELF volume (Marcy et al, 1987). In view of the limitations of the 'urea dilution
technique', the possibility of overestimation of the PELF volume must be considered,
in which case PELF TGF-p concentrations might have been subsequently
underestimated.
Other endogenous markers of BALF dilution, namely albumen, potassium and
calcium and exogenous markers of dilution (i.e. markers which are incorporated to the
lavage solution before BAL), such as the methylene blue dilution technique, have
been used. Unfortunately, the accuracy of all these methods is limited (Rennard et al,
1986). Urea was considered to be a better reference marker than albumin for BALF
studies in patients with interstitial lung disease (Jones et al, 1990). After completion of
this study, a modification of the urea dilution technique which provides superior
accuracy in the measurement of PELF solute concentrations was reported (Peterson et
al, 1993).
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CHAPTER 7: FINAL DISCUSSION
MVV infection, similarly to other lentiviral infections of humans and animals,
is characterised by slow disease progression despite the presence of a sustained virus-
specific immune response (Narayan and Clements, 1990b). The aim of this study was
to further elucidate the cell-mediated immunological response at the bronchoalveolar
level during the course of MVV-induced interstitial pneumonia. Although in vitro
models have proved useful for the study of the immune response, they do not always
reflect accurately what happens in vivo. Hence, while in tissue culture, MVV rapidly
replicates to high titers, being cytolytic and causing cell fusion (Thormar, 1963),
MVV infection in vivo is characterised by restricted viral replication (Narayan et al,
1977; Haase, 1986). This work, therefore, was designed to study natural MVV
infection employing both in vitro and in vivo systems. Furthermore, as the early stages
of the lentivirus-host interactions may be critical for disease establishment and
progression (Bird et al, 1993), this study also investigated the early pulmonary cellular
immune response during MVV infection by inducing the disease experimentally.
During the course of natural and experimental MVV infection, a series of
immunologic alterations takes place in BALF cells of infected sheep (chapters 3 and
6). These changes appear soon after experimental inoculation of the animals with
MVV by the respiratory route, and are mainly characterised by increased proportions
of lymphocytes and neutrophils, and by phenotypic alterations in T lymphocyte
subsets despite MVV not being a T-cell tropic retrovirus (Gendelman et al, 1985;
Gorrell et al, 1992). The main changes in BALF T lymphocyte markers include
decreased proportions of CD4+ and CD5+ T cells, increased proportion of CD8+ T
cells, and an inverted CD4+/CD8+ ratio (chapter 6). Lymphocyte function, as
determined by in vitro studies (chapter 5), is also compromised during MVV
infection. Interestingly, T cell behaviour during MVV infection is independent of the
amount of viral antigen, as extensive lymphocytic responses unrelated to the number
of cells productively infected with the virus, have been observed during MVV
infection (Watt et al, 1992). This suggests that soluble mediators in the lung regulate
the T cell response, rather than the virus per se.
Maedi is an interstitial lung disease. Interstitial lung diseases are a group of
heterogeneous, chronic disorders that involve the entire lung parenchyma as well as
the alveolar interstitium (Spencer, 1977; Fulmer and Crystal, 1979). The term
'interstitial' was originally applied to these disorders because they are associated with
thickening of the alveolar septum. However, it is important to emphasise that
interstitial lung disorders are not confined to the alveolar interstitium, as they also
involve alveolar epithelial and endothelial cells, and even airways, arteries and veins
(Crystal et al, 1981). The initial manifestation of these disorders is an alveolitis,
defined by accumulation of inflammatory and immune effector cells within the
alveolar structures (Barry et al, 1979). The alveolitis in interstitial lung disease
produces a derangement of the alveoli, ultimately leading to loss of functional gas
exchange. This alveolitis is maintained by the local production of specific cell-derived
chemotactic factors that recruit inflammatory cells from the blood into the alveolar
interstitium (Crystal et al, 1981).
In common with other interstitial lung diseases, the earliest manifestation of
pulmonary MVV-infection is a chronic inflammatory process within the alveolar
structures. To characterise and quantify this alveolitis, the recovery of the
inflammatory and immune effector cells involved was necessary. The validity of the
BAL technique as a research tool for the study of the pulmonary inflammatory
component during MVV-infection can be easily deduced from these studies. In this
work, not only did the BAL procedure allow the recovery of BALF for further
immunological studies of its cells and soluble proteins, but also made possible the
follow-up of the early cellular immune response in the lung of animals experimentally
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inoculated with MVV. Since BAL in sheep can be repeated numerous times during the
course of lung disease (Begin et al, 1981), this technique is a valuable clinical and
research tool which permits an immediate approach to maedi by assessment of the
ongoing alveolitis.
During natural MVV-infection, a local inflammatory response with cellular
phenotypic changes occurs in the alveoli without detectable concomitant changes in
peripheral blood cells. Absence of correlation between PB and BALF lymphocyte
phenotypes has also been reported in healthy humans (Yamada et al, 1986) and during
the course of several lung diseases, including pulmonary sarcoidosis (Pinkston et al,
1983; Muller-Quernheim et al, 1986; 1992) and hypersensitivity pneumonitis (Mornex
et al, 1984). The differences between lung and blood lymphocyte populations could
partially explain this divergence. Hence, lung lymphocytes have different migratory
properties from PB lymphocytes (Reynolds, 1978) and they seem to be in a
continuous state of activation (Semenzato, 1991). The tropism of MVV for the lung
(Narayan et al, 1988b) may also partly explain the pulmonary compartmentalisation of
the immune response. Therefore, previous studies have shown that, while PB
monocytes in sheep persistently infected with MVV have viral genomes which
express virus specific products minimally (Narayan et al, 1983; 1984), more alveolar
macrophages of MVV-infected animals contain the viral genome, although only a few
of these macrophages produce infectious virus (Narayan and Cork, 1985; Staskus et
al, 1991).
Comparisons of inflammatory and immune effector cells from BALF and from
open lung biopsies of patients with interstitial lung diseases have demonstrated that
cells and proteins derived from the alveolar epithelial surface accurately reflect the
effector components within the alveolar interstitium (Hunninghake et al, 1979).
However, in this study while BALF from MVV-infected animals had increased
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numbers of lymphocytes, similar to bronchus-associated lymphoid tissue (BALT) and
alveolar septae (Watt et al, 1992), when phenotypic changes of BALF lymphocytes of
MVV-infected animals were compared with those reported in alveolar interstitium
(Watt et al, 1992), some differences were found. Hence, the proportion of CD4+
lymphocytes and the CD4+/CD8+ ratio were reduced in BALF from MVV-infected
animals, whereas, in alveolar interstitium, inversion of the CD4+/CD8+ ratio and
decreased proportions of CD4+ lymphocytes were not observed. These results suggest
a further compartmentalisation of the lymphocyte-mediated immune response within
the lung (Berman et al, 1990). Lymphocyte phenotypic alterations in response to
MVV infection might occur initially within the lung parenchyma with subsequent
recruitment of specific T cell subsets into the alveoli. In healthy lung, entry of
lymphocytes from the blood into the lung parenchyma, and the later recruitment of
specific populations of pulmonary interstitium lymphocytes into the bronchoalveolar
milieu involve a series of defined steps. The two main steps are, firstly, adherence of
blood lymphocytes to endothelia and secondly, induction of a motile response which
permits subsequent migration of lymphocytes through the lung tissue. These steps
require specific lymphocyte-endothelial and lymphocyte-chemoattractant interactions
that are modulated by the local production of regulatory factors, such as cell adhesion
molecules LFA-1 and LFA-3, at the site of inflammation (Pardi et al, 1992). The fact
that LFA-1 and LFA-3 molecules were upregulated on BALF lymphocytes from
MVV-infected animals (chapter 3) could account for the increased recruitment of
lymphocytes to the bronchoalveolar structures in maedi. Cytokines produced by
activated T lymphocytes, such as y-IFN (Duijvestijn et al, 1986) might also regulate
the migration of specific T cell subsets into the alveoli.
As inflammatory and immune processes within the alveolar structures can
operate independently of the rest of the body (Hunninghake et al, 1979), and even
independently in the different lung compartments (Berman et al, 1990), the
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importance of direct assessment of the BALF itself to monitor the evolution of MVV
infection at the bronchoalveolar level can be seen.
The proportion of BALF CD4+ lymphocytes is reduced during lentiviral
infection. Whether this is due to reduced migration of CD4+ lymphocytes from the
pulmonary interstitium into the airways and alveoli, or to destruction of this cell type
in the bronchoalveolar milieu associated with a normal migration rate, is unknown. If
the first postulate is correct, the presence of normal numbers of CD4+ lymphocytes in
the pulmonary interstitium, despite the reduced numbers of CD4+ lymphocytes in
BALF, could explain the lack of a profound immunosuppression in MVV-infected
sheep. This is an important difference with respect to HTV-infection, where a complete
depletion of CD4+ cells is present (Agostini et al, 1993). If the second postulate is
assumed, destruction of BALF CD4+ lymphocytes could be caused by BALF CD8+
cytotoxic lymphocytes. In HIV infection, since the virus is tropic for CD4*" cells, the
principal role of the CD8+ cytotoxic suppressor cell is to target the CD4+ lymphocyte
and possibly mediate its destruction (Rankin et al, 1988). During MVV-infection,
unlike in HIV infection, CD4 does not act as the cellular receptor for MVV (Gorrell et
al, 1992). The mechanism that would induce CD8+ cytotoxic cells within the MVV-
infected lung to attack CD4+ T cells is not well understood, but it is possible that
lymphocytes could bind virus particles and such virus-bearing cells would be targeted
either specifically by cytotoxic T cells, or in a non-specific or antibody-dependent
manner by lymphokine-activated killer cells, NK cells or infected macrophages
(Gorrell et al, 1992). An activation-induced apoptosis of both T cell subsets, as has
been recently observed in HIV infection (Cohen et al, 1993), can not be ruled out. In
this case, differences in the rate of cell replacement between CD4+ and CD84" T cells
can explain the decrease in the BALF CD4+/CD8+ ratio. In HIV infection, it has been
suggested that an increase in the level of activation markers could account for the
decline of CD4+ population (Mahalingam et al, 1993). In BALF of MVV-infected
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animals expression of activation markers is equally increased on both CD4+ and
CD8+ T lymphocytes, while only CD4+ T lymphocytes are diminished. Once more,
the only way to explain this would be by assuming a different replacement rate for
CD4+ and CD8+ T cells.
The augmentation of the proportion of BALF CD8+ T cells could be the result
of a specific proliferative response against MVY-infected cells. Pulmonary
macrophages, latently infected or expressing viral protein on their membrane, could
induce the recruitment and/or the in situ expansion of CD8+ T lymphocytes,
selectively directed against the infected cell. This would account for the 'lymphocytic
alveolitis' that is present from the early phase of the disease. The proliferative
response of BALF CD8+ T cells could be a defence mechanism following previous
reduction of this T cell subset caused either by direct destruction by MVV-infected
macrophages or by activation-induced apoptosis as suggested above. Virus-specific
CD8+ T lymphocytes represent a major host defence mechanism in viral diseases in
clearing virus-infected cells (Meignan et al, 1990). The putative intrapulmonary
immunologic conflict between CD8+ T cells and MVV-infected alveolar macrophages
could lead to immunologically induced inflammation and tissue damage. CD84" T
lymphocytes suppress in vitro replication of HIV in PBMCs (Walker et al, 1986). This
antiviral activity appears to be mediated in part by a diffusible factor which will act
interfering with virus replication (Walker and Levy, 1989; Mackewicz and Levy,
1992), and it has also been reported in studies with simian immunodeficiency virus
(SIV) (Kannagi et al, 1988) and in HIV-1 infected chimpanzees (Castro et al, 1991).
Unfortunately, in spite of evaluating a wide range of cytokines, attempts to identify
and characterise this lymphokine produced by CD8+ T cells have not been successful.
Brinchmann and others (1991) reported that TNFa and IFNa, [3 and y, are not
responsible for this anti-HIV activity of CD8+ cells, based on the inability of MAbs
specific for these cytokines to inhibit the antiviral activity of CDS4" cells. Studies in
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experimental models have shown that cytotoxic T lymphocytes, although capable of
mediating virus clearance can also induce deleterious effects in the lung infected by
the virus (Meignan et al, 1990).
The increased proportion of CD8+ T lymphocytes in lentiviral infected sheep
could also account for the slow replication of MVV in tissues. Slow replication of
MVV in the host alveolar macrophages could help the virus to elicit immunological
responses, favouring its persistence in the host. Induction of CD84" T lymphocytes in a
defective maturation state is a common feature of the immune response to lentiviruses
(Salazar-Gonzalez et al, 1985). Hence, another possibility is that CDS4" T lymphocyte
induced by MVV are unresponsive to viral infection which would allow viral
dissemination. Anergy and suppressor lymphocyte activity could account for this lack
of CD8+ T lymphocyte response (McChesney and Oldstone, 1989).
The proportion of CD5+ cells was significantly decreased both in BALF and
lung interstitium of MVV-infected animals (Watt et al, 1992). Reduction in the
proportion of these cells indicates an ongoing process of activation in the lung during
MVV-infection (Lujan et al, 1993), as decreased expression of ovine cell membrane
CD5 follows cellular activation (Hopkins and Dutia, 1990). The role of ovine CD54" T
lymphocytes remains uncertain. Interestingly, in experimentally MVV-infected
animals, BALF CD5+ T cells followed a similar trend to BALF CD4+ T cells. Hence,
it is possible that ovine CD5+ T cells, as suggested for human CD54" T cells (Srour et
al, 1980), are involved in the execution of CD4+ T helper functions.
During experimental MVV infection, phenotypic changes in the main T cell
populations were detected as early as two weeks PI, but were maintained only for two
or three weeks and then they returned to baseline levels. The short duration of the
cellular immune response is of great interest, as it suggests that MVV probably
temporarily eluded host defence mechanisms and experimentally infected animals
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remained in an state of persistent, but latent, infection. Many animals remained in this
state throughout their lives, without showing clinical signs, although a resurgence of
virus replication has been observed in some animals after a quiescent period ofmonths
to years (Narayan, 1990). The outcome of MVV infection is probably influenced by
many factors, namely (1) characteristics of the virus, such as virus strain,
cytopathogenicity and its ability to mutate; (2) the host immune response, both
humoral and cellular; and (3) genetics of the individual that may influence the
susceptibility of cells to virus infection. In addition, triggering of MVV-infected
macrophages by stress factors, such as concomitant pulmonary infections, could
account for amplification of MVV replication, leading to development of
inflammatory lung lesions and symptoms. These factors could explain the range of
clinical signs and lesions that have been described in MVV-infected flocks (Watt et al,
1992).
During interactions between MVV-infected alveolar macrophages and
lymphocytes, activation of some of the BALF T cell populations takes place. As a
consequence, it is likely that several cytokines with immunoregulatory activities are
simultaneously produced. These cytokines could play a major role in pathogenesis of
MVV-infection, probably being the main determinant of the inflammatory nature of
the viral lesions. Some of those cytokines, such as TNF-a, EL-1, IL-6 or GM-CSF,
could induce accumulation of the immunocompetent cells (including lymphocytes and
PMNs) in lung interstitium (potentiating lung tissue damage) and migration of these
cells into the bronchoalveolar milieu. Whether or not cytokines have any indirect
effects that lead to proliferation of CD8+ cytotoxic T cells and inhibition of CD44"
helper T cells is not known (Narayan et al, 1988b). Increased levels of cytokines in
bacterial pulmonary infections have been reported. TNF-a secretion is elevated in
ovine pulmonary macrophages following infection with Corynebacterium
pseudotuberculosis and Pasteurella haemolytica, but not in lentivirus infection (Ellis
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et al, 1991). IL-1 levels are elevated in BALF from children with bacterial pulmonary
infection (Wilmott et al, 1990). IL-1 and TNF-a are also elevated in BALF from pigs
infected with Mycoplasma hyopneumoniae (Asai et al, 1993), and IL-1 and IL-6 are
elevated in the BALF of mice infected with Chlamydia trachomatis (Magee et al,
1992). In murine acquired immunodeficiency syndrome, the cytokines mainly
secreted are those typical of a predominantly TH2 response: IL-4 and IL-10, while only
small amounts of the cytokines secreted by the Thi subpopulation: EL-2 and y-EFN are
found. IL-4 is the putative cytokine responsible for the induced T cell dysfunction
(Kanagawa et al, 1993) in this syndrome. The characterisation of ovine CD4+ T cells
into the TH1 and TH2 subtypes according to the different cytokines that they produce
has not yet been performed, due to the lack of adequate reagents.
It is known that TGF-(3 is a very pleiotropic cytokine, which can act both as
an immunosuppressive and as a potent proinflammatory molecule. The
multifunctional role of this cytokine prompted the hypothesis that its dysregulation
could account for some of the pulmonary pathological features of MVV infection such
as: accumulation of neutrophils and T lymphocytes (Adams et al, 1991) in BALF and
in the pulmonary interstitium of MVV-infected animals (Watt et al, 1992), enhanced
expression of LFA-1 on BALF lymphocyte surfaces, decreased EL-2R expression by
activated BALF T lymphocytes and diminished IL-2R expression on BALF
lymphocytes from MVV-infected animals following mitogen stimulation. To test this
hypothesis, TGF-[3 present in BALF supernatant and PELF was quantified during the
course of experimental MVV infection. No significant differences between levels of
TGF-J3 in BALF and PELF from control and MVV-experimentally infected animals
were found. However, some participation of TGF-(3 in the pathogenesis of MVV
infection at the lung interstitium level is still likely, as has been observed in human
pulmonary fibrosis (Broekelmann et al, 1991). Once more it is not possible to
generalise between the responses occurring within different lung compartments. It is
possible that the effect of TGF-|3 varies in the different microenvironments or lung
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compartments, and with the state of activation of the target cell (Elias et al, 1990). It is
*
still possible that TGF-P, by acting in the interstitium, plays a major role in the
pathogenesis ofmaedi.
Another cytokine with a putative multiple role in the lung is EFN. Previous in
vitro studies (Kennedy et al, 1985; Narayan et al, 1985) have demonstrated the
contribution of an ovine lentivirus-induced IFN (LV-IFN) to the pathogenesis of
MVV infection (Narayan et al, 1985; Lairmore et al, 1988b). This LV-IFN has
physical properties similar to IFN generated in vitro by other lentivirus-infected cells
(Narayan et al, 1985). It induces MHC Class II antigen expression on alveolar
macrophages (Kennedy et al, 1985), and as a result, the infected cell remains in a state
of continuous or chronic antigen presentation. LV-IFN inhibits maturation of infected
monocytes to macrophages, and thus, indirectly restricts completion of the virus life
cycle. It also causes reduction in the number of transcripts of viral RNA in infected
macrophages, giving rise to the phenomenon of 'slow replication'. Furthermore, as
interferons inhibit the growth of fibroblasts and collagen synthesis in vitro (Elias et al,
1987), it is likely that LV-IFN regulates fibrogenesis in the lung of MVV-infected
animals, where only a limited amount of fibrosis is present. The upregulated
expression of MHC Class II antigens found in this work in BALF lymphocytes and
macrophages suggest the active involvement of LV-IFN in the pathogenesis of MVV
infection. However, our attempts to detect native ovine y-IFN in BALF supernatant
samples by using an ELISA (Emery et al, 1990; Rothel et al, 1990; Entrican et al,
1992) were unsuccessful. Whether these negative results were due to biological or
technical reasons is not clear. In patients with sarcoidosis, attempts to quantify y-IFN
in BALF supernatants (which had been previously concentrated), by using a
radioimmunoassay were also unsuccessful (Prior and Haslam, 1992). Several
biological possibilities could explain the lack of detectable y-IFN in BALF
supernatant: little y-IFN might be produced in vivo due to the immunosuppressive
effect of pulmonary surfactant (Whilsher et al, 1990); locally produced y-IFN may be
253
bound to receptors (Hancock et al, 1986) or inactivated by an inhibitor of proteases
(O'Kelly et al, 1987); and finally, y-IFN might be produced mainly in the interstitial
lung tissue, and not pass to the alveolar spaces. The possible technical reasons to
explain the lack of y-TFN in BALF supernatant are: y-IFN concentrations in BALF
might be below the limits of the assay system employed due to the dilution occurring
during BAL; and, as LV-IFN has not been fully characterised, it could be of a
different type to y-EFN which was not detected by the assay employed. LV-IFN has
some characteristics of y-IFN (Narayan et al, 1985; Narayan, 1986), and some
properties associated with a-IFN (Mclnnes, 1993). Furthermore, all previous studies
of the LV-IFN have been performed in vitro. This cytokine has not been identified in
vivo, and its real role in the pathogenesis of maedi remains obscure.
As the lung is exposed to complex mixtures rather than to individual
cytokines, and cytokines in combination have quantitatively and qualitatively different
effects than they have individually (Elias et al, 1990; Kelley, 1990), further
investigation of the interactions of each individual cytokine with other cytokines in the
lung are required, although this may prove difficult.
Decreased EL-2R expression by activated BALF T lymphocytes from naturally
MVV-infected animals might act as an additional contributory factor to the
dysfunction of the pulmonary immune response. Whether decreased IL-2R expression
is a primary factor that allows MVV replication and persistence or, on the other hand,
this receptor is downregulated as a consequence of previous immunologic defects is
unknown. It is however likely that the downregulation of EL-2R in BALF lymphocytes
is secondary to decreased levels of IL-2 in BALF. Hence, although this study did not
investigate IL-2 levels, decreased levels of IL-2 in mononuclear leukocytes culture
supernatants of MVV-infected sheep have been previously reported (Ellis and
DeMartini, 1985). Lower levels of IL-2 could account for decreased EL-2R expression
and for a diminished T cell cytolytic function, leading to decreased immune
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responsiveness in MVV-infected sheep. The finding that the different BALF T
lymphocyte subpopulations of naturally MVV-infected animals did not demonstrate
upregulation of EL-2R expression argues against high levels of MHC Class II antigens
on BALF T lymphocytes of MVV-infected animals being solely due to the influence
of cytokines. Moreover, in vitro studies confirmed the defective lymphocyte activation
with respect to IL-2R expression observed during the natural course of the disease.
The capacity of BALF T lymphocytes from MVV-infected animals to respond to
exogenous mitogen. stimulation was reduced, and IL-2R expression was also
downregulated in unstimulated BALF T lymphocytes of MVV-infected animals when
compared with those of controls.
Activation of BALF macrophages characterised by upregulation of MHC
Class II molecules was also present in natural MVV infection. Coexpression of both
DR and DQ MHC Class II molecules with MVV viral proteins on BALF
macrophages, demonstrated by immunocytochemical techniques, has been found
(Lujan et al, personal communication). However further studies are necessary to
determine whether there is any connection between those infected BALF macrophages
and the level of expression of MHC Class II molecules. As transcription and
translation from the viral genome are dependent on the maturational/activational status
of the cell (Gendelman et al, 1986), the activation of chronically infected BALF
macrophages could trigger the transition from latency to active viral replication.
Infection of BALF macrophages by MVV, apart from leading to the production of
cytokines, might contribute to perturbation of the cellular pulmonary immune
response by some other mechanisms. Cells of the macrophage lineage are the major
host cell for replication of lentiviruses in vivo (Narayan et al, 1982; Peluso et al,
1985). If the cells involved in the non-specific cellular defence system of the host via
viral antigen presentation, are at the same time the source of antigens, and are possibly
damaged, this will result in disruption of the immune system and incapability of
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responding efficiently to the infecting virus. Additionally, infected macrophages, by
remaining in this state of continuous antigen presentation, may mediate
immunopathologic disease (Narayan etal, 1988b).
In summary, the lung in MVV-infection acts as the major reservoir for MVV
via the infection of cells from the monocyte/macrophage lineage. During natural and
experimental MVV-infection the pulmonary immune response is characterised by
interaction of MVV with pulmonary macrophages and lymphocytes with resultant
production of cytokines. This interaction leads to a series of 'defective' immunologic
phenomena. Although each of these immunologic defects individually is not sufficient
to alter lung homoeostasis, the combination of all of them will lead to a decline of the
functional capabilities of the lung during MVV infection. Despite the presence of
highly specialised effectors in the lung host, the immune surveillance mechanisms fail
to control the progress of the disease, this failure leading to further immune
dysfunction (Agostini et al, 1993). Pulmonary lesions, rather than the result of the
direct action of the virus per se, will result from the response of diverse elements of
the immune response to viral infection.
Finally, if other aspects of the biology of MVV such as antigenic drift
(Narayan et al, 1977), sequestration of viral DNA in nuclei of infected cells (Haase et
al, 1977) and low affinity of the induced neutralising antibodies (Kennedy-Stoskopf et
al, 1986) are added to the failure of the host pulmonary immune response, it is clear
how this lentivirus manages to escape immunological control within the lung. The
current development of molecular reagents for cytokines and in situ techniques will
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Appendix 1.3.3. Percentages of MHC Class II expression on BALF macrophages
from control and MVV-infected animals. The MAbs employed were a pan Class II
MAb (VPM36+ VPM38), VPM37 (DR. specificity) and VPM41 (DQ specificity).
Sheep n° CLASS II VPM37 VPM41
CONTROLS
43 85.08 78.34 88.53
88 93.77 12.66 91.31
89 71.97 59.46 69.96
90 90.60 23.00 79.43
91 58.36 39.67 45.28
92 87.46 66.29 78.54
93 75.94 45.75 77.66
94 45.06 22.90 38.75
95 62.24 56.13 34.89
96 76.64 43.07 67.45
97 89.16 33.13 85.01
98 48.17 41.08 22.48
99 91.06 78.06 88.51
MVV-INFECTED
1 61.56 46.64 50.54
2 93.64 92.65 92.95
8N 88.42 73.53 80.32
27 82.21 75.81 80.67
29 86.68 78.01 79.67
47 70.25 68.32 79.67
53 95.13 93.93 91.53
65 82.09 71.31 70.52
74 82.09 71.31 70.52
75 91.37 89.53 90.34
76 80.81 16.45 73.43
80 81.84 20.12 78.91
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Appendix 1.3.4. Mean channel number of MHC Class II expression on BALF
macrophages from control and MVV-infected animals. The MAbs employed were a
pan Class II MAb (VPM36+ VPM38), VPM37 (DR. specificity) and VPM41 (DQ
specificity).
Sheep n° CLASS II VPM37 VPM41
CONTROLS
43 63.67 44.37 70.95
89 33.23 37.04 44.37
90 62.84 11.25 38.40
91 57.13 46.00 42.79
92 151.49 42.79 49.44
93 47.69 16.14 10.46
95 27.74 47.69 37.72
96 41.27 9.73 15.57
97 233.68 32.05 181.48
98 46.00 39.81 68.46
99 195.07 51.26 76.27
MVV-INFECTED
1 41.27 33.23 46.00
2 209.69 202.25 175.04
8N 270.01 151.49 49.46
27 251.19 47.69 202.25
29 323.45 242.28 270.01
47 97.00 73.56 47.69
53 827.27 181.48 195.07
65 157.06 98.21 57.13
74 47.69 47.69 39.81
75 279.94 217.40 233.68
76 311.97 47.69 95.07
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Appendix 1.3.5. Mean channel number of MHC Class II expression on BALF
lymphocytes from control and MVV-infected animals. The MAbs employed were a
pan Class II MAb (VPM36+ VPM38), VPM37 (DR specificity) and VPM41 (DQ
specificity).
Sheep n° CLASS II VPM37 VPM41
CONTROLS
43 42.79 38.40 39.81
88 49.44 73.56 37.04
89 12.99 8.73 6.31
90 7.56 11.66 20.78
91 16.14 15.57 17.98
93 26.76 32.05 49.44
94 14.48 20.78 24.89
95 41.27 20.78 24.89
96 20.04 33.23 17.35
97 16.14 34.46 21.54
98 46.00 38.40 15.57
99 35.72 25.81 28.76
MVV-INFECTED
1 15.01 16.14 14.48
2 360.46 387.47 195.07
8N 10.09 5.66 23.16
27 10.46 35.72 9.73
29 300.91 260.43 162.84
47 16.23 251.19 44.37
53 51.26 61.41 20.78
74 20.04 49.44 32.05
75 233.68 242.28 209.69
76 217.40 24.01 251.19
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Appendix 1.4.1. IL-2R expression by the different BALF T lymphocyte subsets of
control (n=7) and MW-infected animals (n=7). (Results expressed as the value of
mean channel number of fluorescence intensity).
Sheep n°
CONTROL T4 T8 y5
40 26.76 10.46 15.01
89 8.73 10.46 8.42
91 8.73 10.09 10.46
92 13.97 12.09 13.47
94 5.66 5.27 6.78
96 7.84 7.84 9.05
97 7.84 9.51 7.56
MVV
17 3.81 4.09 8.85
59 7.56 8.73 8.73
79 7.84 8.73 9.05
80 17.98 16.73 17.35
99 13.47 10.85 12.09
109 2.47 4.09 8.85
Not significant (p> 0.05)
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Appendix1.6.3Mediana dra gesofp rcentagesBALFCD4+Tc llfimalsemployedf rexperim ntalMVVinf ctiondiff t samplingtimes.Controlheep(CON)n=4),sin culatedwi hhe ti activat dMVV(IIIC)=2anMVV-in culatedshe p(M V)(n=6).PI=post-inoculation. WeeksPICONHICMVV 044.28(36.26-5 .20)45.1(32.20-58.20)44.49(38. 6-56.47)241.46(37.82-55.77)5 .92(38.70-65.20)40.26(31.98-6 .22)438.30(31.89-64.92)51.83(3 . 0-71.80)56.92/27.26-38.76)51.24(4 .94-58.55)6.92(45.80-68.10)30.76^(12. -44.48)45.86(44.36-63.66)8.78(5 .78-5 .782 .09*(8.11-42.46)1250.59(35.29-58.04)3 .19(17.62-39.62)1644.70(29.90-60.20)33.94(16.71-6 .52) Appendix1.6.4.Mediana dra gesofp rcentagesBALFCD8+Tc llfimalsmployedf rexper m ntalMVVinf ctiondiff t samplingtimes.Controlheep(CON)n=4),in culatedwi hhe ti a tivatedMVV(IIIC)=2nMVV-inocu atedsh ep(M V)(n=6).PI=post-inoculation. WeeksPICONIIICMVV 019.49(13.48-27.31)7 02( .0 -20.97)8.89/9.58-27.69)219.22(12.92-33.93)5.86(11.03-20.70)33.61*( 2.96-54.75)413.19(11.97-17.21)40(12.79-14.0 )59.33 (30.3 -63.55)618.10(17.17-25.88)5 4(11.42-18.85)52.26 (20.25-6 .76)819.92(17.89-27.67)4 55(10.98- 0 5655.33( 9.4 - 0. 0)127.87(11.04-31.76)35.65( .75-62.95)165.98(13.98-17.99)39.(12.26- 3.05) *Significantlydifferentfromthertworoupsatp<0.05(Kruskal-Wallist st).
Appendix1.6.5.Mediana dra gesofpercentagesBALFCD5+Tc llfanimalsemployedf rexperimentalMVVinf ctiondiff t samplingtimes.Controlheep(CON)n=4),sin culatedwi hhe ti ac ivat dMVV(HIC)( =2anMVV-in culatedsheep(M V)(n=6).PI=post-inoculation. WeeksPICONHICMVV 046.83(35.84-59.20)44.20(29.40-59.00)3.70(32.2 -59.55)244.69(40.00-4 .77)51.71(42. 5-6 .37)5.36(2 .70-62.32)46.39(27.90-60.17)54.3 (34.7 -74.10)30.01/23.3 -39.01)654.04(42.74-60.15)6.98(42.5 -71. 0)27.55^(12.46-46.48)45.57(42.07-59.96)52.00(5 .00-52.00)8. 5(14.73-43.53)1249. 1(33.26-58.87)4.39(21.21-36.65)1643.02(32.30-53.70)2. 5(16.22-58.25) Appendix1.6.6.Mediana dra gesofp rcentagesBALFyS4"Tc llimalsmployedf rexperimentalMVVinf ctiondiff t samplingtimes.Controheep(CON)(n=4),in culatedwi hhe tinactivat dMVVHIC)( =2nMVV- nocu atedsh ep(M V)(n=6).PI=post-inoculation. WeeksPICONHICMVV 09.06(5.02-14.71)8.22(4.6 -11.79)6.82/5.53-11.86)29.02(9.00-14.37)11 17(10.75-11.595 0(2.28-6.98)49.74(4.14-15.44)8 68(8 2- 9.66/1.6 -8.69)612.54(9.52-17.41)0.15(9.50- 0.80)3.16,(1.61- .29)812.42(10.12-17.51)1.35(1 .35-11.35)5 9( .83- 71)122.03(5.95-14.20)6 12(3.0 -8.82)162.93(8.95-15.92). 7(3.08-10.94) *Significantlydifferentfromthertwogroupsatp<0.05(Kruskal-Wallisst).
Appendix1.6.7.Mediana drangesofBALFCD4+/CD8+r tiofan malsemployedf rex rim ntalMVVi fectioniff ts mplingtimes.Controlsheep(CON)n=4),epi oculat dwi hh tnactivat dMVV(HIC)n=2nMVV-inoculatede p(M V)(n=6 .PI= post-inoculation. WeeksPICONHIC
MVV
0 2 4 6 8
12 16
2.25(1.5 -4.31) 2.47(1.1 -3.16) 2.97(2.51-3.77) 2.72(1.92-3.14) 2.50(1.80-2.96) 3.10(1.52-3.19) 2.96(1.62-4.30)
2.98(1.53-4.44) 3.88(1.86-5.90) 3.92(2.27-5.57) 4.19(2.42-5.96) 4.03(4.03-4.03)
2.45(1.60- .89) 1.17/0.58-2.62) 0.47^(0.44-1.27) 0.59*(0.25-2.19) 0.50*( .13-2.15) 1.03(0.3 -2.36) 1.23(0.2 -12.28)
Appendix1.6.8.Medianandra gesofpercentagesBALFCD4+/VPM54+Tllofanimalsemployedf rxperimentalVVi fection





























Appendix1.6.9.Mediana drangesofpercentagesBALFCD4+/VPM36+Tellofan malsemployedf rex erim ntalVVi f ction
























































*Significantlyd fferentfromthertwogroupsatp<0.05(Kruskal-W llist st).
Appendix1.6.11.Mediana dra gesofpercentagesBALFCD8+/VPM54+Tllofanimalsemployedf rexperimentalVVinf ction




























Appendix1.6.12.Mediana dra gesofpercentagesBALFCD8+/VPM36fTc llfimalmployedf rexperim ntalMVVinf ction












































































































































Appendix 1.6.17. Urea concentrations of plasma and BALF (mg/dl) of animals
employed for experimental MVV infection at different sampling times. Control sheep
(CON) (n=4), sheep inoculated with heat inactivated MVV (HIC) (n=2) and MVV-
inoculated sheep (MVV) (n=6).
Sheep n° Week* PLASMA BALF
CON 70 2 24.70 0.84
ti 4 28.31 0.39
ti 6 46.38 0.68
if 8 34.93 0.59
II 12 30.12 0.34
It 16 27.10 0.89
CON 107 2 24.09 0.19
it 4 43.37 0.34
ii 6 54.21 0.45
ii 8 44.57 0.48
ii 12 30.72 0.46
it 16 35.54 0.25
CON 125 2 33.13 1.11
ii 4 27.10 1.28
ii 6 42.77 1.16
ii 8 30.12 0.49
it 12 36.14 0.49
CON 129 2 34.33 1.06
ti 4 28.91 0.68
ff 6 34.93 0.74
if 8 22.28 0.41
ff 12 33.13 0.42
HIC 141 2 43.97 0.98
if 4 43.37 0.86
if 6 37.95 0.59
if 8 27.71 0.62
HIC 35 2 37.95 1.10
if 4 48.79 0.85





Sheep n° Week* PLASMA BALF
MVV 14 2 36.74 0.38
tt 4 28.31 0.28
it 6 33.13 0.61
»» 8 40.36 0.52
n 12 26.50 0.60
tt 16 25.30 0.20
MVV 56 2 45.18 0.24
Jt 4 38.55 0.93
tt 6 36.74 0.02
tt 8 32.89 0.50
tt 12 19.87 0.07
tt 16 39.15 0.37
MVV 95 2 42.16 0.74
tt 4 34.93 0.46
tt 6 31.92 0.57
8 33.73 0.61
tt 12 13.25 0.63
it 16 33.73 0.97
MVV 102 2 40.36 0.69
it 4 43.37 0.46
tt 6 38.55 0.45
ft 8 37.34 0.49
tt 12 15.66 0.59
it 16 45.18 0.54
MVV 105 2 31.32 0.66
tt 4 34.33 0.58
ft 6 38.55 0.72
tt 8 30.72 0.73
tt 12 21.08 0.83
tt 16 39.15 0.94
MVV 120 2 31.92 0.52
tt 4 45.18 0.64
tt 6 40.36 0.61
it 8 38.55 0.73
tt 12 23.49 0.55
tt 16 38.55 0.95
Weeks post-inoculation.
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Appendix 1.6.18. TGF-p concentrations in plasma (ng/ml) of animals employed for
experimental MVV infection at different sampling times. Control sheep (CON) (n=4),
sheep inoculated with heat inactivated MVV (HIC) (n=2) and MVV-inoculated sheep
(MVV) (n=6).
Week* Sheep n° TGF-(3 Sheep n° TGF-(3
2 CON 70 5.05 MVV 14 0.44
4 it 8.87 ii 5.90
6 it 13.90 it 10.71
8 it 10.40 ii 7.18
12 if 11.86 ii 5.95
16 ii 9.64 ii 10.40
2 CON 107 0.44 MVV 56 12.02
4 it 3.83 ii 17.78
6 tt 11.64 it 8.39
8 if 7.74 it 9.10
12 it 16.45 if 7.11
16 ri 11.35 ii 16.60
2 CON 125 15.31 MVV 95 6.02
4 if 17.78 if 9.18
6 ii 20.99 it 6.54
8 it 19.91 it 9.89
12 ti 29.66 it 7.53
16 ii 15.10
2 CON 129 5.61 MVV 102 3.77
4 ti 2.70 it 3.26
6 ti 6.09 ii 6.20
8 it 4.84 ii 3.32
12 ii 7.08 it 5.50
16 it 9.64
2 HIC 35 12.56 MVV 105 12.79
4 if 8.32 ii 15.81






2 HIC 141 9.33 MVV 120 15.81
4 it 11.80 ii 6.87
6 ii 6.65 it 7.51





Appendix 1.6.19. TGF-(3 concentrations in BALF (ng/ml) of animals employed for
experimental MVV infection at different sampling times. Control sheep (CON) (n=4),
sheep inoculated with heat inactivated MVV (HIC) (n=2) and MVV-inoculated sheep
(MVV) (n=6).
Week* Sheep n° TGF-{3 Sheep n° TGF-p
2 CON 70 13.99 MVV 14 22.43
4 tt 12.43 tt 29.46
6 tt 11.33 it 23.95
8 rt 24.22 tt 25.96
12 »t 14.59 tt 21.44
16 28.96 tt 26.26
2 CON 107 15.64 MVV 56 16.57
4 tt 25.96 tt 20.86
6 ft 19.73 tt 28.14
8 tt 48.90 tt 17.35
12 tt 22.61 tt 24.22
16 tt 35.02 it 32.68
2 CON 125 13.62 MVV 95 98.46
4 tt 18.16 it 30.50
6 tt 17.35 tt 83.51
8 tt 18.98 it 72.33
12 ft 76.61 tt 36.67
16 it 26.66
2 CON 129 13.59 MVV 102 15.11
4 tt 11.12 tt 10.76
6 tt 17.55 tt 13.97
8 it 13.51 it 15.00
12 tt 38.84 tt 13.99
16 tt 12.14
2 HIC 35 32.68 MVV 105 22.61
4 tt 18.46 tt 68.90




2 HIC 141 16.19 MVV 120 19.24
4 tt 15.46 tt 34.22
6 ft 16.00 it 22.09





Appendix 1.6.20. TGF-(3 concentrations in PELF (ng/ml) of animals employed for
experimental MVV infection at different sampling times. Control sheep (CON) (n=4),
sheep inoculated with heat inactivated MVV (HIC) (n=2) and MVV-inoculated sheep
(MVV) (n=6).
Week* Sheep n° TGF-(3 Sheep n° TGF-(3
2 CON 70 412.28 MVV 14 2204.42
4 it 909.87 it 2940.69
6 ti 796.08 it 1309.50
8 m 1426.80 ti 2031.88
12 ii 1310.91 it 958.15
16 ii 882.41 it 3435.85
2 CON 107 2087.94 MVV 56 3226.17
4 it 3349.61 ii 866.31
6 ii 2370.55 ii 3820.00
8 it 4569.70 it 2515.22
12 ii 1496.55 ii 622.45
16 ii 5735.92 it 3544.79
2 CON 125 255.37 MVV 95 5650.00
4 it 396.15 2296.04
6 ti 639.34 4700.00
8 it 1166.89 4026.61
12 it 5652.28 768.96
16 895.02
2 CON 129 441.40 MVV 102 892.54
4 it 470.48 it 1005.52
6 ii 834.32 it 1193.59
8 ii 729.81 it 1143.45
12 ii 3023.30 ii 369.47
16 ii 1012.96
2 HIC 35 1131.70 MVV 105 1077.14
4 ii 1058.49 it 3989.85




2 HIC 141 726.60 MVV 120 1162.09
4 it 776.24 it 2399.18
6 ii 1020.48 it 1920.94























































1. Immunofluorescence Buffer (PBA)
Bovine serum albumin (BSA) (Sigma, Poole, UK) 1%
Sodium azide (Sigma, Poole, UK) 0.1%
Heparin (Leo Laboratories, Princes Risborough, UK) 20 IU/ml
Make up in Phosphate Buffered Saline (PBS) pH 7.2 (see Appendix 1.2).
2. Paraformaldehyde Fixative
(a) Preparation of PBS pH 7.2
Sodium Chloride (NaCl) 8.00 g/1
Potassium Chloride (KC1) 0.20 g/1
Disodium hydrogen phosphate (Na2HP04) 1.15 g/1
Potassium dihydrogen phosphate (KH2PO4) 0.20 g/1
Dissolve in 1 1 distilled water
(b) Dissolve 1 g paraformaldehyde in 50 ml warm PBS. Add 1M sodium hydroxide
dropwise until the paraformaldehyde dissolves. Adjust pH to 7.2 and store at 4°C.
3. Tris-ammonium Chloride Buffer (Tris-NK^CI)
(a) 0.17M Tris (hydroximethyl) aminomethane 20.6 g
Distilled water 1000 ml
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(c) To prepare lysing solution add 10 ml of (a) to 90 ml of (b) and adjust pH to 7.2
using 1M HC1.
4. RPMI1640 Supplemented Culture Medium
RPMI 1640 (Gibco, Paisley, UK) supplemented with 2 mM L-glutamine, 100
U/ml benzylpenicillin, 100 U/ml streptomycin, 5 x 10"5 M 2-mercaptoethanol, 2 g/1
sodium bicarbonate and 10 % inactivated foetal calf serum (FCS) (Ato Tek, Hereford,
UK).
5. RPMI 1640 Complete Culture Medium
This medium was prepared as the RPMI 1640 "Supplemented Culture
Medium" but also contained 5000 U/ml mycostatin (Nystatin, Squibb, Upjohn,
Crawley, UK) and 100 U/ml gentamicin.
6. RPMI 1640 Wash Culture Medium
RPMI 1640 (Gibco, Paisley, UK) supplemented with 2 mM L-glutamine, 100
U/ml benzyl penicillin, 100 U/ml streptomycin, 2 g/1 sodium bicarbonate and 1%
FCS.
7. Supplemented Dulbecco's modified Eagle medium (DMEM)
Dulbecco's modified Eagle medium (DMEM) (Gibco, Paisley, Scotland)
supplemented with 10% heat-inactivated FCS.
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8. 0.02% Versene
To make 5 1:
(a) Dissolve 1 g EDTA disodium salt (BDH, Poole, UK) in 21 of PBS.
(b) Adjust pH to 7.1-7.3.
(c) Make up to 5 1 with PBS.
(d) Dispense into aliquots as required.
(e) Autoclave at 1516 g for 2 min.
9. Trypsin/Versene
(a) 1 volume of 0.25% trypsin (DIFCO, Detroit, Michigan, USA).




1. Lymphoprep (Density gradient) Separation of Peripheral Blood Leucocytes.
(a) Collect 20 ml of jugular blood into sterile glass universals containing 4-5 mm
sterile glass beads.
(b) Defibrinate the blood by vigorous shaking for 5-10 min or until a discernible white
fibrin clot forms.
(c) After allowing the clot to settle down, pipette off the defibrinated blood from the
top.
(d) Gently layer the defibrinated blood over 10 ml of Lymphoprep (Nycomed,
Birmingham, UK) and centrifuge at 800 g for 20 min at 4°C, with the brake off to
prevent excessive deceleration.
(e) Using a sterile long tipped Pasteur pipette recover the lymphocytes and monocytes
from the Lymphoprep/plasma interphase.
(f) Wash cells thoroughly for three times in RPMI 1640 "culture wash medium"
(Appendix II.6) by centrifugation at 350 g for 10 min at 4°C.
(g) Resuspend cells at 2 x K^/ml in RPMI 1640 "supplemented culture medium"
(Appendix II.4).
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2. Separation of PBL by Hypotonic Lysis with Tris-ammonium Chloride
(a) Prepare Tris-ammonium chloride as detailed in Appendix II.3.
(b) Collect 10 ml jugular blood into heparinised vacutainer (Becton-Dickinson,
Rutherford, USA).
(b) Mix blood with 35 ml 37°C tris-ammonium chloride and allow to stand at room
temperature for approximately 3 min for complete lysis of the red blood cells to occur.
(c) Centrifuge at 800 g for 15 min at 4°C and discard supernatant.
(d) Resuspend cell pellet, wash three times, count and adjust cell concentration as
above.
3. Separation of Peripheral Blood Leucocytes by Osmotic Shock Lysis
(a) Collect 10 ml jugular blood into heparinised vacutainer (Becton-Dickinson,
Rutherford, USA).
(b) Centrifuge the samples at 800 g for 10 min.
(c) Collect the leucocyte rich supernatant and resuspend it in 10 ml PBS.
(d) Add 20 ml double deionised distilled water and mix quickly.
(e) After 30 s, add 2ml 10 x PBS to restore the isotonicity.
(f) Centrifuge the samples at 800 g for 5 min.
334
(g) Discard the supernatant and resuspend the cell pellet in 5 ml PBS.
(h) Wash three times in PBA (Appendix II. 1)
4. Toluidine Blue Staining Technique
Cytospin preparations, prepared and fixed as described previously (Chapter 2),
were stained overnight in 0.5% toluidine blue (Sigma, Poole, UK) in 0.7N HC1 at
room temperature, washed quickly in distilled water, air dried and mounted in DPX
neutral medium (BHD, Poole, UK).
5. Leishman's Staining Technique
Cytospin preparations, prepared and fixed as described previously (Chapter 2),
were covered with one volume of Leishman's staining solution, (BDH, Poole, UK)
and incubated at room temperature for 2 min. Two volumes of Leishman's buffer (pH
6.8) were then added to completely cover the slide and left for 8 min. The preparations
were finally washed in Leishman's buffer (pH 6.8), blotted dry and mounted in DPX
neutral medium.
6. Trypan Blue Exclusion
Trypan blue is one of the several stains recommended for use in dye exclusion
procedures for viable cell counting (Hunt, 1987). This method is based on the
principle that live cells do not take up certain dyes, whereas dead cells do.
(a) In an Eppendorf tube, 20 pi of the BALF cell suspension are mixed with 20 pi of a
0.4% Trypan blue solution (Sigma, Poole, UK) and resuspended with a pipette tip.
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(b) Without delay, 12 [ll of the previous mixture are run into a haemocytometer
chamber (Improved Neubauer, Hawksley and Sons, London) and 1 min is allowed for
the cells to settle.
(c) Within the next 5 min, blue cells (dead) versus unstained cells (live) are scored,
counting all the cells in the four 1 mm comer squares of the haemocytometer chamber
and keeping a separate count of viable and non-viable cells. Erythrocytes are ignored.
(d) Cell counts were determined following the following calculations:
- Cells per ml: the average count per square x dilution factor x 10*.
- Total Cells: cells per ml x the original volume of fluid from which cell sample was
removed.
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SUMMARY
A phenotypic analysis of bronchoalveolar lavage fluid (BALF) and peripheral blood (PB) cells in
maedi visna virus (MW)-infected sheep has been performed. The differential cell count in BALF
from MVV-infected animals was characterized by a significant increase (P < 0 05) in lymphocytes and
neutrophils. Lymphocyte phenotyping in BALF from MW-infected sheep showed a significant
decrease (/><005) of CD4+ cells, a significant increase (P<0-05) of CD8+ cells and a significant
inversion (P< 0-001) of the CD4+/CD8+ ratio. CD5+ lymphocytes were also significantly decreased
(PcO-05). yd T cells and B cells did not differ significantly when compared with the controls. No
correlation was observed between BALF and PB lymphocyte phenotypes. BALF macrophages from
MVV-infected animals showed increased MHC class II expression and BALF lymphocytes from the
same animals demonstrated up-regulation of LFA-1 and LFA-3 expression. These findings and their
relationship with lentiviral pathogenesis are discussed.
Keywords maedi lentivirus bronchoalveolar lavage cell phenotype sheep
INTRODUCTION
ledi visna virus (MVV) is a lentivirus responsible for an ovine
Itisystemic disease, a chronic progressive interstitial pneu-
nia being one of its main clinical manifestations [1,2]. Other
nifestations are meningoencephalitis, indurative mastitis and
iritis [3-5]. The virus causes persistent infection of the
nocyte/macrophage cell lineage leading to chronic inflam-
tory lesions [6,7]. In the interstitial lung disease, lesions
sist of interstitial mononuclear cell infiltration, lymphoid
ue and smooth muscle hyperplasia [8]. The study of the
TStitial lung diseases both in humans and animals is a vast
;arch field, the etiology of most of these diseases still being
mown. The study of the immune response in the lungs during
course ofMW infection might provide useful information
ut the pathogenesis of the lentiviral-induced interstitial
umonias, including the lymphocytic pneumonia observed in
)S [9]. This study reports the phenotypic alterations induced
latural MVV infection in cells recoveied by bronchoalveolar
ige (BAL) and the absence of changes in peripheral blood
phocytes (PBL).
Zorrespondence: Dr N. J. Watt. Department of Veterinary Patho-
, University of Edinburgh, Veterinary Field Station. Easter Bush,
lothian EH25 9RG, UK.
MATERIAL AND METHODS
Animals, bronchoalveolar lavage technique andsample orocessing
Twelve adult Texel ewes, seropositive for MW by the agar gel
immunodiffusion test (AGID) [10] and 13 breed, sex, and age-
matched seronegative control ewes were used. The seropositive
animals were selected from a naturally infected flock [11] and
represented different stages of clinical respiratory disease sever¬
ity, as assessed by pulmonary function testing (Collie et al., Am J
Vet Res, manuscript accepted). The control animals were
purchased from an accredited MVV-free Texel flock. Animals
were kept in separate buildings but under similar management
conditions.
Animals were anaesthetized with intravenous thiopentone
sodium (20 mg/kg) (Intraval Sodium; May & Baker Ltd),
intubated with 9-5—10-5 mm cuffed endotracheal tubes and
placed in sternal recumbency. A fibreoptic bronchoscope
(American Optical) was introduced through the endotracheal
tube and wedged in the lobar bronchus of the diaphragmatic
lobe. Two hundred milhhtres of sterile saline solution, divided
into four aliquots of 50 ml. were infused through the lumen of
the bronchoscope. A gentle aspiration of the bronchoalveolar
lavage fluid (BALF) was carried out after each of the infusions
and the four recoveries were pooled together in precooled plastic
containers. Peripheral blood (PB) samples were taken from each
animal by jugular venepuncture and collected into EDTA tubes.
BALF was filtered through a loose cotton gauze and the
recovered volume measured, the normal recovery being between
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40% and 60%. Cell pellets were harvested by a 10 min
centrifugation at 800 g and resuspended in sterile PBS. A total
BALF cell count was performed by using an automatic counter
(Serono, Baker Diagnostics). Viability of the cells, determined
by trypan blue dye exclusion, was always higher than 90%.
Finally, cytocentrifuge smears were prepared (Cystospin 3,
Shandon) and stained with Leishmann's dye for differential cell
J counting. In blood, erythrocytes were lysed with NH4C1 buffer
i [12] and a total and differential leucocyte count was performed.
i
i immunofluorescent labelling technique
! The reactivity of the MoAbs used in this study was: Leucocyte
Common Antigen (LCA, CD45 analogue) (VPM 18), CD4
| (17D. 13), CD8 (SBU-T8), y<5 TCR (86D), CD5 (ST1), IgG light
I chain for B cells (VPM 8), a Pan MHC class II reagent (VPM
f 36 +VPM 38), an MHC class II-DR (VPM 37), an MHC class
II-DQ (VPM 41) and the Lymphocyte Function-Associated
Antigen-1 (LFA-1) (F10-150-39) and 3 (LFA-3) (L180/1) [13-
21]. All MoAbs were used on lymphocytes and macrophages
recovered from BALF, while only the first seven MoAbs were
used for analysis of lymphocytes in PB. MoAbs were used as
hybridoma supernatant fluids at previously determined optimal
dilutions.
The procedure was essentially the same for both BALF and
PB samples. Cells (1-5 xlO5) were incubated with 50 pi of
primary MoAbs for 45 min at 4°C. Cells were then washed three
times with PBA (PBS+ 2% bovine serum albumin +0T%
sodium azide) and incubated with 50 ^1 of a 1:100 dilution
FITC-conjugated rabbit F(ab'): anti-mouse immunoglobulin
(whole molecule) (Dako) for 30 min at 4°C in the dark. Three
further washes with PBA were performed and cells were finally
fixed in a 1% paraformaldehyde solution (pH 7-2) and kept at
4°C until analysed within 24 h.
Flow cytometry, data analysis and statistics
Samples were analysed on a FACScan flow cytometer (Becton
Dickinson). Ten thousand individual cells from each sample
were analysed by setting separate live gates around the lympho¬
cyte or macrophage populations respectively, being dis¬
tinguished by their FSC/SSC profiles. The macrophage auto-
fluorescence was corrected by setting an appropriate
fluorescence threshold value for each animal by using control
cells stained without the addition of MoAb. Consort 30 and
Lysis software packages were used to analyse data. The results
were expressed either as the percentage of cells positively stained
or as the value of the mode channel number of fluorescence
intensity. All the sample comparisons between MVV-infected
and control animals were made using the Mann-Whitney non-
parametric rank test.
RESULTS
Total and differential BALF cell count
BALF from MW-infected animals presented a slightly
increased cellularity when compared with controls (MW
(n= 12) = 3-9 x 106 (range 0-2-6-3); control (ti=13) = 2-5x 106
(range 1 -6-6-9) (values expressed asmedian ofcells permillilitre))
although this difference was not significant. MVV-infected
animals also had significantly increased (R<0-05) lymphocytes
and neutrophils and significantly decreased macrophages
(FcO-05) (Table 1). However, absolute number showed a
significant increase of lymphocytes (P< 0-001), neutrophils
(P<0-001) and macrophages (Re0-05) (data not shown).
Lymphocyte phenotyping in BALF and PB (Table 2)
In BALF of MVV-infected animals, the most noticeable
changes were a significant decrease (P < 0-05) ofCD4+ lympho¬
cytes and a significant increase (P < 0-05) of CD8+ T lympho¬
cytes ratios, leading to a significant inversion (P < 0-001) of the
CD4+/CD8+ ratio when compared with controls. A significant
decrease (P < 0-05) of CD5+ lymphocytes was also observed.
The percentage of y<5 T cells in BALF did not show statistical
variations and B cells in BALF of MVV-infected animals were
increased, although this difference was not statistically signifi¬
cant. In PB, no significant differences in lymphocyte subsets
between control and MW-infected sheep were found for any
of the reagents used (data not shown). The CD4+/CD8 + ratio in
Table 1. Differential cell count in bronchoalveolar lavage fluid (BALF)
from control and maedi visna virus (MVV)-infected animals
Control (n = 9) Maedi (n = 12)
Neutrophils 1-0 (0-0-3-0)* 5-5f (1-0-30-0)
Lymphocytes 5-0 (3-0-20-0) 13-Of (6-0-57-0)
Macrophages 86-0 (79-0-91-0) 69-5t (37-0-91-0)
Eosinophils 4-0 (0-0-11-0) 1-0 (0-0-9-0)
Mast cells 1-0 (0-0-2-0) 0-5 (0-0-2-0)
* Results are expressed as median of percentages with ranges in
parentheses.
t Significantly different from controls at P < 0-05 (Mann-Whitney
non-parametric rank test).
Table 2. Lymphocyte subsets in bronchoalveolar lavage fluid (BALF) from control and maedi visna virus (MW)-infected animals
CD45 CD4 CD8 y<5TCR CD5 B cells CD4/CD8 ratio
Control 86-9* 54-6 18-8 8-3 53-9 21-1 3-0
("=13) (68-4-96-7) (42-3-67-1) (8-5-30-4) (3-8-19-6) (40-6-66-9) (13-1-51 1) (1-8-5-3)
Maedi 89-6 33-4f 29-Ot 5-4 32-6t 33-1 0-9f
(i=12) (73-3-98-9) (10-6-67-1) (2-9-68-3) (1-8-25-8) (10-7-57-6) (11-9-92-6) (0-3^-0)
* Results are expressed as median of percentages of positively labelled cells in lymphocyte gate with ranges in parentheses,
t Significantly different from controls at RcO-05 (Mann-Whitney non-parametric rank test),
t Significantly different from controls at P< 0-001 (Mann-Whitney non-parametric rank test).
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Table 3. MHC class II expression on bronchoalveolar lavage fluid
(BALF) macrophages from control and maedi visna virus (MW)-
infected animals
Pan class II VPM 37 (DR) VPM 41 (DQ)
Control 57-1* 37-1 43-6
(n= 13) (10-5-233-7) (5-87-51-26) (9-4-195-1)
Maedi 251-2T 98-2} 175-0t
(n= 12) (41-3-827-3) (33-2-242-3) (39-8-270-0)
* Results are expressed as median of the value of mode channel
number of fluorescence intensity with ranges in parentheses.
t Significantly different from controls at /><0 05 (Mann-Whitney
non-parametric rank test).
I Significantly different from controls at P < 0 001 (Mann-Whitney
non-parametric rank test).
PB was similar for both groups and without significant
statistical difference (control = 0-88 (range 0-2-3-7);
MW = 0-86 (range 0-3-2-2) (results expressed as median of
percentages of positively labelled cells in lymphocyte gate)).
Macrophage phenotyping in BALF
Most of the macrophages expressed LCA (CD45 analogue), but
neither the control nor the MW-infected animals showed
expression of CD4, CD8, yd TCR, CD5 or IgG light chain
molecules on the alveolar macrophage population.
MHC class II expression on macrophages and lymphocytes
The results of the expression of the MHC class II on alveolar
macrophages are shown in Table 3 and Fig. 1. As these
molecules are constitutively expressed on most of the ovine
alveolar macrophages [22] no significant differences in the
percentages of cells expressing MHC class II between the two
groups of animals were revealed. However, MVV-infected
animals showed a higher fluorescence intensity when compared
300 r 300 r
with controls. By using the mode channel number, a significant
increase in MHC class II molecule expression was observed on
the alveolar macrophages of MVV-infected animals with the
three reagents used. Similar studies on the lymphocyte popula¬
tions ofMVV-infected and control animals revealed no signifi¬
cant differences in the expression of these molecules (data not
shown).
LFA-I and LFA-3 expression on BALF lymphocytes andmacro¬
phages
The mode channel number was also used for the study of LFA-1
and LFA-3 as they were constitutively expressed on both
lymphocytes and macrophages recovered from BALF. BALF
lymphocytes from MVV-infected animals had significantly
increased (Re 005) LFA-1 (control = 188-1 (range 47-7-311-9);
MW = 255-8 (range 76-3-360-4)) and LFA-3 (control = 42-8
(range 12-1-88-1); MVV= 70-9 (range 51-3-126-5) (values
expressed as median of the value of mode channel number))
(Fig. 2). Although alveolar macrophages from MVV-infected
animals showed a higher expression of both molecules, no
significant differences were found.
DISCUSSION
The characterization of the cellular phenotypes occurring in
BALF during the course of MVV infection has not previously
been described. The results shown in this study demonstrate
alterations in the normal composition of CD4, CD8 and CD5
lymphocyte subsets and in the level of the expression of
molecules that could play a key role in the pathogenesis ofMVV
in the lung and could provide a better understanding of the
pathogenic mechanisms of lentiviruses.
The total BALF cell count in MVV-infected animals did not
differ significantly from the controls. Considering that MVV
lesions in lungs are characterized by an increased interstitial
cellularity and a thickening of the alveolar septa [8] and also
increased cellularity in BALF from MVV pathologically








Fig. 1. Fluorescence histograms ofMHC class II expression on bronchoalveolar lavage fluid (BALF) macrophages from control and
maedi visna virus (MVV)-infected sheep, (a), (b), (c) Control animals, (d), (e), (f) MVV-infected sheep, (a), (d) Pan class II (VPM 36 and
VPM 38). (b), (e) VPM 37 (DR). (c), (f) VPM 41 (DQ). ( ), Negative control. Fluorescence profiles are shifted to the right in MVV-
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Fig. 2. Fluorescence histograms of LFA-1 and LFA-3 expression on
bronchoalveolar lavage fluid (BALF) lymphocytes from control and
maedi visna virus (MVV)-infected sheep, (a), (b) Control animals, (c),
;d) MVV-infected sheep, (a), (c) LFA-1. (b), (d) LFA-3. ( ), Negative
rontrol. Fluorescence profiles are shifted to the right in MVV-infected
tnimals in both cases.
:hese data could appear paradoxical. However, as we previously
nentioned. our study is a cross section of an infected flock with
inimais in different stages of the disease (Collie et al., manu-
icript accepted). This increase in the total cell count, even
hough not significant, seems to indicate a progressive tendency
o an accumulation of cells in the lung interstitium.
A marked increase of BALF lymphocytes and neutrophils
ind a slight increase of macrophages in MVV-infected animals
vere the most noticeable results. Lymphocytes are the main
nononuclear cell type found in MVV lung lesions [8] and an
ncreased recovery of these cells can be expected. On the other
land, an increased secretion of Neutrophil Chemotactic Acti-
'ity (NCA) by alveolar cells from MVV pathologically affected
inimais from slaughterhouses has been reported [23] and this
ould account for the increased recruitment of neutrophils into
he affected lungs. However, the pathogenic role of these
leutrophils, if any, remains to be determined. The increased
lercentage of neutrophils and lymphocytes seen in BALF of
dVV-infected animals appeared to be a local phenomenon
vithin the lung as none of these animals had elevated numbers
if circulating neutrophils or lymphocytes. These findings are
oncordant with many other interstitial lung diseases in humans
nd animals [24],
The significant decrease (FcOOOl) in the CD4+/CD8 +
atio of lymphocytes from BALF of MVV-infected animals is
iue to both a significant increase ofCD8+ T lymphocytes and a
ignificant decrease of CD4+ T lymphocytes. Similar findings
ave been found in synovial fluid of sheep with MVV-induced
rthritis [25] and in humans with AIDS-related lymphoid
iterstitial pneumonia [26]. However, the total depletion of
:D4+ T lymphocytes that characterizes AIDS and predisposes
3 opportunistic infections [27] is not found during the course of
1VV infection, the CD4+ T cell population being significantly
ecreased, but never absent. This finding would suggest that
lthough lentiviruses both in humans and sheep induce inflam¬
matory changes by similar mechanisms, they differ in some
aspects of their pathogenesis. Further investigations are
required to determine if the decrease in CD4+ T lymphocytes
reflects an infection in some cells of this lymphocytic subset.
However, recent work demonstrated that sheep lentivirus is not
lymphocytotropic and does not replicate productively in CD4+
T lymphocytes obtained from blood and lymph [28]. Therefore,
other explanations are needed for the CD4+ T cell reduction.
The decrease of CD5 + cells seems to indicate lymphocyte
activation as previous workers have reported an almost total
loss of cell membrane CD5+ expression during lymphocyte
activation, as previous workers have reported an almost total
infected animals. The biological role of these cells in the
ruminant immune system remains unclear, although protection
ofepithelial surfaces has been proposed [29]. The fact that MVV
does not involve epithelial damage in the lungs during its
pathogenesis, could account for the lack of changes seen in y<5 T
cells in BALF from MVV-infected animals.
Alterations in the distribution of lymphocyte phenotypes in
BALF from MVV-infected animals were distinct from and not
correlated with lymphocyte phenotype changes in PB. However,
correlated changes between PB lymphocytes and synovial fluid
lymphocytes in MVV-infected-cachexic animals have been
observed [30]. It is known that blood lymphocytes do not
necessarily reflect pathological changes in other organs/tissues
[31] and previous studies have shown lack of correlation
between alterations in lymphocyte subsets in blood and those in
BALF [32],
Cell surface phenotypes of ovine bronchoalveolar macro¬
phages from control and MVV-infected animals were similar,
with expression of LCA and lack of CD4, CD8, CD5 and yd
TCR. Similar results have been described in healthy sheep [22],
However, expression of CD4 and CD8 molecules on cultured
ovine macrophages derived from blood monocytes from both
MVV-infected and control animals has been observed (Wei-
Cheng Lee, personal communication).
The two- to four-fold greater expression ofMHC class II on
alveolar macrophages of MVV-infected animals and the
increased expression of LFA-1 and LFA-3 molecules on
lymphocytes can account for the pathogenesis of the lympho-
proliferative response and viral persistence. It has been demon¬
strated that class II antigens act as a component of the cellular
receptor for MVV [33], and hence an increase of these molecules
could promote the spread of the infection to uninfected
macrophages, allowing persistence within the host. MVV-
infected macrophages also induce the release of a specific
interferon by T lymphocytes that is essential for the persistent
expression of MHC class II antigens on the alveolar macro¬
phages [34,35]. The continuous presence of these antigens could
promote constant lymphocyte recruitment into the lungs,
mediating local lesions and tissue damage. Furthermore, the
increased expression of LFA-1 and LFA-3 in BALF lympho¬
cytes of MW-infected sheep would also contribute to the
accelerated entry and accumulation of lymphocytes into the
lung interstitium during the disease pathogenesis. LFA-1 and
LFA-3 are cell adhesion molecules with a key role in leucocyte
trafficking, activation and proliferation [36], The increased
expression of these molecules could have an important role as
factors favouring the entrance and retention of new lympho¬
cytes, their activation in situ, and their proliferation within the
lungs, ending with the interstitial lymphoid proliferation seen in
276 L. Lujan et al.
the pulmonary parenchyma of MVV-infected animals. More
studies are needed to understand the exact role of these and
other adhesion molecules in the pathogenesis of the ovine
lymphoid interstitial pneumonia.
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Effects on lung compliance, lung volume,
and single-breath transfer factor for carbon
monoxide in sheep with lentivirus-induced
lymphoid interstitial pneumonia
D. David S. Collie, BVM&S, MPhil; NeilJ. Watt, BVM&S, PhD] P. M. Warren, BSc, PhD] I. Begara, DVM;
L. Lujdn, DVM, PhD
Summary
Static lung compliance, static lung volumes, and
iransfer factor for carbon monoxide were measured
in 12 anesthetized adult Texel ewes seropositive for
naedi-visna virus (MW) and in 11 breed-, sex-, and
ige-matched seronegative controls. Median static lung
:ompliance in MW-infected sheep (1.24 L-kPa-1;
range, 0.27 to 2.20 L-kPa"1) was not significantly dif¬
ferent from that in controls (1.58 L-kPa-1; range, 0.82
:o 2.08 L-kPa-1). Median body weight of MW-in-
ected sheep (56 kg; range, 40 to 75 kg) was signif-
cantly (P < 0.05) less than that of controls (65 kg;
•ange, 53 to 87 kg). Median effective alveolar lung
volume in MW-infected sheep (3-36 L; range, 1.44 to
i.52 L) was significantly (P < 0.01) less than that in
rontrols (4.12 L; range, 3.75 to 4.90 L). Median ef¬
fective end expiratory lung volume in MW-infected
heep (1.20 L; range, 0.56 to 1.99 L) was significantly
P < 0.001) less than that of controls (1.98 L; range:
L.76 to 2.78 L). Median lung volumes expressed per
init of body weight did not differ significantly be-
ween the groups. Median single-breath transfer fac-
or for carbon monoxide in MW-infected sheep (7.89
nmol,min~1*kPa~1; range, 3.45 to 12.74
nmol-min_1-kPa_1) was significandy (P < 0.001) less
han that in controls (14.10 mmol*min-1-kPa~1; range,
.0.02 to 18.30 mmol*min-1-kPa-1). Median transfer
actor expressed per liter of alveolar volume in MW-
nfected sheep (2.44 mmol-min-1-kPa~1*L~1; range,
.28 to 3.72 mmol*min-1*kPa_1*L-1) was signifi-
antly (P < 0.05) less than that in controls (3.22
amol-min-1,kPa_1-L-1; range, 2.47 to 3-74
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mmol-min-^kPa'i-L-1). These findings indicate that
static lung volumes and transfer factor for carbon
monoxide are significantly decreased in adult sheep
naturally infected with MW.
The principal pathologic feature of maedi-visna
virus (MW) infection in sheep is a slowly progressive
lymphoid interstitial pneumonia1 that causes dys¬
pnea, reduced exercise tolerance, and loss of body
condition.2 The MW shares considerable sequence
homology and morphologic similarities with human
immunodeficiency virus, also a lentivirus, the etio-
logic agent of the acquired immune deficiency syn¬
drome (AIDS).3 Lymphoid interstitial pneumonia (LIP)
is a recognized pulmonary complication of AIDS in
adults4 and children5; however, the pathogenesis of
LIP in people has yet to be elucidated, as have ap¬
propriate diagnostic and therapeutic measures.5 It is
likely that the primary lymphoproliferative response
seen in association with MW-infection and with AIDS
is a result of similar immunologic dysregulation.6 As
a consequence, further investigation into the patho¬
genesis of MW-infection is warranted.
Functional changes in human interstitial lung
disorders are characterized by reduction in compli¬
ance, lung volumes, and transfer factor for carbon
monoxide.78 Physiologic assessment of these func¬
tional changes, in combination with other investiga¬
tive techniques, such as radiography, have proved
useful in quantifying and monitoring the progression
of LIP associated with AIDS in human beings.9,10
Clinical signs ofMW infection are apparent only
in the later stages of the natural disease, and little is
known about disease progression in the preclinical
phase. Meaningful investigation of- the pathogenesis
of naturally acquired maedi-visna requires the use of
minimally invasive techniques to stage and monitor
the course of disease. The use of physiologic tech¬
niques to measure lung function of infected sheep is
a logical progression from clinical examination, which
Am J Vet Res, Vol 54, No. 3, March 1993
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to identify sheep only in the latter stages of the
>e.
"o the authors' knowledge, lung functional
;es associated with MW infection have not been
ibed; however, if present, these changes may be
ue for staging the disease in the preclinical phase,
i, therefore, considered appropriate to examine
i with natural MW infection to characterize the
of this disease on static and gas exchange prop-
of the lungs.
;rials and Methods
heep—Twelve adult Texel ewes (median body
it, 55 kg; range, 40 to 75 kg), seropositive for
Dn the basis of results of the agar gel immuno-
ion test,11 and 11 breed-, age-, and sex-matched
ols (median, 65 kg; range, 53 to 87 kg), sero-
ive forMW), were studied. Bodyweight median
ange values reflect the poorer body condition
: seropositive sheep; however, both groups had
r skeletal conformation and were managed un-
imilar conditions. The sheep had no evidence
ipiratory tract disease unrelated to MW infec-
is indicated by results of clinical examination,
le hematologic analysis, thoracic radiography,
:cal examination for lungworm larvae by use of
dified Baermann technique.12
Lnimal preparation and anesthesia—General
lesia was induced by IV administration of thio-
ne sodium (20 mg/kg of body weight). Sheep
intubated with cuffed endotracheal tubes (9 5
.5 mm)a and positioned in sternal recumbency
:he head supported on a cushioned rest. Esoph-
pressure was measured by use of a latex balloon
h, 15 cm; diameter, 1.5 cm; thickness, 0.05 mm),
i was sealed over the end of a polyethylene
ter (3 mm ID, 4.5 mm OD), which in turn had
tber of holes cut in spiral manner in the end
ed by the balloon. Prior to each series of mea-
lents, the pressure-volume characteristics of the
>n-catheter assembly were validated according
: method of Senterre and Geubelle.13 The bal-
vas then evacuated, and 2 ml of air was added,
volume was shown to be within the range of
:ompliance of this pressure recording system
'as close to the minimal relaxed volume of the
in in air. The free end of the esophageal cath-
vas connected to a differential pressure trans-
,b and pressures were recorded on a strip chart
ier.c Prior to passing the balloon catheter as-
y, the distance from the nares to the middle of
loracic portion of the esophagus was visually
ximated, and this length was marked on the
:er to serve as initial validation of balloon po-
affer insertion. The balloon was passed via the
i and advanced until tracheal artifacts were ab-
rom the tracings,14 negative deflections were
/ed in inspiration, and clearly defined cardiac
Hue Line, Portex, Kent, United Kingdom.
iS9, Mercury Electronics, Glasgow, United Kingdom.
inseis L6514, Belmont Instruments, Glasgow, United King-
oscillations were discernible in the waveform. These
precautions ensured that the balloon was placed in
the midthoracic portion of the esophagus where the
influences of periesophageal structures are minimal
in cattle and goats.15,16 The other side of the differ¬
ential pressure transducer was connected to a side
port perpendicular to the airway opening, and the
pressure thus recorded was defined as transpulmon-
ary pressure (Pl). The pressure recording system was
calibrated against a water manometer prior to each
series of measurements.
If required, anesthesia was maintained, using an
rv administered saline solution drip containing 0.20
to 0.25 mg of thiopentone sodium/kg infused at a rate
of 2.0 to 2.5 ml/min.17 Sheep were ventilated, using
a mechanical ventilatord adjusted to maintain a tidal
volume of 10 ml/kg and respiratory rate of 10 breaths/
min.
Respiratory flow was measured, using a heated
pneumotachograph*1 connected to the end of the en¬
dotracheal tube. The pressure decrease across the
pneumotachograph was measured, using a sensitive
differential pressure transducer, and the signal was
integrated to yield respiratory volumes,b which were
plotted on the chart recorder. The flow recording
system was calibrated, using a 3-L syringe.
Static lung compliance (CL) —After discon¬
necting the ventilator and allowing the sheep to pas¬
sively expire to its relaxed functional residual capacity
(FRC), the 3-L calibrated syringe was attached to the
endotracheal tube and the lungs were inflated to PL
of 3 kPa. The volume of the lungs at PL of 3 kPa was
defined as total lung capacity (TLC). The sheep was
then allowed to passively exhale to FRC; and the pro¬
cedure was repeated twice to standardize the volume
history of the lungs prior to measurements being
made.18 To measure CL, the lungs were again inflated
to PL of 3 kPa; however, the passive expiration was
interrupted in stepwise manner by occluding the air¬
way opening 8 to 15 times for 2- to 3-second inter¬
vals. By plotting PL against expired volume, a static
deflation curve was obtained. The slope of the linear
portion of the curve from FRC to 40% of the way
from FRC to TLC was determined by use of least-
squares linear regression, and this value was taken as
CL, expressed in units of L-kPa-1.
Lung volumes and transfer factor for carbon
monoxide (TL co) — Lung volumes were measured,
using a single-breath helium-dilution method per¬
formed in conjunction with the measurement of the
transfer factor. A carbon monoxide and helium mix¬
ture (14% helium, 0.3% carbon monoxide, 85.7%
air) was used to inflate the lungs from FRC to PL of
3 kPa, at which point the airway opening was closed
for 10 to 12 seconds. The valve was opened momen¬
tarily to allow washout of dead space, and thereafter,
the expired alveolar gas was collected in an evacu¬
ated rebreathing bag. The concentration of helium in
d Manley MN2, Hutchinson Blease, Chesham, Bucks, United
Kingdom.
e Fleisch Ho. 2, Linton Instrumentation, Palgrave, Norfolk,
United Kingdom.
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Table I —Means, medians, ranges, and coefficients of variation (cv) for pulmonary variables in control
sheep (n = 11) and sheep with maedi-visna virus (mw) infection (n = 12)
Control MW-infected
Measurement Mean Median Range CV [%) Mean Median Range CV |%)
Body weight
(kg) 69.1 65.0 53 to 87 18 55.1 55.5' 40 to 75 15
CL
(L-kPa"') 1.56 1.58 0.82 to 2.08 25 1.26 1.24 0.27 to 2.20 48
v
A cff (L) 4.31 4.12 3.75 to 4.90 9 3.30 3.37* 1.44 to 4.52 26
(ml-kg"1) 64 64 51 to 82 15 60 61 32 to 90 27
VEELcI (0 2.09 1.98 1.76 to 2.78 14 1.31 1.20f 0.56 to 1.99 34
SV;:EI. ,:f
(ml-kg"1) 31 28 23 to 49 27 24 24 12 to 38 37
Tl CO »b
(mmol-min-'-kPa"1) 14.02 14.10 10.02 to 18.30 16 8.15 7.89t 3.45 to 12.74 38
TL/VA
(mmol-min-'-kPa-1-!.-1) 3.24 3.22 2.47 to 3.74 11 2.50 2.44$ 1.28 to 3.72 30
* Median value significantly (P < 0.01) different from value for control sheep. | Median value significandy (P < 0.001)
different from value for control sheep. ± Median value significantly (P < 0.05) different from value for control sheep.
CL = static lung compliance; VA cff = effective alveolar lung volume; sVA cff = specific effective alveolar lung volume (ie,
VA expressed per unit of body weight); VEEL elt = end-expiratory lung volume; sVEEL cB = specific end-expiratory lung volume;








0.5 1 1.5 2 2.5 3 3.5
Body Condition Score
Figure I — Body weight for i I control (CON) and 12 maedi-
visna virus (MW)-infected sheep. ** Significantly (P < 0.01)
lower than values for controls.
the bag was determined, using a katharometer/ Dead
space of equipment was estimated from internal di¬
mensions, and anatomic dead space was estimated,
using the appropriate allometric equation of Stahl,19
which relates anatomic dead space to body weight.
The effective alveolar volume (VA eff) in liters
(ie, the alveolar volume at which the breath was held
' Resparameter Mk 4, PK Morgan, Chatham, Kent, United
Kingdom.
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Figure 2—Histogram illustrating body condition scores for 11
CON and 12 MW-infected sheep. Condition scores for the
MW-infected sheep were significantly (P < 0.01) less than
the values for CON sheep.
minus the dead space of the airways) was calculated
as follows:
VA cff = 1.05 x (Vsyr - VD an - VD eq) x (He/HeE)
where = volume used to inflate lungs to PL of 3
kPa, VD an = anatomic dead space, VD cq = instru¬
mental dead space, He] = helium concentration in
the syringe, and HeE = helium concentration in the
expired sample. The coefficient 1.05 is a factor used
to account for a change in HeE attributable to carbon
Am J Vet Res, Vol 54, No. 3, March 1993
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CON MVV
igure 3 —Static lung compliance values (L-kPa-') for 11 CON
nd 12 MW-infected sheep. NS = no significant difference
'etween the groups.
lioxide absorption during breath-holding.20 By sub-
racting from VA cff, an estimate of the lung vol-
ime at the end-expiratory level (VEEL eft) was obtained.
The single-breath transfer factor for carbon mon-
ixide (Tl co sb) was determined, using a modification
if the technique described by Karp et al.21 The tech-
lique involves 10-seconds of breath-holding of a car-
ion monoxide and helium in air gas mixture, with
ubsequent collection of an alveolar gas sample. The
oncentration of carbon monoxide in the syringe ini-
ially and in the alveolar gas sample, together with
he time of breath-holding and the alveolar volume
luring breath-holding, are used in the calculation of
\ CO sb as follows:
= 53.6 X V,A cff x r
(CCVHeE-CCV^He,-1)
x logi
inhere t is the time of breath-holding in seconds,
a eff is the effective alveolar volume, and HeE and
:Oe are end-tidal alveolar concentrations and He, and
lO, are syringe concentrations of helium and carbon
lonoxide respectively.22 Units of 1L co sb are ex-
ressed as mmol-min-1-kPa-1. Because the transfer
ictor is positively correlated with the lung volume
t which the measurement is made, it is also ex-
ressed per liter of alveolar volume (ie, T^Va).
During the period of anesthesia, a blood sample
/as collected and hemoglobin concentration was
Figure 4— Effective alveolar lung volume values for ! I CON
and 12 MW-infected sheep. See Figure 1 for key.
measured by use of an automated analyzer.8 This con¬
centration of hemoglobin was used in the equation
of Cotes,23 to adjust observed TL co sb to a standard
hemoglobin concentration of 14.6 g/dl.
Analysis of data — Three determinations of CL
lung volumes, and transfer factor were made on each
sheep, and the mean value was calculated. Absolute
lung volumes were also expressed per unit of body
weight (ie, specific end expiratory lung volume
[sVEEL eff] and specific effective alveolar volume
[sVA efr]). The values recorded for the MW-seroposi-
tive and -seronegative groups of sheep were statisti¬
cally compared, using the Mann-Whitney test. Linear
regression analysis with ANOVA was used to examine
the relation between CL and body weight and CL and
VA eff for each group.
Results
Mean, median, range, and coefficients of varia¬
tion were determined for measurements of body
weight, CL, absolute and specific lung volumes, trans¬
fer factor, and transfer factor expressed per unit of
alveolar volume for each group of sheep (Table 1).
The 95.5% confidence interval for the difference
in population medians for body weight ranged from
— 26 to —3 kg. This difference was statistically sig¬
nificant (P < 0.01; Fig 1). Body condition scores for
Pa.
8 Baker System 9000, Serono Baker Diagnostics, Allentown.






























Figure 5 — Lung volume values at end-expiratory level for 11
CON and 12 mw-infected sheep. *** Significantly \P < 0.001)































Figure 6—Specific effective alveolar lung volume values for
11 con and 12 mw-infected sheep. See Figure 3 for key.
mw-infected sheep were significantly (P < 0.01) less
than scores for controls (Fig 2).
Figure 7 —Specific end-expiratory level lung volume values
for 11 con and 12 mw-infected sheep. See Figure 3 for key.
Figure 8—Single-breath transfer factor for carbon monoxide
values for 11 con and 12 MW-infected sheep. See Figure 5
for key.
The 95 5% confidence interval for the difference
in population medians for CL ranged from — 0.76 to
0.19 L-kPa-1 (Fig 3). This difference was not statis¬
tically significant.
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0
9-Transfer factor values expressed per liter of effec-
'eolar volume for 11 CON and 12 MW-infected sheep,
ificantly (P < 0.05) lower than values for controls.
Static lung compliance (LkPa"')
10—Relation between effective alveolar volume and
ung compliance for control sheep. The solid line rep-
; the line of best fit by least-squares linear regression.
he 95.5% confidence interval for the difference
lulation medians for VA eff ranged from — 1.53
).43 L (Fig 4). This difference was statistically
cant (P < 0.01).
he 95-5% confidence interval for the difference
>ulation medians for VEEL eff) ranged from — 1.09
).40 L (Fig 5). This difference was statistically
cant (P < 0.001). Specific lung volume values
determined for individual sheep (Fig 6 and 7).
ences between groups were not statistically sig-
lt for sVA cff and sVEEL eff.
he 95.5% confidence interval for the difference
lulation medians for transfer factor values ranged
-8.44 to —3.28 mmol-min^-kPa-1 (Fig 8).
ifference was statistically significant (P < 0.001).
Transfer factor values were also expressed per unit
of alveolar volume (Fig 9). The 95.5% confidence
interval for the difference in population medians for
Tl/Va ranged from —1.32 to —0.22
mmol-min~1-kPa~l-L-1. This difference also was sta¬
tistically significant (P < 0.05).
The relation between effective alveolar volume
and CL was determined for control (Fig 10) and mw-
infected (Fig 11) sheep. Results of least-square
regression analysis relating CL to body weight and
VAeff to CL were tabulated for control and mw-in-
fected sheep (Table 2).
Discussion
The history of the flock from which these mw-
infected sheep were derived has been described.24
Postmortem examination of sheep from the parent
flock have indicated that lungs with diffuse and ex¬
tensive mw lesions have a characteristic gross ap¬
pearance.24 On opening the thoracic cavity, the lungs
tended not to collapse, appearing larger than normal.
Lung weight was increased (0.52 to 1.96 kg; normal
0.4 to 0.6 kg), and the lungs were firm when cut and
were rubbery. Consistent histopathologic features
were smooth muscle hyperplasia and interstitial in¬
filtration with lymphocytes, monocytes, macro¬
phages, and some plasma cells.
Although all sheep of this study were adult, it is
acknowledged that factors including age and time and
route of infection would differ between individual
sheep and, as such, they would probably have a spec¬
trum of pulmonary pathologic features. Attempt was
not made to grade or classify these sheep on a clinical
basis; they represented a cross-section of the adult
sheep within the flock.
The body weight and body condition score of
mw-infected sheep were significantly lower than val¬
ues for the control sheep. With loss of body condi¬
tion being a frequent early sign ofmw infection,2,25
it is assumed that these observations are a feature of
the disease process. Nutritional management of the
2 groups of sheep was identical and intercurrent dis¬
ease was not apparent in either group on the basis
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Figure 11 —Relation between effective alveolar volume and
static lung compliance for MW-infected sheep. See Figure
10 for key.
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Table 2 — Least-squares regression equations relating static lung compliance (QJ to body weight
(BW) and effective alveolar volume to Q_ for control (CON) and MW-infected sheep
Dependent Independent
variable variable Regression






















1.89 + 1.11 x cL 15.55 60.9 0.003
The coefficients of determination (r2) in percentage units, F-ratios (F), and significance of the association between
the variables (P) are shown.
loss and cachexia were commonly observed in the
flock of origin.24
The normal pulmonary interstitium is composed
of connective tissue components (collagen, elastic
fibers, proteoglycans, and fibronectin), mesenchymal
cells, and inflammatory and immune effector cells.26
The most obvious physical effect of LIP is a thicken¬
ing of the interstitial space, with consequent altera¬
tion of the number, form, and location of its cellular
and noncellular elements. The anticipated physio¬
logic consequences of such structural alterations in¬
clude changes in compliance, lung volumes, and
transfer factor. Because the pressure-volume char¬
acteristics of the lung are principally determined by
the tissue network of collagen and elastic fibers (ie,
the noncellular elements in the interstitium),27 any
change to this network is liable to lead to changes in
compliance. Static lung volumes are influenced by
lung and thoracic wall recoil pressures23 and the vol¬
ume of tissue and fluid within the thoracic cavity.28
Changes in both determinants would be anticipated
in LIP.
Defined as the rate of transfer of a gas per unit
driving pressure between the alveoli and the eryth¬
rocytes within the pulmonary capillaries, transfer fac¬
tor is affected by a number of structural lung
dimensions, including lung volume, the path length
for diffusion in the gas phase, the surface area of the
alveolar capillary membrane, and the volume of blood
in the capillaries perfusing ventilated alveoli.22 Changes
to several of these dimensions occur in LIP; thus, al¬
terations in transfer factor would be anticipated.
The single-breath helium dilution method is
commonly used to measure VA eff in human beings,
though it does tend to underestimate the true lung
volume in subjects with airflow restriction.20 How¬
ever, for subjects with only slight airflow limitation
or interstitial lung disease, use of this technique is
accepted.29 The use of the derived measurement,
VEELeff> is subject to the same limitations.
Use of the equation ofCotes22 to correct transfer
factor values for differences in hemoglobin concen¬
tration between individual sheep assumes that the
reaction rates of carbon monoxide with sheep and
human oxyhemoglobin are similar.
Fisher and Hyde30 documented that pulmonary
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diffusing capacity and capillary blood flow were sig¬
nificantly reduced during passive lung inflation and
breath-holding in anesthetized dogs. The cause of this
reduction was attributed to decreased venous return
to the right side of the heart and increased pulmo¬
nary vascular resistance. The magnitude of this re¬
duction was significantly correlated with the level of
transthoracic pressure used to induce lung inflation.
In addition, a temporal change in diffusing capacity
was detected, with a significant decrease in the first
7 seconds and no significant change between 7 and
11 seconds.30 Therefore, it is necessary, when com¬
paring single-breath transfer factor values between
animals, to control lung inflation pressures and du¬
ration of breath-holding as was done in the sheep of
this study.
The range of compliance values was wide for
control and MW-infected sheep. Halmagyi and
Colebatch17 studied anesthetized sheep (n = 27) with
mean ± SD body weight of 42.6 ± 4.7 kg and re¬
ported dynamic lung compliance of 1.08 ± 0.316
L-kPa-1. By expressing this value per unit of body
weight, an approximate value of 25 ml-kPa_1-kg-1 is
obtained. This is in reasonable agreement with the
value of 22.7 ml-kPa^-kg"1 for our control sheep.
In their series, Halmagyi and Colebatch obtained an
intersubject coefficient of variation of 29% for mea¬
surements of dynamic compliance and commented
that this degree of scatter was not dissimilar to that
obtained in human beings. The coefficient of varia¬
tion between control sheep for compliance measure¬
ments in this study was 25%; thus, intersubject
variability was comparable to previous observations
in anesthetized sheep. One factor that might contrib¬
ute to this variation is body weight. Although com¬
pliance was positively correlated with body weight
in control and MW-infected sheep, the relation was
not statistically significant as assessed by linear
regression. Analysis of variance indicated that body
weight accounted for only 19-6% of the variation in
compliance in MW-infected sheep and for 28.1% in
the control sheep.
Given the observation that MW-affected lungs
tend not to collapse when removed from the thorax,24
suggesting low compliance, lack of any significant dif¬
ference between the groups was unexpected. Al-
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gh significant difference was not observed
een the groups as a whole, the range of values
was greater for the MW-infected sheep with 5
■idual sheep having CL < 1 L-kPa-1. Thus, changes
smpliance may be a functional change only de-
■ble at a particular stage of the disease, and per-
if a more critical selection procedure had been
to select sheep (eg, on a clinical or age-related
), significant differences would have been ob-
d between MW-infected and control sheep.
Changes in compliance in people with intersti-
ung disease seem to reflect predominantly
>is31 and are not correlated with inflammatory
.s.32 In visna and maedi, the predominant lesions
ellular infiltration of the interstitium together
distinct smooth muscle hyperplasia. Although
xact pathophysiologic role of the smooth mus-
^perplasia is unknown, one theory is that it may
to compensate for the lack of elastic recoil re-
-g from the thickening of the interalveolar septa
■ragmentation and destruction of elastic fibers
in the disease.1 Accordingly, measurements of
diance in MW-infected animals will presumably
duenced by the quantity and functional tone of
nooth muscle in the lungs.
'reviously reported33 static lung volume val-
TLC of 76 ml-kg~1 and FRC of 25 ml-kg-1—in
:sthetized sheep compare with values of 64
-1 for VA eff and 31 ml-kg-1 for VEEL eff in our
i. The differences in these measurements likely
t the effects of anesthesia and different methods
in these studies. Intersubject coefficients ofvar-
of 10 to 15% were reported33 for static lung
le measurements and compare favorably with
^efficients of variation of 9% for VA eff and 14%
:EL str¬
ung volumes were significantly lower in mw-
ed sheep than in controls; however, when cor-
■1 for body weight, significant difference be-
l the groups could not be detected. It might be
ted that the difference in lung volumes be-
l the groups is simply a reflection of different
sizes, with a normal ratio of lung volume to
weight being maintained in the smaller mw-
ed sheep. However, our subjective opinion that
teep of both groups had similar skeletal dimen-
coupled with the significantly poorer condi-
scores of mw-infected sheep, counters this
tent and suggests that there is a concomitant
ased in body weight and lung volume as a result
disease process. To support this argument, that
taller lung volumes of the diseased sheep are a
tion of the disease process, is the observation
ompliance shares a significant linear relation
ung volume in mw-infected sheep (r = 0.78;
).01), whereas no such relation can be docu-
:d for the control sheep (r = 0.51; F > 0.1).
d, compliance accounted for 60.9% of the var-
in lung volume in mw-infected sheep and only
nted for 9.4% in the control sheep. In contrast,
weight accounted for 33.3% of the variation in
olume in the control sheep and for only 11.3%
v-infected sheep. Thus, a major influence on
lung volume in MW-infected sheep would appear to
be compliance.
Similar changes in lung volumes are recognized
in human beings with idiopathic pulmonary fibrosis,
inwhom volume reduction may also be accompanied
by a decrease in lung compliance.34 A reduction in
lung volume is also a common feature of sarcoidosis35
and may be seen in people with LIP.10,36
Transfer factor per se and transfer factor cor¬
rected for alveolar lung volume values were signifi¬
cantly reduced in MW-infected sheep. This is a
common finding in human beings with interstitial lung
disease26 in whom transfer factor measurements may
be useful for the follow-up evaluation of individual
cases of sarcoidosis and interstitial fibrosis.37 The
VAeff value is the single greatest source of variability
of Tl co sb29 with a decrease in VA eff exposing a-
smaller alveolar membrane surface area to participate
in gas exchange. The significantly lower VAeff in MW-
infected sheep may, therefore, contribute to the ob¬
served difference in TLCOsb. That other factors are
involved in the reduction of the transfer factor in
MW-infected sheep is evidenced by the still signifi¬
cant reduction in transfer factor after correction for
lung volume. Such factors are likely to include alter¬
ations in ventilation-to-perfusion ratio, pulmonary
hypoperfusion, capillary transit time, and thickening
and functional alterations of the interalveolar mem¬
brane brought about by the cellular infiltration.38
In people with interstitial lung disease, ventila-
tion-perfusion inequalities account for the major part
of observed hypoxemia.34 These inequalities, which
are thought to arise as a result of nonuniform alter¬
ations to the mechanical properties of the lung pa¬
renchyma,39 can reduce the effective interface for gas
transfer and complicate the interpretation of transfer
factor measurements made using steady-state meth¬
ods.23 However, for the single-breath technique, where
a uniform distribution of the inspirate can be antici¬
pated, maldistribution of ventilation to perfusion is
unimportant unless it is extreme.40 Other unequal
distributions (eg, the distributions of diffusion prop¬
erties relative to alveolar volumes and pulmonary
capillary blood flow throughout the lung), are likely
present in MW-infected sheep, and may reduce ap¬
parent single-breath transfer factor values with in¬
creasing time of breath-holding.40 Despite these latter
limitations, single-breath transfer factor values should
provide a useful numerical index of the overall trans¬
fer characteristics of the lungs in MW-infected ani¬
mals.
These physiologic changes, specifically reduc¬
tion in lung volumes and transfer factor, are consis¬
tent with those found in people with interstitial lung
disease.78 Knowledge that measurable changes in lung
function do occur in natural MW infection provides
a basis for further investigation of the potential of
lung function studies as a means of staging this dis¬
ease.
Sheep are useful experimental animals in pul¬
monary research— their lungs being of comparable
size to those of human beings.41 In addition, sequen¬
tial analysis of the bronchoalveolar milieu of con-
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scious sheep by physiologic, histologic, and
bronchoalveolar measurements is well tolerated, with
reproducibility and variations ofmeasurements being
similar to those found in human beings.33 Accord¬
ingly, integration of these techniques with recently
developed immunologic and molecular biological
technologies will provide a powerful means for in¬
vestigating the pathogenesis of LIP induced by ovine
lentivirus infection.
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^ung compliance, lung volume and transfer factor for carbon
nonoxide in anaesthetised sheep: normal values and
eproducibility of measurements
i. D. S. COLLIE, N. J. WATT, Department ofVeterinary Pathology, Royal (Dick) School ofVeterinary
tudies, Veterinary Field Station, Easter Bush, Roslin, Midlothian EH25 9RG, P. M. WARREN,
apartment ofRespiratory Medicine, Rayne Laboratory, City Hospital, Edinburgh, I. BEGARA,
. LUJAN, Department ofVeterinary Pathology, Royal (Dick) School ofVeterinary Studies,
eterinary Field Station, Easter Bush, Roslin, Midlothian EH25 9RG
leasurements of quasistatic compliance (Cqst),
Tective alveolar volume (V\<eff) and single-
reath transfer factor for carbon monoxide
vL,CO, 'sb') were completed in 16 normal,
naesthetised, adult Texel ewes. Regression
juations were computed for these variables as
function of bodyweight and the optimal equa-
ons selected. The 95 per cent prediction inter-
ils for the equations were calculated such that
Drmal lung function in similar sheep could be
xurately predicted. The long term repro-
ucibility of these measurements was assessed
i nine sheep, measured at monthly intervals
i'er a period of five months. Although mea-
lrements made in individual sheep were often
ighly variable, the variation between repeated
ieasurements on the separate days for the
oup was insignificant.
I human respiratory research, lung function data
e frequently assessed in relation to predicted val-
:s for the subject under study. These predicted
ilues are generated using multiple regression
luations previously calculated for a population
milar to that from which the subject was
Gained. The best reference (independent) vari¬
ces used for humans are age. sex, stature and
hnic group, with these variables accounting for
) per cent of the total variability about the regres-
on lines (Cotes 1979). In comparative respiratory
search, Stahl (1967) demonstrated, using data
'ailable from the literature, the relationship of
veral respiratory variables to bodyweight over a
'de range of mammalian species. Such predic¬
ts, based on values over such a large weight
range, may not agree with studies on smaller
groups of animals of a particular species (Stahl
1967) where social and environmental factors may
lead to physiological adaptation. Indeed in
humans, bodyweight is not the anthropometric
variable of choice due to large differences within
populations regarding the contribution of adipose
tissue and muscle in individuals (Cotes 1979).
In sheep, where breed, age, sex and environ¬
mental and social factors may influence body con¬
dition and hence bodyweight, reference to such
predictions of respiratory variables based solely on
bodyweight should be cautious. For this reason,
where the study of respiratory variables in a par¬
ticular category of sheep is planned, predicted
normal values should ideally be generated using
normal sheep of similar description.
Certain routine pulmonary function tests
applied to humans can show considerable intra-
subject variability (Guyatt et al 1975, Hutchison et
al 1981, Pennock et al 1981) and similar variabi¬
lity is seen when comparable lung function mea¬
surements are applied to trained conscious sheep
(Begin et al 1981) and cattle (Gallivan and
McDonell 1988). Although this variability can
preclude the use of these measurements to monitor
individual animals over time, the use of groups of
animals can overcome this limitation (Gallivan
and McDonell 1988).
Whether for ethical or procedural reasons, cir¬
cumstances may dictate that lung function
measurements cannot be undertaken in naive con¬
scious animals and in these situations anaesthesia
is a frequently considered alternative. However,
Southorn et al (1980) demonstrated that anaes-
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■a can contribute to intrasubject variability of
tonary mechanics and static lung volume
mrements in dogs. This variable effect of
sthesia on pulmonary function measurements
-tdividuals will presumably occur in other
■ies and may limit their potential for monitor-
ranges in lung function in groups of animals
time.
te purposes of this study were, first, to gener-
egression equations relating pulmonary func-
variables to bodyweight for anaesthetised
Texel sheep such that normal values could in
■e be generated for sheep of similar breed, age
sex, managed under similar conditions, and,
-idly, to examine the long term reproducibility




<teen adult Texel ewes (bodyweight 52 to 87
were used. All the animals were free from
:ally apparent cardiopulmonary dysfunction,
tional examinations including routine haema-
y, thoracic radiography, faecal examination
ungworm larvae and serological testing for
-nee of maedi-visna virus infection, confirmed
■bsence of significant cardiopulmonary dys-
■ion. The sheep were housed during the period
e measurements.
sthesia
od was withheld for 12 hours before anaes-
a which was achieved by intravenous admin-
ion of a single bolus of thiopentone sodium at
■e rate of 20 mg kg-1 bodyweight. The sheep
weighed on the morning of the procedure,
wing induction the sheep were intubated
cuffed endotracheal tubes (diameter 9-5 to
mm) and placed in sternal recumbency with
ead supported on a cushioned rest. They were
lated with medical air (BOC) using a mechani-
entilator (Manley MN2, Hutchinson Blease)
ted to maintain a tidal volume of 10 ml kg-1
weight and respiratory rate of 10 breaths
l. To facilitate the measurement of respirato-
ows a heated pneumotachograph (Fleisch
>er 2, Linton Instrumentation) was connected
i end of the endotracheal tube and the pres-
drop across the pneumotachograph was mea-
4. Wan-en, I. Begara, L. Lujan
sured using a sensitive differential pressure trans¬
ducer (CS9, Mercury Electronics) with the signal
subsequently integrated to yield respiratory vol¬
umes. Changes in transpulmonary pressure (a Ptp)
were measured using a differential pressure trans¬
ducer (CS9, Mercury Electronics). One side of this
transducer was connected via a polyethylene
catheter (3 mm inner diameter, 4-5 mm outer
diameter) to a latex balloon (length 15 cm, diame¬
ter 1-5 cm) sealed over the distal end of the
catheter and placed in the caudal third of the tho¬
racic oesophagus. The balloon was then evacuated
and 2 ml of air was added. This volume was
shown to be within the range of high compliance
of this pressure recording system and was close to
the minimal relaxed volume of the balloon in air.
The other side of this transducer was connected to
a side port perpendicular to the airway opening.
Outputs from pressure and flow measuring
devices were recorded on a strip chart recorder
(Linseis L6514, Belmont Instruments). Before
measurements were made, the pressure recording
system was calibrated against a water manometer
and the integrated volume recording was cali¬
brated using a 3 litre syringe.
Lung function measurements
Quasistatic compliance (Cqst). Following cessa¬
tion of spontaneous respiratory efforts (within two
to three minutes of commencing mechanical venti¬
lation in every case) the sheep were disconnected
from the ventilator and allowed to exhale passive¬
ly to functional residual capacity (FRC). The lungs
were then actively inflated to a Ptp= 3 kPa using
the 3 litre calibrated syringe filled with room air
and immediately thereafter allowed to deflate pas¬
sively to FRC. This procedure was repeated twice
to stabilise lung volume history before measure¬
ments of quasistatic compliance were made. The
volume of the lungs at a Ptp = 3 kPa was defined
as total lung capacity (TLC). To measure Cqst, the
lungs were again inflated to TLC, however the pas¬
sive exhalation was interrupted in a stepwise fash¬
ion by occluding the airway opening eight to 15
times for two to three second intervals. By plotting
a Ptp against expired volume a quasistatic defla¬
tion curve was obtained. The slope of the linear
portion of the curve from FRC to 40 per cent of
TLC was determined by least squares linear regres¬
sion and this value taken as Cqst, expressed in
units of litres kPa-1. To achieve adequate data
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or the least squares regression, the mea-
it procedure outlined above was repeated
ith pooling of data points such that a single
procedure' value of Cqst for each sheep
lined.
? alveolar volume (VA eff) and transfer
'/• carbon monoxide (T^ Cq)
, using a single-breath helium dilution
le, and TL C0, using a forced single-breath-
:hnique, were measured concurrently as
he same procedure. Following a period of
cal ventilation the sheep were disconnect-
the ventilator and allowed to exale pas-
) frc. The 3 litre calibrated syringe was
d to inflate the lungs to a Ptp = 3 kPa with
i monoxide and helium in air gas mixture
cent helium, 0-3 per cent carbon mono-
7 per cent air; boc). A valve at the airway
was closed and this gas mixture was held
ngs for a period of 10 to 12 seconds. The
is then opened momentarily to allow wash
iad space before the remaining gas in the
as collected in an evacuated rebreathing
: concentration of helium in this expired
gas sample was measured using a
leter (Resparameter Mk 4, P. K. Morgan)
ff in litres, that is, the alveolar volume at
e breath was held minus the dead space of
ays and equipment was calculated as fol-
1-05 . (Vsyr- VD.an - VDxq). (Hej/HeE)
iyr = volume used to inflate lungs to a Ptp
VD^ = anatomical dead space, VD eq =
ntal dead space, He{ = helium concentra-
■e syringe and HeE = helium concentration
expired sample (Quanjer et al 1983).
ntal dead space was calculated from inter-
nsions and the anatomical dead space was
d using the equations of Stahl (1967)
late respiratory variables to bodyweight in
»f species.
-breath transfer factor for carbon mon-
co 'sb') was calculated as follows:
=53-6.VA. r1. log jo (CDEHeE.COE~'1.Hei~1)
= time of breathholding in seconds and
COE were alveolar concentrations, and
20j syringe concentrations of helium and
onoxide, respectively (Cotes 1983). Time
of breathholding was calculated according to the
recommendations of the Epidemiology Standard¬
isation Project (esp) (Ferris 1978). A blood sample
was taken during the period of anaesthesia and
haemoglobin concentration measured using an
automated analyser. TLC0^b- values were then
adjusted to a standard haemoglobin concentration
of 14-6 g dH according to the method of Cotes
(1979). TLC0>sb> is expressed in units of mmol
min_l kPa-1. Since the transfer factor is positively
correlated with the lung volume at which the mea¬
surement is made, it was also expressed per litre of
alveolar volume, that is, TJVA. The mean value of
three determinations of V^A.eff ^L.CO:sb' was
calculated and used in the statistical analyses. The
average duration of the completed series of mea¬
surements was approximately 20 minutes.
Experimental design and statistical analysis
Long term reproducibility of the lung function
data was examined by repeating measurements in
the same group of nine sheep at monthly intervals
over a period of five months. A two-way mixed
model analysis of variance (anova) without repli¬
cation was used to estimate the between day vari¬
ability of lung function variables for the group. In
this analysis, the individual sheep are considered
the random factor and the time dimension a fixed
treatment effect (Sokal and Rohlf 1981). A
Kolmogorov-Smimov test was used to test for
normal distribution of the pooled error terms in
each anova and a Bartlett's test was used to
check for homogeneity of variances between sam¬
ples in each anova (Sokal and Rohlf 1981). Data
from each anova satisfied both of the above pre¬
conditions. The coefficient of variation (cv) for
the repeated measurements of each variable in
individual sheep was also calculated.
The relationship of individual lung function
variables to bodyweight was examined for all 16
sheep. Lung function and bodyweight measure¬
ments were made at least three times on each
sheep with the interval between measurements
being between 30 and 77 days. The data from a
total of 70 procedures were used in the analysis.
Regression analyses based on linear, polynomial
and allometric regression equations were executed
to determine the relationship between bodyweight
(the independent variable) and the lung function
data (the dependent variable). Using the most sta¬
tistically significant regression equations, 95 per





1: Long term variability of Cqst (litres kPa-1) and VA eft (litre-1)
surements made in nine sheep at monthly intervals over a
id of five months. Error bars in the upper graph represent the
er cent confidence limits for the slope of the regression line
een pressure and volume measurements, that is, the compli-
. Error bars in the lower graph represent ± SD
t prediction intervals for individual lung func-
variables were calculated over the range of
yweights studied.
TABLE 1: Results of analysis of variance for repeated Cqs-
VAeff, Tl,CO;'sb' and TJVft measurements made in mm









tL.CO:sb" 2-60 NS 12-77
TJVA 2-15 NS 11-31
For all variables there was no significant differences between
days. Differences between sheep were highly significant. NS No-
significant, P>0-05; *" P<0-001
illustrated in Fig 1. Coefficients of variation for
repeated measurements of each variable in indi¬
vidual sheep are illustrated in Fig 2. The average
intrasubject CV for the repeated measurements was
18-8 ± 9-23 (mean ± standard deviation) for Cqst.
10-3 ± 4-45 for TLC0:sb<, 9-8 ± 4-02 for TJVA and
3-4 ±1-71 for VA_eff. TTie results of the analyses ot
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!: Individual coefficients of variation for repeated measure-
5 of £qst» ^A.eff' Tl,co:sb* and made in nine sheep at
lly intervals over a period of five months. The horizontal
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FIG 3: Relationship between of Cqst (litres kPa*1) and VAetti
(litre-1) and bodyweight (kg). Repeated measurements were(
made in 16 sheep. Solid lines depict the regression equations
that best represent the relationship between the dependent vari-'
ables and bodyweight. Dotted lines represent the 95 per cent pre¬
diction intervals for the dependent variables in individual subjects
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2: Selected regression equations relating Cqst (litres kPa-1), VAeff (litre-1), r^C0,'sb' (mmoi mi"'1 kPa-1) and 7L/VA
min-1 kPa-1 litre-1) to bodyweight (kg) 1
Unit Regression equation F r2 (%) P
(litres kPa-1) 0-460+0-0201 xBW 11-72 14-9 0-001
(litre-1) 3-09+0-0181 XBW 17-53 20-7 <0001
(mmol min-1 kPa-1) 3-27+0-110xBW 40-79 37-8 <0-001
(mmol min-1 kPa-1 litre-1) 1-52+0-0143xBW 10-47 13-5 <0-005
ice ratio, r2 Determination coefficient (expressed as a percentage), P Degree of significance of the variance ratio
icant differences between days for the
for any of the lung function variables
:gh between sheep differences were highly
icant.
ignificant relationship was found between all
measured variables and bodyweight. These
•nships are illustrated in Figs 3 and 4. The
significant regression equations were linear
variables and these equations, together with
iriance ratio (F), the determination coeffi-
(r2) and degree of significance of the vari-
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lelationship between T^co,'sb' (mmol min-1 kPa-1) and
imol min-1 kPa-1 litre-1) and bodyweight (kg). Repeated
ments were made in 16 sheep. Solid lines depict the
jn equations that best represent the relationship between
indent variables and bodyweight. Dotted lines represent
sr cent prediction intervals for the dependent variables in
I subjects
g- 50 58 66 74 82 90
©
Bodyweight (kg)
FIG 5: Relationship between log sVA eft (ml kg-1) and bodyweight.
Repeated measurements were made in 16 sheep. Solid lines
depict the regression equation that best represents the relation¬
ship between the dependent variable and bodyweight. Dotted
lines represent the 95 per cent prediction intervals for the depen¬
dent variable in individual subjects
The predictions of Stahl (1967) encompassed
the variables measured in this study and these
variables were shown to be positively correlated
with bodyweight. For mammals within the range
of weights studied in this paper (52 to 87 kg),
Stahl's (mean) predictions are 1-53 to 2-66 litre
kPa-1 for lung compliance, 6-67 to 11-99 mmol
min-1 kPa-1 for diffusing capacity, 1-876 to 1-976
mmol min-1 kPa-1 litre-1 for diffusing capacity/TLC
and 3-5 to 6-0 litres for total lung capacity.
Values of VA e{{ and Cqst for the heavier body-
weight sheep were lower than Stahl's predictions
and the converse was true for TJVA, that is, mea¬
sured values for the heavier sheep were greater
than predicted. The latter finding is presumably a
reflection of the reduction in VA eff. One explana¬
tion for these anomalies would be that rather than
reflecting an increase in skeletal dimensions,
greater weight in these sheep reflects an increase
in adipose and perhaps muscle tissue. That this is
indeed likely is shown by the reduction in specific
effective alveolar volume (sVA eff), that is, alveo¬
lar volume expressed per unit bodyweight, with
Discussion
\
D. D. S. Collie, N. J. Watt, P.
reasing bodyweight in these sheep (Fig 5). The
ios of various lung volumes to bodyweight are
itively constant and independent of size, that is,
y do not change appreciably between species
ahl 1967). The reduction in >yFAeff with
reasing bodyweight indicates that overfeeding
:ep can deleteriously alter the normally optimal
itionship between body size and lung functional
ices. This is a recognised concept in humans
hoenberg et al 1978) where increased muscu-
ty or obesity have opposite effects on ventilato-
function. The above hypothesis does not, how-
:r, explain the agreement between measured
I predicted TLC0<sb-. As is thought to be the
e in dogs (Robinson et al 1972), TL co -sb- in
ep may be related to metabolic bodyweight
ter than bodyweight per se.
)ne previous study of respiratory variables in
.esthetised sheep of bodyweight 42-6 ± 4-7 kg
;an ± SD) reported a value of dynamic lung
npliance of 1-08 ± 0-316 litre kPa-1 (mean ±
(Halmagyi and Coiebatch 1961). This low
ue may simply be a reflection of the method of
esthetic maintenance they used. In their study
mechanical ventilation was used during anaes-
5ia, and, therefore, progressive atelectasis of
>endent lung units and reduced lung compliance
> a likely consequence. In the present study,
>pentone was administered as a single bolus
e, and so the level of anaesthesia would have
ied during the procedure. As a consequence,
ic lung volumes and mechanical and gas
hange properties of the lung would also have
ied (Southorn et al 1980). This variation will
essarily be included in the measurements
ie, however, the adoption of a standardised
age regime and procedural protocol will have
?ed to minimise such between procedure varia-
Tie observed regression equations relating
yweight to lung function variables should
ve valuable in predicting normal values for
ep of similar breed, age, sex, weight and con-
nation to those used in the present study and
lied under identical conditions. The 95 per cent
fiction intervals were calculated using the esti-
:ed standard deviation of the dependent vari-
:s over the range of weights studied (Gardner
Altman 1989). These intervals serve to define
limits of normality for measurements of pul-
tary function variables made in sheep with
ilar characteristics to those studied. The use of
M. Warren, I. Begara, L. Lujan
the standard deviation as a measure of variabi
within a population is appropriate where the c
are homoscedastic, that is, the variation is in
pendent of the magnitude of the value measui
There are, however, inadequate data points c.
lected in this study to determine accurat
whether the data are homo- or heteroscedastic. 1
A knowledge of the intrasubject variation ove
period of time is essential if time sequenr
changes in pulmonary function values for in
viduals are to be accurately interpreted. In hurr
respiratory research, data are often treated
heteroscedastic and reproducibility is expressed.
terms of the cv. By expressing the long term vat
ability for repeated measurements in terms of t
CV, knowledge of what would constitute a signi
cant change in an individual's lung function c
be gained. Given the calculated average CVs 1 '
repeated measurements in normal anaesthetis
sheep (Fig 2), it can be predicted (Pennock et
1981) that significant (P<0-05) month-to-mon'
changes are approximately 30-8 per cent in t
CqSt, 16-9 per cent in the sb'> ^-1 per ce
in the TJVA and 5-6 per cent in the VA<eff me
surements. Previous reports have demonstrati
similar intrasubject variability of lung functic
measurements in humans (Guyatt et al 197;
Hutchison et al 1981), ponies (Derksen et al 198 •
and cattle (Gallivan and McDonell 1988) ar
illustrate the problems of interpreting lung fun
tion in individuals over time.
For all of the measured variables, the variatic
between repeated measurements on the separa
days for the group was insignificant, whereas tl
variation between individual sheep was highly sis
nificant. Collective lung functional measurement
on groups (n=9) of normal anaesthetised sheep d
not therefore change significantly over time
Gallivan and McDonell (1988) in repeated anah
ses on four conscious adult cows found significar
differences between days for the group for respire
tory frequency and inspiratory and expirator
times and concluded that a control group shoul
be used during any long-term study on sma!
groups of animals.
Knowledge of both the predicted normal range
for the variables C t, VAef{, Tl co:sb' and TJVA
and awareness of the long term reproducibility o
measurements of these variables in anaesthetisei
adult Texel sheep will allow more accurate inter
pretation, on a research basis, of respiratory dis
ease in similar animals.
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Exponential analysis of the pressure-volume
characteristics of ovine lungs
D. David S. Collie*"1, Neil J. Watta, Pat M. Warrenb, Isabel Begara'1 and
Luis Lujana-1
' Royal' Dick) School of Veterinary Studies. Veterinary Field Station. Easter Bush. Rosiin. Midlothian EH25
9R G. i'K: "Unit of Respiratory Medicine. Department of Medicine RIEi. Rayne Laboratory. City Hospital.
Edinburgh. C'K
(Accepted 4 October 1993)
Abstract. Static pressure-volume curves were generated from data obtained from 18 normal anaesthetized
adult sheep. Lung volumes were determined by heiium dilution. An exponential curve of the form V =
Vmax - Ae " KP was ritted to the pressure-volume data from each sheep where P is the static recoil pressure.
Vmax represents the volume asymptote. A is the difference between Vmax and the intercept on the volume
axis and K. defines the slope and hence the shape of the P-V curve. Quality of fit of the data was assessed
visually, by means of a sign test and a runs test and by the coefficient of determination (r). Exponential
equations were found to adequately describe the shape of the pressure-volume curve in sheep. The expo¬
nent K was not correlated with effective alveolar volume (VA.^) (rs = 0.183: P>0.05'l. Static lung compli¬
ance was determined over a volume range from the end-expiratory level (VEEL) to VEEL plus 400 mi.
Measurements of static lung compliance were significantly correlated with measurements of effective alveolar
volume (VA.,,.) (rs =0.505: P< 0.025). In the ovine, the exponent K, an index of distensibiiitv, is indepen¬
dent of lung volume and offers a means of assessing lung distensibility in this species.
Distensibility, lung; Mammals, sheep: Mechanics of breathing, static pressure-volume: Pressure, static, lung
volume: Volume, lung, static pressure
Static lung compliance (Cst), analysed as the lung volume change per unit pressure
change (dV/dP) in the tidal volume range, is often assumed to be an index of lung elastic
recoil, and is frequently used as such. Unfortunately, when comparing animals of
different body size or comparing animals with varying stages of lung disease, the above
assumption is subject to qualifications which limit the value of this measurement.
Firstly, variation in the end-expiratory level will alter the portion of the curve over
which the compliance measurement is made i.e. the measurement of compliance will
depend on the end-expiratory lung volume, and secondly, compliance values intuitively
depend on the inflatable volume of the lungs themselves. Thus, accurate interpretation
Correspondence to: "Corresponding author.
'Present address: Dpto. Patologia Animal, Facuitad de Veterinaria. Miguel Servet 177, 50013 Zaragoza.
Spain.
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of compliance values demands both a knowledge of the lung volumes over which the
measurement is made and a perception of the predicted normal value for the animal
concerned. These latter requirements place an extra burden on measurement protocol
and rely heavily on the accuracy of prediction equations based on anthropometric data.
An alternative means of analysing pressure-volume curves was pioneered by Salazar
and Knowles (1964) who used an exponential equation to describe the-pressure vol¬
ume curve of human adults. Glaister etal. (1973) employed the same principle to de¬
scribe the pressure volume curves of excised dog and monkey lungs. The basis behind
this method of analysis, which utilizes all the pressure and volume data points collected,
has been developed and applied to the analysis of pressure-volume curves from both
healthy adults (Pengelly, 1977; Colebatch et al., 1979a,b; Gibson et al., 1979; Knudson
and Kaltenborn, 1981; Colebatch and Ng, 1986) and those with respirator}' disease
(Gibson et al., 1979; Colebatch etal., 1985; Thompson and Colebatch, 1989). The
exponent K of the fitted exponential equation is not influenced by absolute values of
pressure or volume and only delineates the relative changes of one with respect to the
other. In other words, K is an index of pulmonary distensibility and appears not to
suffer from the aforementioned limitations of compliance measurements.
Due to structural and functional similarities between the lungs of sheep and those
of humans, this species has frequently been used to model human lung disease. Al¬
though pulmonary mechanics measurements are frequently included in such studies,
there has. to the authors knowledge, been only one attempt to fit an exponential
equation to the normal ovine pressure-volume curve (Schroter. 1980). In view of the
relative advantages of expressing pulmonary distensibility in this way we sought to
determine whether the ovine pressure-volume curve could be adequately described by
an exponential equation and to report normal values of K for this species such that
in future the distensibility of the ovine lung could be accurate!}" assessed in disease and
in relation to other species.
Materials and methods
Animals. 18 adult Texel and Texel-cross female sheep (median bodvweight 63.5:
range 54-82 kg) were used in this study. The sheep were fed on a diet of proprietary
concentrate and hay and were assessed to be free of significant cardiopulmonary
dysfunction on the basis of a thorough clinical examination.
Anaesthesia. Sheep were starved for 12 h prior to anaesthesia which was achieved
using intravenous administration of thiopentone sodium at a dose rate of 20 mg-kg"1
bodyweight. The sheep were then intubated using cuffed endotracheal tubes (diameter
9.5-10.5 mm) and placed in sternal recumbency with the head supported on a cush¬
ioned rest. A mechanical ventilator (Manley MN2; Hutchinson Blease) was adjusted
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Measurements. Transpuimonary pressure was measured using a differential pressure
transducer (CS9; Mercury Electronics) which was connected to an oesophageal bal¬
loon catheter assembly and to a port at the proximal end of the endotracheal tube. The
catheter (3 mm ID. 4.5 mm OD) had a number of holes cut in a spiral manner in the
end covered by a latex balloon (length, 15 cm: diameter, 1.5 cm; thickness, 0.05 mm)
and this assembly was passed into the middle thoracic portion of the oesophagus. Prior
to each series of measurements, the pressure-volume characteristics of the balloon-
catheter assembly were validated according to the method of Senterre and Geubeile
(1970). The bailoon was then evacuated and 2 ml of air was added (this volume being
within the range of high compliance of this pressure recording system and close to the
minimal relaxed volume of the balloon in air). The positioning of the balloon catheter
assembly was confirmed by observing cardiogenic oscillations in the transpuimonary
pressure recorder trace and by the absence of any deflection of this trace during
inspiratory efforts against a closed airway (Milic-Emili et al.. 1964). Respiratory flows
were measured using a Fleisch pneumotachograph (No 2) connected to a second
differential pressure transducer (CS9; Mercury Electronics). Integration of the derived
signal yielded respiratory volumes which were displayed on the chart recorder (Linseis
L6514; Belmont Instruments). Pressure and volume recording equipment were cali¬
brated using a water manometer and calibrated syringe respectively.
Lung volumes were measured using a single-breath helium dilution technique per¬
formed in conjunction with the measurement of single-breath transfer factor as previ¬
ously described (Collie et al., 1993). Lungs were inflated from the resting end expira¬
tory level to a transpuimonary pressure of 3 kPa (defined as total lung capacity (TLC))
with a carbon monoxide and helium in air gas mixture (heiium 14%, carbon monox¬
ide 3%, balance air). After a 10-sec breathhold. a sample of alveolar gas was obtained
and the concentration of helium determined (Resparameter Mk 4; P.K. Morgan).
Effective alveolar lung volume (VAeff) was calculated as previously described (Collie
etal., 1993).
Pressure-volume data were obtained after three forced inflations to TLC. The lungs
were again inflated to TLC, however a stepwise deflation was achieved by intermittently
interrupting the airway opening for 2-3 sec intervals.
Three collections of lung volume and pressure-volume data were made on each
animal during the period of anaesthesia. To obtain absolute values for pressure-volume
curves the expired volumes were subtracted from the VAeff values determined imme¬
diately prior to collection of pressure-volume data. Static lung compliance (Cst) was
calculated as the slope of the pressure-volume curve between the end-expiratory level
and this level plus 400 ml.
Exponential analysis of pressure-volume curves. An exponential curve of the form
V = Vmax - Ae ~ Kp was fitted to the data from each sheep where P is the static recoil
pressure, Vmax represents the volume asymptote, A is the difference between Vmax and
the intercept on the voiume axis and K represents the slope of the P-V curve and
therefore defines its shape. The method of Pengelly (1977) was used to determine the
242
exponential function that best fitted the data. Briefly, by expressing the difference be¬
tween Vmax and the measured volume as a fraction of Vmax and taking the natural
logarithm of this value a straight fine plot with P is obtained. Least squares regression
is then used to solve for slope and intercept. However, since Vmax is unknown at the
outset an iterative regression is conducted until values of the coefficient of determina¬
tion (r2) are maximized. Curves were fitted both over the whole data range and over
a restricted data range in which the data points less than 50% of TLC were excluded
from the analysis. In addition to assessing r2, curves were evaluated visually for good¬
ness of fit and both a sign test for distribution of the data about the fitted regression
fine and a runs test to determine whether the order of the data was random (P< 0.05)
were performed (Gibson et al., 1979). Associations between variables were assessed
using the Spearman rank correlation coefficient (rs)
5000
Results
The summary results of curve-fitting analysis over the whole data range for 18 sheep
are shown in Table 1. The pressure-volume data from two sheep with exponential
curves fitted are presented in Fig. 1. These examples represent the opposite ends of the
spectrum in terms of goodness of fit as assessed by r2. In general the regression lines
appeared to closely fit the pressure-volume data on visual inspection. Although only
one pressure-volume curve failed the sign test (P<0.05), all but two failed the runs test
(P<0.05) indicating that there were systematic deviations from the fitted regression
lines in almost all the sheep i.e. the order of these deviations was not random. The
nature of these deviations is demonstrated in a plot of the residuals against pressure
(Fig. 2) (with pressures expressed as percentages of the range between the minimum
(0%) and maximum (100%) pressure recorded for each set of data points). Tne
most obvious systematic deviations from the fitted regression lines occurred when
transpulmonary pressure was maximal with measured volumes being greater than the
TABLEl
Summary results from exponential pressure-volume curve fitting analysis of the form V = \'nlax - Ac ~ KP in
18 normal sheep. Vmas is the volume asymptote. A is the difference between Vm:lx and the intercept or. the
volume axis. A defines the slope and hence the shape of the fitted pressure-volume cure anc r is the
coeffcicnt of determination of the regression. Cst is the static lung complicance.
Measurement Median Range
Data points animal 41 26-48
A" (kPa" ') 1.456 1.091-2.119
A 2542 1590-3252
v„u, <ml 1 4168 3277-4896
r 98.74 96.11-99.74
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Fig. 1. Pressure-volume curves from two normal sheep. The two curves are representative of the extremes
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Fig. 2. Plot of residuals for all fitted curves for 18 sheep. Pressures are expressed as percentages of the range
between the minimum (0%) and maximum (100%) pressure recorded for each set of data points. The fit¬





Fig. 3. Relationship between transpulmonary pressure and lung volume (expressed as percentage of pre¬
dicted Vmax) in normal sheep. The .shaded area represents the 950o confidence interval.
regression would seem to predict. Curves fitted data well at lower volume limits. Curve
fitting over the restricted data range improved the quality of fit (as assessed by r~) in
only one instance. In the remaining sheep, fitting a curve to the restricted data range
led to a slight reduction in r~ (median 98.34:range 95.42-99.39) and K (median
1.348:rangc 0.820-2.098). and an increase in Vmax (median 4202:range 3468-4896).
The iterative regression was repeated on the pooled data from all sheep with
volume expressed as percent of Vmax. The exponential equation V/Vmax
("„)= 100 - 56.7-e~1",7'p was found to best fit this pooled data. The relationship be¬
tween transpulmonary pressure and lung volume expressed as percent predicted Vmax
is depicted in Fig. 3 with the shaded area representing the 95 °0 confidence interval for
normal sheep.
A significant positive correlation was apparent between Cst and VAcff (;'s = 0.505:
P< 0.025) whereas no significant relationship existed between K and VAcff (rs = 0.183:
P> 0.05).
Discussion
The best-fit exponential curve was chosen by maximizing the coefficient of determina¬
tion obtained by least-squares regression analysis of the linearised data. Visually, ex¬
ponential curves appeared to closeiy fit the pressure-volume data and this was reflected
in the regression analyses, where 96.1 1-99.74°,, of the variation in the dependent
variable was explained by the fitted curve. Indeed, in only 4 eases did the unexplained
variation exceed 2°; of the total variation.
Systematic deviations from the exponential functions were frequently noted at high
transpuimonarv pressures and much of the error variance was attributable to this
portion of the curve. The implications of these observations are that (a) in sheep, lung
volumes measured at a transpuimonarv' pressure of 3 kPa are not maximal, and (b) an
exponential curve is not the most accurate description of the relationship between
transpulmonary pressure and lung volume in this species. Examination of a previously
published pressure-volume curve obtained from an anaesthetized sheep (Colebatch and
Halmagvi. 1961) suggests that the first assumption might be valid. With regard to the
second assumption, it is quite likely that a more complex mathematical formulation
could be derived to better fit the pressure-volume data from sheep, just as in humans
a hvperbolic-sigmoid model appears to offer a better fit to the full range of pressure-
volume data than the exponential model (Murphy and Engel. 1978). However, the
relative simplicity and lack of constants in the exponential equation together with the
predictable effect of a change in any constant on the shape and position of the curve
weigh heavily in its favour and. in our opinion, compensate for the poor description
of the curve at high transpulmonary pressure. Certainly, it would appear that the ex¬
ponential constant K holds several advantages over Cst measurements in describing
pressure-volume curves. Firstly, the full range of data is used in the exponential analy¬
sis, whereas only data points in the linear portion of the pressure-volume curve are used
in the calculation of Cst. Secondly, whereas Cst is positively correlated with VAeff, K
is independent of this variable and thus is a more useful index of distensibility for use
in comparative studies or when studying the effects of lung disease on pulmonary
mechanics.
Data points at low volume levels tend not to conform to the exponential model in
humans (Colebatch el al., 1979a; Gibson et al., 1979). Below about 46% TLC in seated
healthy men (Sutherland et al.. 1968) there is an inflection in the curve caused primarily
by the sequential closure of small airways and oesophageal artefacts. Inclusion of data
points below this point of airway closure in the exponential curve fitting analysis leads
to underestimation of K and overestimation of Vmax (Gibson et al., 1979). Inflection
points were not well defined in our ovine pressure-volume curves and curves appeared
to underestimate Vmax rather than the converse. In addition, exclusion of data points
below 50% TLC did not improve the quality of curve fit. We therefore conclude that
the factors responsible for curve inflection have less influence in the low volume range
in anaesthetized sheep relative to humans and the whole data range from VEEL to TLC
can be used for exponential curve fitting.
The results of the pooled regression indicate that the ratio of A/Vmax% is approxi¬
mately 57%. This ratio describes the position of the curve relative to the transpulmo¬
nary pressure axis and is considerably lower than the equivalent ratio previously de¬
scribed for humans (Colebatch et al., 1979a; Gibson et al. 1979; Knudson and
Kaltenborn. 1981) indicating that relative to these studies, the sheep pressure-volume
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curves are displaced to the left. Knudson and Kaltenborn (1981) reason that differences
in oesophageal balloon volume can account for much of the variation in this ratio seen
in human studies and comment that, compared to measurements of K which are
seemingly less variable between studies, the value of this ratio to compare various
studies is limited.
K does not seem to be volume dependent in humans (Colebatch et al., 1979a) al¬
though a progressive increase in this parameter occurs with age (Colebatch et al.,
1979b) such that between 20 and 80 years of age the value of K would be expected
to increase from approximately 1.224—1.748 kPa. The age related increase in K is
believed to be due to increased unstressed alveolar dimensions and reduced total
surface acting forces (Colebatch and Ng, 1986). This relationship between airspace size
and K has been demonstrated in excised human lungs (Greaves and Colebatch, 1980)
and for lungs of severalmammalian species (Haber et al., 1983). Thus, species with very
small alveoli would be expected to have relatively large surface acting forces and low
values of K. In this regard it is interesting that the values of K we have obtained for
adult sheep (median 1.456 kPa; range 1.091-2.119) are similar to those reported for
humans: this despite sheep having smaller alveolar dimensions and correspondingly
greater alveolar surface density jrelative to humans (Gehr et al.. 1978; Warner et al.,
1986). Whether this represents an intrinsic difference between species with regard to
the type and extent of tissue related forces or a difference due to methodological in¬
consistencies between studies remains to be ascertained.
In conclusion, our studies indicate that an exponential equation adequately describes
the whole pressure-volume curve of normal anaesthetized sheep. The index of aisten-
sibility K. is independent of lung volume and offers a means of comparing lung dis-
tensibilitv both with other species and during lung disease in this species.
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